Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,transmitter-gated ion channel activity (GO:0022824),-0.7688188479975044,-2.2200019519978453,0.0,0.0,0.0,21/29,17.12%,GRID2;GRIK2;GRIA4;GABRG3;GRIK1;GABRB3;GRIA2;GABRB1;GABRA3;GABRA2;GRIK4;GABRB2;GLRA3;GABRG2;GRID1;GABRA4;GABRG1;GLRA2;GRIK3;GABRA5;GABRE
prerank,glutamate receptor activity (GO:0008066),-0.8385586729354664,-2.1810599079783177,0.0,0.0,0.0,13/19,9.50%,GRID2;GRIK2;GRIA4;GRM7;GRM5;GRM3;GRIK1;GRIA1;GRIA2;GRM8;GRIK4;GRM1;GRID1
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.8297122552502134,-2.1411688359499634,0.0,0.0,0.0,11/17,7.11%,GRIK2;GRIA4;GRIK1;GRIN2B;GRIA1;GRIA2;PTK2B;GRIA3;GRIK4;GRIN3A;GRIN2A
prerank,ligand-gated ion channel activity (GO:0015276),-0.7284227359231633,-2.139199225341564,0.0,0.0,0.0,13/30,9.50%,GRID2;GRIK2;GRIA4;GRIK1;GRIN2B;GRIA1;GRIA2;GABRB1;GRIA3;GRIK4;GRIN3A;GRIN2A;GRID1
prerank,cell adhesion mediator activity (GO:0098631),-0.7623474548011424,-2.126179362819712,0.0,0.0,0.0,12/24,9.64%,LRRC4C;BSG;CNTN4;ESAM;NPTN;NTNG1;DSCAML1;CNTN6;BCAM;ROBO4;EMB;CD47
prerank,ligand-gated channel activity (GO:0022834),-0.7317667038216558,-2.1231558500890055,0.0,0.0,0.0,13/29,9.50%,GRID2;GRIK2;GRIA4;GRIK1;GRIN2B;GRIA1;GRIA2;GABRB1;GRIA3;GRIK4;GRIN3A;GRIN2A;GRID1
prerank,retinoid binding (GO:0005501),0.8831969104064585,2.1187238793878556,0.0,0.001007318376330224,0.001,9/22,7.54%,PTGDS;ALDH1A2;ABCA4;RBP1;CRABP2;NR2F2;CYP26B1;CRABP1;RBP4
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.8335787842605021,-2.1022534270307727,0.0,0.0001236810301569689,0.001,11/16,8.75%,PTPRB;PTPRM;PTPRD;PTPRG;PTPRK;PTPRT;PTPRN2;PTPRC;PTPRF;PTPRZ1;PTPRE
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.8335787842605021,-2.1022534270307727,0.0,0.0001236810301569689,0.001,11/16,8.75%,PTPRB;PTPRM;PTPRD;PTPRG;PTPRK;PTPRT;PTPRN2;PTPRC;PTPRF;PTPRZ1;PTPRE
prerank,anion channel activity (GO:0005253),-0.6063782154201427,-2.052518269612048,0.0,0.0005496934673643063,0.005,34/61,22.02%,SLC26A7;CLIC4;ANO4;GABRG3;GABRB3;ANO1;LRRC8C;GABRB1;GABRA3;LRRC8D;GLRB;GABRA2;ANO3;GABRB2;GLRA3;LRRC8B;SLC1A4;GLRA1;VDAC1;GABRG2;GABRA4;GABRG1;GLRA2;ANO5;ANO2;CLCN3;GABRA5;GABRE;GPR89A;GPR89B;CFTR;GABRA1;BEST1;VDAC3
prerank,ligand-gated anion channel activity (GO:0099095),-0.7887102850684415,-2.0054075219241896,0.0,0.001879951658385927,0.017,17/17,21.22%,GABRG3;GABRB3;GABRB1;GABRA3;GLRB;GABRA2;GABRB2;GLRA3;GLRA1;GABRG2;GABRA4;GABRG1;GLRA2;GABRA5;GABRE;CFTR;GABRA1
prerank,chloride channel activity (GO:0005254),-0.5845335081295933,-2.0037341937182602,0.0,0.0017090469621690247,0.017,31/59,21.28%,SLC26A7;CLIC4;ANO4;GABRG3;GABRB3;ANO1;GABRB1;GABRA3;GLRB;GABRA2;ANO3;GABRB2;GLRA3;SLC1A4;GLRA1;GABRG2;GABRA4;GABRG1;TTYH2;GLRA2;CLCN1;TTYH1;ANO5;ANO2;CLCN3;GABRA5;GABRE;CLCN6;CFTR;GABRA1;BEST1
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.7505519613558168,-1.94931778474301,0.0,0.004122701005232297,0.045,14/19,17.12%,GRID2;GRIK2;GABRG3;GRIK1;GABRA3;GABRA2;GRIK4;GABRG2;GRID1;GABRA4;GABRG1;GRIK3;GABRA5;GABRE
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.6090702971711093,-1.9406958202413453,0.0,0.004033904368196524,0.046,15/42,9.64%,STXBP6;LRRC4C;BSG;CD200;CNTN4;ESAM;NPTN;NTNG1;DSCAML1;ANXA1;CNTN6;ROBO4;EMB;PDLIM1;CD47
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.670383138892158,-1.9392636894842523,0.0,0.003957792965023005,0.048,15/28,17.12%,GRID2;GRIK2;GABRG3;GRIK1;GABRA3;GABRA2;GRIK4;GABRG2;GRID1;GABRA4;GABRG1;GRIK3;CHRNA7;GABRA5;GABRE
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.822978432078242,1.8771250413999088,0.0018315018315018315,0.16671119128265205,0.248,7/15,8.15%,ALDH1A2;ALDH7A1;ALDH1A1;ALDH4A1;ALDH3B1;ALDH2;ALDH1L1
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.7932141448600677,-1.8757665853300947,0.0,0.009630629548222644,0.126,12/13,17.12%,GABRG3;GABRA3;GLRB;GABRA2;GLRA3;GLRA1;GABRG2;GABRA4;GABRG1;GLRA2;GABRA5;GABRE
prerank,GABA receptor activity (GO:0016917),-0.7082959057876349,-1.8714491301849645,0.0,0.009585279837165091,0.134,13/21,17.12%,GABRG3;GABRB3;GABRB1;GABRA3;GABRA2;GABRB2;GABRG2;GPR156;GABBR2;GABRA4;GABRG1;GABRA5;GABRE
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.7940862288050495,-1.8586104629931128,0.0,0.011174944842417897,0.165,11/12,17.12%,GABRG3;GABRB3;GABRB1;GABRA3;GABRA2;GABRB2;GABRG2;GABRA4;GABRG1;GABRA5;GABRE
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.8822380676122342,1.8455227356389337,0.0038314176245210726,0.17124412397613809,0.354,4/10,5.12%,SLC6A13;SLC6A1;SLC6A12;SLC10A4
prerank,GABA-A receptor activity (GO:0004890),-0.720746277996909,-1.828316568932961,0.0,0.01660074271440205,0.249,11/18,17.12%,GABRG3;GABRB3;GABRB1;GABRA3;GABRA2;GABRB2;GABRG2;GABRA4;GABRG1;GABRA5;GABRE
prerank,cAMP binding (GO:0030552),-0.7901038658972022,-1.8246520801588995,0.004415011037527594,0.01666439143167581,0.262,5/11,2.10%,PDE4D;PDE4B;PDE10A;RAPGEF4;HCN1
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.6070621460902252,-1.8183938667053228,0.0,0.017463761458164008,0.282,12/31,16.01%,SLC12A7;HCN1;ABCC9;KCNK5;SLC12A2;KCNK9;SLC12A8;SLC12A4;KCNK1;SLC12A6;TMEM38A;SLC12A5
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.6237604537020598,1.8161840235292477,0.0030534351145038168,0.19995269770154944,0.495,12/55,5.94%,SLC16A6;SLC13A3;SLC6A13;SLC6A12;SLC16A12;SLC16A11;SLC38A4;SLC38A3;SLC7A2;PDPN;SLC16A13;SLC19A1
prerank,AMP binding (GO:0016208),0.8426069300062106,1.8102254503885291,0.0019120458891013384,0.17527339748145895,0.519,3/11,2.80%,PRKAG2;MPPED2;PRKAG3
prerank,glutamate receptor binding (GO:0035254),-0.7081616509497761,-1.7783724987874132,0.002173913043478261,0.033264307539360015,0.479,10/17,13.90%,HIP1;SHANK3;GNAS;IGSF11;SYNDIG1;SHISA6;NSF;SHANK2;HOMER1;SHANK1
prerank,store-operated calcium channel activity (GO:0015279),-0.7931770080812072,-1.7777971214280004,0.0019230769230769232,0.03206711800069775,0.481,7/10,15.04%,STIM2;TRPC3;TRPC4;TRPC1;TRPC6;TRPC5;TRPC7
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.8039400542199839,1.7777601607283453,0.01125703564727955,0.2298364761993461,0.663,6/13,8.15%,ALDH1A2;ALDH7A1;ALDH1A1;ALDH4A1;ALDH2;ALDH1L1
prerank,frizzled binding (GO:0005109),0.6490894236442386,1.7653170110832355,0.011308562197092083,0.22736614780025055,0.713,4/34,1.96%,WNT5B;RNF43;WNT4;WNT6
prerank,semaphorin receptor binding (GO:0030215),-0.6369386749433731,-1.7539962982472201,0.004694835680751174,0.04018020249273355,0.583,11/23,14.99%,SEMA3C;SEMA6A;SEMA6D;RIT2;SEMA5A;SEMA7A;SEMA3E;SEMA4D;SEMA3D;SEMA3G;SEMA4C
prerank,cadherin binding (GO:0045296),-0.40433792784839123,-1.73986550817632,0.0,0.04543216507765991,0.638,110/315,17.57%,STXBP6;CDH11;COBLL1;CTNND2;DOCK9;SPTBN1;CTNNA2;PTPRB;PTPRM;FMNL2;PTPRJ;AHNAK;MRTFB;CDH8;CDH2;CDH13;ITGA6;BSG;ANK3;MYO1B;BMPR2;CTNNA3;FNBP1L;ESYT2;RTN4;NOTCH3;LRRFIP1;PTPRT;IQGAP1;PROM1;FXYD5;CLINT1;CDH10;CDH12;F11R;EHD4;MYH9;YWHAE;EPN2;HSP90AB1;SHTN1;KDR;TRPC4;ANXA1;OLA1;DAB2IP;YWHAB;LIMA1;CDH6;FLNA;SH3GLB1;HSPA8;PSEN1;ITGB1;CDH20;CDH19;CDH7;CD2AP;TAGLN2;RPL14;BZW1;BZW2;HSPA5;RPL34;RDX;ANLN;PDLIM1;ABI1;RPL7A;RPS2;EFHD2;RPL23A;PCBP1;CALD1;MB21D2;RPL29;ERC1;MARK2;HNRNPK;CDH1;PAICS;AHSA1;CTNNB1;RANBP1;TNKS1BP1;RPL6;TES;ARGLU1;GAPVD1;ACVR1;GCN1;TMPO;CDK5R1;NCK1;RPS26;ALDOA;CCT8;CDH9;CBL;PKM;SEPTIN9;USP8;CAPZA1;APC;WASF2;PRDX1;SCRIB;PPP1CA;EMD;SCYL1
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.7751479681257241,-1.7345403750741273,0.003795066413662239,0.046306177690769154,0.659,9/10,21.22%,GABRG3;GABRA3;GABRA2;GABRG2;GABRA4;GABRG1;GABRA5;GABRE;GABRA1
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.6950814923020836,1.7317659097475608,0.008880994671403197,0.3113872930830805,0.855,6/26,1.42%,SLC16A6;SLC6A13;SLC6A1;SLC6A12;SLC16A12;SLC16A11
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.740516702649898,-1.726062698723889,0.004219409282700422,0.049396300659614034,0.69,9/12,15.67%,PDE4D;PDE4B;PDE3A;PDE8A;PDE3B;PDE7B;PDE2A;PDE8B;PDE4C
prerank,amyloid-beta binding (GO:0001540),-0.4767891309733144,-1.71193628520252,0.0,0.05537245527916445,0.742,21/79,7.96%,NLGN1;APBB2;GRIA4;COL25A1;GRIN2B;CST3;GRIA1;GRIA2;TGFB2;GRIA3;APBA2;FZD4;APOE;GSAP;ITM2A;LDLR;GRIN2A;CACNA1B;HSPG2;SORL1;EPHB2
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.840141686489609,1.7072318777163662,0.009881422924901186,0.37539398157906345,0.922,1/11,0.03%,PPP1R1A
prerank,CoA-ligase activity (GO:0016405),0.7566861867120832,1.6999665604317515,0.017241379310344827,0.3681748665486968,0.939,3/14,4.33%,ACSL1;ACSS3;ACSBG2
prerank,pentosyltransferase activity (GO:0016763),0.6309023276336753,1.6938169493053197,0.010033444816053512,0.3571401516079885,0.95,19/36,14.45%,LACC1;LARGE1;ART5;PARP10;PARP14;TIPARP;SIRT5;PARP4;TNKS2;SIRT3;PARP9;SIRT1;ZC3HAV1;PARP11;PARP6;LARGE2;SIRT4;ART4;QPRT
prerank,chemorepellent activity (GO:0045499),-0.5950887664244301,-1.690432852727961,0.00234192037470726,0.06901401482758865,0.823,11/25,12.47%,NRG3;SEMA3C;SEMA6A;SEMA6D;SEMA5A;SEMA7A;SEMA3E;EPHA7;SEMA4D;SEMA3D;SEMA3G
prerank,voltage-gated sodium channel activity (GO:0005248),-0.6026978406878661,-1.6827816936598416,0.009478672985781991,0.07141086789476851,0.843,10/22,16.28%,HCN1;SCN1A;SCN2A;CACNA1G;SCN7A;SCN3A;SCN9A;SCN8A;CACNA1H;SCN2B
prerank,histone acetyltransferase binding (GO:0035035),0.6827139492697196,1.6700464629966085,0.018018018018018018,0.4244168092271344,0.98,6/21,7.92%,EPAS1;KANSL1L;GLI3;TP53;BCAS3;MEF2A
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.6531683976782474,1.662304159849833,0.01950354609929078,0.41795964014809445,0.983,15/25,13.20%,ART5;PARP10;PARP14;TIPARP;SIRT5;PARP4;TNKS2;SIRT3;PARP9;SIRT1;ZC3HAV1;PARP11;PARP6;SIRT4;ART4
prerank,diacylglycerol kinase activity (GO:0004143),-0.7274890461881545,-1.6619094708027156,0.01609657947686117,0.0864447946777108,0.902,6/11,13.00%,DGKH;DGKB;DGKI;DGKK;DGKG;DGKZ
prerank,histone demethylase activity (GO:0032452),0.6683605065409193,1.6611696169993133,0.015706806282722512,0.39213465364283717,0.983,14/27,21.00%,KDM7A;JARID2;FBXL19;KDM2B;KDM2A;JMJD6;HR;RIOX2;KDM3B;PHF2;KDM6B;KDM1A;KDM6A;RIOX1
prerank,lysine-acetylated histone binding (GO:0070577),0.6779628368734968,1.660026403324707,0.024054982817869417,0.347398925036886,0.984,7/20,12.51%,ZMYND8;KMT2A;PHIP;ATAD2B;SMARCA4;BRD7;BRD9
prerank,acetylation-dependent protein binding (GO:0140033),0.6779628368734968,1.660026403324707,0.024054982817869417,0.347398925036886,0.984,7/20,12.51%,ZMYND8;KMT2A;PHIP;ATAD2B;SMARCA4;BRD7;BRD9
prerank,BMP binding (GO:0036122),-0.7084059990166819,-1.6568895593062953,0.016666666666666666,0.08774171661974388,0.908,3/11,1.86%,GREM2;BMPR2;ENG
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.7344311597889998,1.6546252801998738,0.016728624535315983,0.3437325824171547,0.989,9/15,19.69%,KMT2A;CXXC1;ASH2L;KMT2C;WDR82;KMT2D;SETD1B;SETD3;SETD1A
prerank,sodium channel activity (GO:0005272),-0.5211862325011225,-1.6492178003500488,0.012987012987012988,0.0924824902998735,0.924,14/37,15.43%,GRIK2;HCN1;GRIK1;SCN1A;SCN2A;GRIK4;CACNA1G;SCN7A;SCN3A;SCN9A;KCNK1;SCN8A;CACNA1H;GRIK3
prerank,amino acid:sodium symporter activity (GO:0005283),0.7725910338374113,1.6375697259858344,0.026748971193415638,0.382445210213375,0.993,5/11,8.27%,SLC6A13;SLC6A1;SLC6A12;SLC38A1;SLC1A3
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.6440683571031498,-1.6243788914364654,0.019693654266958426,0.11459609630543882,0.954,10/17,14.29%,ATP10A;ATP8B1;PITPNC1;PLTP;ABCG1;PITPNB;MTTP;PITPNA;ATP8B2;ABCB4
prerank,fatty acid synthase activity (GO:0004312),-0.72089849339586,-1.6087215557648038,0.03821656050955414,0.13008334230627083,0.976,3/10,10.29%,ELOVL7;ELOVL5;ELOVL6
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.7272373008162643,-1.608610728257454,0.01417004048582996,0.12650802513198534,0.977,7/10,13.90%,SHANK3;GNAS;IGSF11;SHISA6;NSF;SHANK2;SHANK1
prerank,sulfotransferase activity (GO:0008146),0.6159936209635032,1.5917961518953563,0.020967741935483872,0.5507910848260367,1.0,5/33,3.35%,HS3ST3A1;UST;CHST15;CHST11;HS2ST1
prerank,protein phosphatase inhibitor activity (GO:0004864),0.6342919815909819,1.5876500930051258,0.034482758620689655,0.5389153313366698,1.0,1/26,0.03%,PPP1R1A
prerank,sodium:proton antiporter activity (GO:0015385),-0.685180531682258,-1.584256672591014,0.024896265560165973,0.153309508047905,0.99,4/11,8.67%,SLC9A2;SLC9B2;SLC9A6;SLC9A7
prerank,amino acid binding (GO:0016597),-0.5266834024519869,-1.5765162575633251,0.017114914425427872,0.16002319663984907,0.994,10/31,15.27%,GRM7;NOS3;GRIN2B;GLRB;GRIN3A;GLRA3;GLRA1;NOS1;GLRA2;GRIN1
prerank,active ion transmembrane transporter activity (GO:0022853),0.5833999318908937,1.5704733700006173,0.02287581699346405,0.5886097045689609,1.0,3/37,1.25%,SLC22A6;SLC22A8;ATP13A3
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),-0.45417670219194484,-1.5627354007780256,0.008875739644970414,0.17643424428286764,0.996,19/60,9.84%,NRP1;TEK;ERBB4;NTRK3;ROR1;EPHB1;EPHA5;MERTK;NRP2;EPHA6;TIE1;NTRK2;KDR;ROR2;MET;EPHA7;EPHB2;FLT4;ERBB2
prerank,metal ion:proton antiporter activity (GO:0051139),-0.6445379144827391,-1.5416787756234103,0.03404255319148936,0.2035726330214397,1.0,4/13,8.67%,SLC9A2;SLC9B2;SLC9A6;SLC9A7
prerank,acid-thiol ligase activity (GO:0016878),0.6983890828116894,1.531575528711409,0.05363984674329502,0.7536115070917799,1.0,2/13,3.76%,ACSL1;ACSS3
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.649021837302286,-1.531471241176286,0.044585987261146494,0.21614496830231886,1.0,4/12,8.67%,SLC9A2;SLC9B2;SLC9A6;SLC9A7
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.7428410105543551,1.5286794843914253,0.064453125,0.7366125118042625,1.0,4/10,11.82%,KDM7A;KDM2B;KDM2A;RIOX2
prerank,LRR domain binding (GO:0030275),0.6690603744279513,1.5258302612304275,0.05018587360594796,0.7211979858534266,1.0,2/14,0.75%,ROBO1;PAWR
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.6116530135160823,1.5240753419881752,0.04208754208754209,0.701697980951634,1.0,3/27,1.22%,SLC22A6;SLC22A8;SLC5A5
prerank,phospholipase C activity (GO:0004629),-0.5453043377415288,-1.5226239543157385,0.018561484918793503,0.22532873728304753,1.0,8/25,9.31%,PLCB4;EDNRA;PLCL1;PLCE1;CHRM3;PLCG2;PDIA3;PLCH1
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.7457809323258512,1.5218582380180157,0.051330798479087454,0.6860225572953567,1.0,1/10,0.04%,PRKAG2
prerank,R-SMAD binding (GO:0070412),0.6362733381563002,1.5157702044294439,0.0595903165735568,0.6909457899865091,1.0,5/18,6.17%,SMAD3;DDX5;PMEPA1;SMAD6;LDLRAD4
prerank,NAD binding (GO:0051287),0.5968734768616722,1.5126276278445074,0.06779661016949153,0.681558808556289,1.0,10/26,9.51%,SORD;ALDH1A1;CRYL1;SIRT5;BDH2;ALDH2;SIRT3;PARP9;SIRT1;ZC3HAV1
prerank,cyclic nucleotide binding (GO:0030551),-0.5569656604964782,-1.5054671543373,0.04849884526558892,0.25018905528895424,1.0,6/21,2.15%,PDE4D;PDE4B;PDE10A;RAPGEF4;HCN1;PDE11A
prerank,ion channel activity (GO:0005216),-0.41936411888523933,-1.5038921422299423,0.015479876160990712,0.247477112435014,1.0,20/80,9.55%,GRID2;GRIK2;PIEZO2;GRIA4;GRIK1;GRIN2B;GRIA1;GRIA2;GABRB1;ABCC9;GRIA3;UNC80;GRIK4;GRIN3A;TRPC1;GRIN2A;TRPC6;PIEZO1;GRID1;TRPV4
prerank,outward rectifier potassium channel activity (GO:0015271),0.7092903180534468,1.4951027193860567,0.065439672801636,0.7401011256713133,1.0,4/11,1.80%,KCNK2;KCNT1;KCND3;KCNA5
prerank,metal ion transmembrane transporter activity (GO:0046873),0.5807766730752557,1.4950092570936613,0.05472636815920398,0.7158004382202572,1.0,5/27,6.34%,SLC41A1;ITPR2;ITPR1;CNNM2;MRS2
prerank,mRNA 3'-UTR binding (GO:0003730),0.4880908000860667,1.4938129241459415,0.02575107296137339,0.6980716347968452,1.0,27/79,18.47%,CPEB2;CELF2;DDX5;CPEB4;RBMS2;LARP4B;IGF2BP1;TP53;HNRNPA2B1;PABPC4L;LARP1;CPEB3;IGF2BP2;CSDC2;RBMS1;HNRNPC;RSL1D1;PABPC5;ZFP36L1;RBM4;DAZAP1;ILF3;CRYZ;RBMS3;BOLL;RNF20;LARP4
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.6041578374448368,-1.4932134745205239,0.046052631578947366,0.26141672283177514,1.0,8/15,15.39%,SLC1A5;SLC1A2;SLC1A1;SLC25A13;SLC1A4;SLC17A6;SLC38A7;SLC1A6
prerank,thyroid hormone receptor binding (GO:0046966),0.5837181525933058,1.4923271982328559,0.05518394648829431,0.683465518340057,1.0,15/28,20.46%,BRD8;NSD1;NCOA3;MED12;TRIP12;MED17;TRIP6;THRAP3;TAF11;HMGN3;NCOR1;TAF7;MED1;NCOA6;MED13
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.6358263590867415,1.4911581524458384,0.05805243445692884,0.667455261116263,1.0,4/20,4.25%,LPGAT1;AGPAT4;MOGAT3;GPAT2
prerank,glycine binding (GO:0016594),-0.6559486864957969,-1.4895082768937282,0.05052631578947368,0.26277546513883293,1.0,7/11,15.27%,GRIN2B;GLRB;GRIN3A;GLRA3;GLRA1;GLRA2;GRIN1
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.5832786003725084,-1.4889900836567531,0.05921052631578947,0.2524987703323719,1.0,7/16,15.40%,ANO4;ANO1;ANO3;TTYH2;TTYH1;ANO5;ANO2
prerank,intracellular chloride channel activity (GO:0061778),-0.5832786003725084,-1.4889900836567531,0.05921052631578947,0.2524987703323719,1.0,7/16,15.40%,ANO4;ANO1;ANO3;TTYH2;TTYH1;ANO5;ANO2
prerank,fibroblast growth factor receptor binding (GO:0005104),0.6277266734348101,1.4875908516520948,0.06956521739130435,0.6631710157581099,1.0,3/21,3.11%,FGF1;KL;FRS2
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.495357834562535,-1.4859066612474816,0.035046728971962614,0.25305138770115837,1.0,9/32,10.94%,KCNB2;KCNQ5;KCNC2;KCNQ3;KCNS3;KCNA6;KCNQ1;KCNC1;KCNB1
prerank,retinoic acid binding (GO:0001972),0.6878943158079915,1.4836074114693278,0.059880239520958084,0.661203782223159,1.0,2/12,4.67%,NR2F2;CYP26B1
prerank,secondary active transmembrane transporter activity (GO:0015291),0.5247353815958155,1.4812663924537957,0.04393939393939394,0.6536377019742786,1.0,7/51,7.02%,SLC22A6;SLC22A8;SLC5A5;MCU;TMEM241;SLC5A8;SLC20A2
prerank,serotonin receptor activity (GO:0099589),-0.5477704083475963,-1.4722454867558914,0.05393258426966292,0.2627858123099833,1.0,9/22,15.28%,CHRM3;HTR2C;HTR2A;CHRM2;HTR1F;HTR7;HTR4;HTR1B;HRH1
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.5477704083475963,-1.4722454867558914,0.05393258426966292,0.2627858123099833,1.0,9/22,15.28%,CHRM3;HTR2C;HTR2A;CHRM2;HTR1F;HTR7;HTR4;HTR1B;HRH1
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.5477704083475963,-1.4722454867558914,0.05393258426966292,0.2627858123099833,1.0,9/22,15.28%,CHRM3;HTR2C;HTR2A;CHRM2;HTR1F;HTR7;HTR4;HTR1B;HRH1
prerank,calcium ion binding (GO:0005509),-0.3429622617756712,-1.4713857442909504,0.0,0.2589690492978995,1.0,95/323,18.90%,KCNIP4;ADGRL3;CDH11;SLC8A1;NRXN1;SLIT2;SYT1;ASTN2;CDH8;CDH2;CDH13;GSN;SPOCK2;LTBP4;MCTP1;PLA2G4A;ESYT2;RYR2;RASGRP3;THBS1;TPD52;ACER3;STIM2;IQGAP1;TPT1;CDH10;PCLO;DNER;CDH12;KCNIP1;S100A6;RYR3;SLC25A13;ANXA1;ASPN;CALM1;CDH6;MICU3;CALM2;GLCE;ENPP1;TKT;PPP3R1;CDH20;CDH19;CDH7;PAM;PPP3CA;HSPA5;SPOCK1;DYSF;CALR;CRACR2A;S100B;TPM4;CAMKK2;EFHD2;TUBB4A;ESYT3;AGRN;CALM3;ENPP2;SPARCL1;CDH1;ASAH2;S100A16;SNCA;PITPNM3;RET;CETN3;CDK5R1;SDF4;MAN1B1;SYT7;TRPM2;PCP4;GRIN1;CDH9;RASGRP2;AOC3;CLEC3B;AMY1A;AMY1B;AMY1C;AOAH;SYT6;GCA;ITPR3;CETN2;EFCAB11;PLA2G4E;CASQ2;SYT10;EML1;MCTP2
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.6169062954179028,1.459186858541634,0.08243727598566308,0.7300335746295934,1.0,5/18,7.88%,ALDH1A2;ALDH1A1;AKR1B10;ALDH3B1;ALDH2
prerank,alkali metal ion binding (GO:0031420),0.674344130579196,1.4546906376218471,0.07532956685499058,0.731445683107365,1.0,4/13,12.70%,ATP1A2;ATP4A;HDAC4;TDG
prerank,phospholipid transfer activity (GO:0120014),-0.5469996990965239,-1.454535542392518,0.051111111111111114,0.28628658074824426,1.0,9/21,13.42%,CERT1;PITPNC1;PLTP;GLTP;PITPNB;TNFAIP8L3;MTTP;PITPNA;PLEKHA3
prerank,phosphatidate phosphatase activity (GO:0008195),-0.6111558820765379,-1.4534433284519497,0.06611570247933884,0.28300052011472365,1.0,5/13,13.68%,PLPP1;PLPPR1;PLPPR5;PLPPR4;LPIN3
prerank,MAP kinase activity (GO:0004707),0.656203626945322,1.452860783473287,0.09505703422053231,0.7207492126024334,1.0,1/14,0.10%,MAPK4
prerank,ubiquitin-specific protease binding (GO:1990381),0.5982851561850892,1.4490291384152465,0.10070671378091872,0.7191749547809634,1.0,10/19,23.60%,PRKN;LCOR;PTEN;CLTC;AMFR;SYVN1;SUMO1;DERL1;SELENOS;BAG6
prerank,acylglycerol lipase activity (GO:0047372),-0.6404279921305154,-1.448934081204141,0.05443548387096774,0.2873177792926473,1.0,3/11,13.46%,ABHD2;MGLL;LIPE
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.473230891949929,-1.4485059652502286,0.04580152671755725,0.2829468595619571,1.0,12/35,11.87%,PLCB4;PLCL1;PLCE1;PDE11A;PLCXD3;GPCPD1;ENPP6;ENPP1;GDPD1;PDIA3;ENPP2;SMPDL3A
prerank,ribosomal small subunit binding (GO:0043024),0.6342011123198622,1.4483254662919696,0.08818342151675485,0.7045577823907764,1.0,3/17,8.30%,CPEB2;DDX3X;LARP1
prerank,ribosomal large subunit binding (GO:0043023),0.6815087834735165,1.4410493267225284,0.11363636363636363,0.7181220672399896,1.0,1/11,0.33%,CPEB2
prerank,sialyltransferase activity (GO:0008373),-0.5418612818329662,-1.4392172346793866,0.0591016548463357,0.2951159570103338,1.0,9/20,8.77%,ST6GALNAC3;ST3GAL4;ST8SIA4;ST3GAL1;ST6GAL2;ST8SIA1;ST6GALNAC5;ST3GAL6;ST8SIA6
prerank,endopeptidase regulator activity (GO:0061135),0.5232920921225683,1.4375796669623833,0.06984126984126984,0.7156879933782482,1.0,7/40,9.31%,ITIH2;TFPI;SERPIND1;RENBP;KNG1;HRG;APH1B
prerank,ligand-gated cation channel activity (GO:0099094),-0.40066017216910205,-1.4375348366481824,0.0219435736677116,0.2932008090079758,1.0,13/75,4.76%,GRIK2;GRIA4;KCNJ3;GRIK1;GRIN2B;GRIA1;KCNJ2;GRIA2;KCNN2;PTK2B;GRIA3;GRIK4;GRIN3A
prerank,kinase activator activity (GO:0019209),0.5446208996480926,1.4368171863934487,0.07705779334500876,0.7019177595064697,1.0,2/30,2.35%,PRKAG2;GPRC5C
prerank,peptidase inhibitor activity (GO:0030414),0.5541430622159966,1.431538763340451,0.07419898819561552,0.707652351798386,1.0,6/33,8.46%,ITIH2;TFPI;SERPIND1;RENBP;KNG1;HRG
prerank,protein tyrosine kinase activator activity (GO:0030296),-0.5462343006958326,-1.430722612052256,0.07640449438202247,0.3009599684334866,1.0,6/19,13.17%,NRG3;GRM5;EFNA5;GAS6;ABI1;ERCC6
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),-0.5370524987070213,-1.4282480525021097,0.05921052631578947,0.29563415811684135,1.0,4/21,16.29%,CDK14;CDK19;CDK8;CDKL4
prerank,cyclin-dependent protein kinase activity (GO:0097472),-0.5370524987070213,-1.4282480525021097,0.05921052631578947,0.29563415811684135,1.0,4/21,16.29%,CDK14;CDK19;CDK8;CDKL4
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.5531115779382367,1.4263549176214028,0.07537688442211055,0.7136850696299637,1.0,12/32,18.13%,KDM7A;TET2;BBOX1;TMLHE;KDM2B;KDM2A;RIOX2;TET1;HIF1AN;ALKBH5;TET3;PHYH
prerank,phosphotyrosine residue binding (GO:0001784),-0.4674625671496944,-1.425714299791979,0.054187192118226604,0.29535030001484175,1.0,16/37,23.23%,PIK3R1;NCK2;BCAR3;SHE;PLCG2;CRK;RASA1;PTPN3;SAMSN1;VAV1;SYK;LDLRAP1;IRS1;SHC1;YES1;SHC3
prerank,transcription coactivator binding (GO:0001223),0.598620443444636,1.4253322802827413,0.08576642335766424,0.7020366113845281,1.0,7/20,8.89%,RORA;THRB;SMAD3;VGLL4;CCNT2;TERT;TEAD2
prerank,potassium:proton antiporter activity (GO:0015386),-0.621678151092907,-1.423803189338677,0.09330628803245436,0.29403888845698684,1.0,3/10,8.67%,SLC9A2;SLC9A6;SLC9A7
prerank,potassium channel activity (GO:0005267),-0.3940543239080031,-1.4214135345063215,0.013793103448275862,0.29334048327479095,1.0,25/89,11.64%,GRIK2;KCNT2;KCND2;KCNB2;KCNQ5;KCNC2;KCNH7;HCN1;KCNMA1;GRIK1;KCNN2;ABCC9;KCNQ3;KCNK5;KCNMB2;GRIK4;KCNS3;KCNK13;KCNA6;KCNQ1;KCNK9;KCNC1;KCNH5;KCNB1;KCNK1
prerank,calcium-activated potassium channel activity (GO:0015269),-0.6050245729237245,-1.4095335369708757,0.10204081632653061,0.31096074880573055,1.0,3/11,4.51%,KCNMA1;KCNN2;KCNMB2
prerank,nucleotide diphosphatase activity (GO:0004551),0.6333823343965373,1.4063441867455273,0.1157495256166983,0.7668420997808899,1.0,4/14,5.04%,NUDT4;FHIT;CILP2;NUDT13
prerank,organic anion transmembrane transporter activity (GO:0008514),0.42710666681638343,1.4061855875941258,0.03443708609271523,0.7519940042073386,1.0,20/134,8.49%,SLC22A6;SLC13A3;SLC6A13;SLC6A1;SLC16A12;SLC16A11;SLC38A3;SLC7A2;PDPN;SFXN2;SLC6A9;SLC26A3;SLC25A23;SLC25A2;SLC19A1;SLC27A1;SLC26A1;SLC38A1;SLC1A3;CTNS
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.6670498730770833,1.4044939248512862,0.11596958174904944,0.7441060845951364,1.0,6/11,19.67%,SLC25A48;SLC25A20;SLC22A5;SLC25A47;SLC25A29;SLC22A4
prerank,carboxylic acid binding (GO:0031406),-0.4509175174331407,-1.3941095571305675,0.04071246819338423,0.33803149914901026,1.0,14/38,15.27%,GRM7;NOS3;SESN3;GRIN2B;GLRB;GRIN3A;GLRA3;PSAP;EPDR1;GLRA1;GLUD1;NOS1;GLRA2;GRIN1
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.6533397730965852,1.3901940500975074,0.13358778625954199,0.7860243549889724,1.0,4/12,12.83%,KDM7A;HR;KDM3B;PHF2
prerank,transforming growth factor beta receptor binding (GO:0005160),0.5960328940957694,1.3881370683649445,0.1059245960502693,0.7785602473670775,1.0,5/18,7.34%,TGFBR3;SMAD3;TGFBR1;SMAD6;TGFBR2
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.6282749762358969,1.3867142623726605,0.13148148148148148,0.7696482575375928,1.0,2/15,1.57%,CCR9;ACKR2
prerank,muscle alpha-actinin binding (GO:0051371),-0.5557815347305283,-1.3850084174802875,0.0894854586129754,0.35219927023445385,1.0,8/15,30.32%,PDLIM1;SYNPO2;PDLIM3;LDB3;PDLIM2;TTN;PDLIM4;NRAP
prerank,protein phosphorylated amino acid binding (GO:0045309),-0.43876852104661807,-1.3832260279298785,0.0663265306122449,0.35073030010630335,1.0,17/42,21.39%,PIK3R1;NCK2;BCAR3;SHE;YWHAE;YWHAB;PLCG2;CRK;RASA1;PTPN3;SAMSN1;VAV1;SYK;LDLRAP1;IRS1;SHC1;YES1
prerank,acetyltransferase activity (GO:0016407),0.5198385247346531,1.383215539954807,0.11467116357504216,0.7693673909882176,1.0,9/31,16.31%,SPHK1;PAFAH2;NAA80;SAT1;KAT6B;SMARCE1;KAT2B;NAA16;CREBBP
prerank,monocarboxylic acid binding (GO:0033293),0.5830536911599907,1.3822932108665453,0.11538461538461539,0.7592982771981532,1.0,3/18,4.67%,NAPEPLD;NR2F2;CYP26B1
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.3996332678599337,-1.3770257129403287,0.0547112462006079,0.35858177856291756,1.0,18/60,9.84%,TEK;ERBB4;NTRK3;ROR1;EPHB1;EPHA5;MERTK;EPHA6;TIE1;ACVRL1;NTRK2;KDR;ROR2;MET;EPHA7;EPHB2;FLT4;ERBB2
prerank,histone acetyltransferase activity (GO:0004402),0.5233305000592535,1.376366506089722,0.11149228130360206,0.7687817872495972,1.0,11/30,18.47%,ARRB1;NCOA3;SRCAP;KAT6B;ATF2;BAZ1A;KAT14;KAT7;KAT2B;CREBBP;TAF1
prerank,actinin binding (GO:0042805),0.5717021157273466,1.3754129800942778,0.13652482269503546,0.7587581489076872,1.0,5/21,4.75%,CACNA1D;KCNA5;CSRP3;DAG1;CACNA1C
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.6477101917582939,1.3713517194948885,0.1529175050301811,0.7623837028580662,1.0,1/10,0.09%,SLC22A6
prerank,vitamin D receptor binding (GO:0042809),0.6165375939797191,1.3709537452539842,0.1191806331471136,0.7511863376572406,1.0,9/14,24.29%,MED12;MED17;THRAP3;TAF11;TAF7;RXRA;MED1;MED13;MED24
prerank,death receptor activity (GO:0005035),-0.6045474968110556,-1.3707943648882845,0.09406952965235174,0.36663297830988106,1.0,5/11,18.20%,TNFRSF11A;TNFRSF19;TNFRSF1B;FAS;TNFRSF25
prerank,methylated histone binding (GO:0035064),0.47633736674863475,1.3686316466783282,0.07680722891566265,0.7477492193895309,1.0,18/62,18.47%,KDM7A;ZMYND8;CXXC1;ZCWPW2;TDRD3;ATRX;CBX5;PHF1;PHF2;MPHOSPH8;TAF7;MORC4;LRWD1;NCAPD3;SGF29;KMT2E;CHD8;TAF1
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.6240026351680454,1.3680277383378474,0.12476007677543186,0.7377698868738592,1.0,2/13,0.46%,BMP6;BMP7
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.4654264397141098,-1.3656093634273754,0.06585365853658537,0.372576038450317,1.0,13/32,13.40%,SLC6A6;SLC1A5;SLC7A5;SLC38A6;SLC1A1;SLC1A4;SLC38A5;SLC43A2;SLC6A7;SLC43A1;SFXN1;SLC38A7;SFXN3
prerank,NAD+ binding (GO:0070403),0.6321604019296581,1.3619179466693005,0.16302186878727634,0.7491036835073812,1.0,6/12,9.51%,CRYL1;SIRT5;SIRT3;PARP9;SIRT1;ZC3HAV1
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.49368913709897216,1.3612812896000688,0.10371517027863777,0.7397554285602244,1.0,21/44,18.15%,KMT2A;CXXC1;SMYD3;KMT5C;NSD1;KMT5B;SETD7;NSD3;ASH2L;KMT2C;WDR82;KMT2D;KMT5A;DOT1L;SETD1B;SETDB2;EHMT2;EHMT1;ASH1L;KMT2E;SETD3
prerank,nuclear receptor coactivator activity (GO:0030374),0.472626138553417,1.36036539612922,0.0873015873015873,0.7315964495090854,1.0,15/52,11.90%,PPARGC1B;PPARGC1A;BRD8;PRKCB;NCOA3;HMGA1;MED12;TMF1;CALCOCO1;CCAR1;MED17;THRAP3;ZMIZ2;ZMIZ1;CCDC62
prerank,metal ion binding (GO:0046872),-0.30662944366805167,-1.3572548682261882,0.0,0.38512898557211706,1.0,133/477,19.06%,KCNIP4;ADGRL3;CDH11;SLC8A1;NRXN1;SLIT2;SYT1;MARK1;ASTN2;CDH8;CDH2;CSGALNACT1;CDH13;GSN;SPOCK2;LTBP4;SNRK;MAP3K5;HMGCLL1;MCTP1;PLA2G4A;ESYT2;ADCY2;RYR2;RASGRP3;THBS1;CDC42BPA;TPD52;ACER3;STIM2;IQGAP1;TPT1;CDH10;PCLO;DNER;CDH12;KCNIP1;S100A6;RYR3;SLC25A13;ANXA1;NLK;ASPN;CALM1;CDH6;APOE;MICU3;CALM2;GLCE;GNAI1;ENPP1;TKT;PPP3R1;CDH20;CDH19;CDH7;PAM;PPP3CA;HSPA5;SPOCK1;DYSF;CALR;IRAK3;CRACR2A;PDE2A;S100B;RAP2A;TPM4;CAMKK2;EFHD2;TUBB4A;ESYT3;AGRN;CALM3;MT1G;MT1A;MT1B;MT1F;MT1M;MT1E;MT1X;MT1H;ENPP2;SPARCL1;TRIM27;MARK2;CDH1;ASAH2;S100A16;SNCA;DUT;PITPNM3;RPE;RET;CETN3;PINK1;CDK5R1;SDF4;MT3;MAN1B1;SYT7;MAPK12;TRPM2;PCP4;GRIN1;CDH9;RASGRP2;AOC3;CLEC3B;PDXK;TOP2A;TPPP;ENDOV;AMY1A;AMY1B;AMY1C;AOAH;SYT6;GCA;ITPR3;CETN2;EFCAB11;PLA2G4E;CASQ2;HPRT1;IMPA1;SYT10;HSPE1;EML1;EXD2;MCTP2;RHEB;RAN
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.45156904252229674,1.3569811080865504,0.07807807807807808,0.7329403478236606,1.0,12/74,9.41%,NADK2;FAM20A;HK2;SPHK1;PI4KA;GK5;TKFC;GALK2;GK;PANK1;PIK3CA;DCAKD
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.5436645244545579,-1.3566894656217845,0.09282700421940929,0.381100221909424,1.0,4/15,23.28%,PLA2G4A;PLA2G12A;PLA2G4E;PLA2G4F
prerank,voltage-gated ion channel activity (GO:0005244),-0.5558784864628381,-1.355130170723506,0.10480349344978165,0.3790790147005649,1.0,9/14,22.95%,KCND2;CACNA1E;HCN1;VDAC1;CACNA1H;GPR89A;GPR89B;VDAC3;HVCN1
prerank,carbohydrate kinase activity (GO:0019200),0.6347255503589759,1.3543207954683059,0.16310679611650486,0.7314199780132322,1.0,6/11,23.83%,HK2;GALK2;GALK1;HK1;NAGK;GNE
prerank,glycerophospholipid flippase activity (GO:0140333),-0.5974671002384084,-1.353045139627744,0.1413934426229508,0.37820669573759835,1.0,8/11,14.29%,ATP10A;ATP8A1;ATP8B1;ATP11A;ATP8A2;ATP11C;ATP8B2;ABCB4
prerank,nuclear receptor binding (GO:0016922),0.4227530190518748,1.3522634787579606,0.08180535966149506,0.7271034524788402,1.0,26/111,11.90%,PPARGC1B;SMAD3;DDX5;PPARGC1A;BRD8;NCOR2;PRKCB;NSD1;NCOA3;LCOR;HMGA1;BCAS3;MED12;WIPI1;SMARCD3;TRIP12;SMARCA4;TMF1;SMARCE1;SIRT1;TCF7L2;MED17;TRIP6;THRAP3;TAF11;CCDC62
prerank,amino acid transmembrane transporter activity (GO:0015171),0.48775495378950645,1.348751437477035,0.08617886178861789,0.7282615590756834,1.0,7/47,3.73%,SLC6A13;SLC6A1;SLC38A4;SLC38A3;SLC7A11;SLC7A2;PDPN
prerank,protein tyrosine kinase activity (GO:0004713),-0.36123811802263195,-1.346752373650696,0.04727272727272727,0.3862233095406989,1.0,26/108,10.50%,TEK;ERBB4;NTRK3;ROR1;EPHB1;EPHA5;MERTK;PEAK1;EPHA6;TIE1;PTK2B;NTRK2;KDR;LYN;ROR2;BMX;MET;EPHA7;EPHB2;PTK2;TEC;JAK1;FLT4;ERBB2;CAMKK2;HIPK1
prerank,sulfuric ester hydrolase activity (GO:0008484),0.6225761184858196,1.34621511535966,0.1594488188976378,0.7261159623465606,1.0,4/12,13.29%,SULF2;ARSG;ARSB;SULF1
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.3611759161637058,1.3461429744135769,0.0010309278350515464,0.7160594629455992,1.0,142/831,12.98%,AEBP1;EPAS1;HLF;ZKSCAN2;RORA;MAF;THRB;SMAD3;TFDP2;GLIS3;OSR1;ZIC2;MXI1;NFYC;CUX1;PPARA;PKNOX2;CREBRF;ZFHX2;FOXP4;IKZF2;ZNF423;CREB5;HOXB4;DNMT3A;GLI2;ZBTB20;ZNF160;HOXB6;NPAS3;FOXD1;HOXC6;HOXA1;ZNF568;NFAT5;SOX5;NR2F2;KCNIP3;ZNF697;ELF1;NR6A1;GLI3;MITF;ARNT2;FOXC1;NFIB;RFX8;HOXB3;VEZF1;ZBTB38;MAFG;ASCL3;ATOH1;NACC2;NFYB;NHLH2;FOXP2;SALL4;CUX2;RREB1;MEIS1;NSD1;TEF;OTP;ESRRA;TEAD3;STAT2;HOXB9;HOXA3;HOXB5;TP53;BHLHE41;RORC;SOX12;MGA;ZSCAN29;ZIC5;MEF2A;NR1D2;HOXC4;RBL2;ZSCAN25;ZIC1;IRX1;NEUROD4;TEAD2;KLF3;CALCOCO1;HDAC4;GLI1;ZBTB26;ZIC4;TFDP1;TCF7;NR2C2;HDAC1;SOX13;CCAR1;ZFP90;FOXC2;TCF7L2;TCF4;HBP1;ZBTB8B;ZNF219;MYBL1;HIVEP2;FOXL1;ZFP28;RBL1;ZFP3;THRAP3;PRDM5;ZBTB6;ZKSCAN5;ZNF569;ZNF367;NFATC3;RARG;MNT;ATF2;TFAP2D;ZNF467;ZBTB1;SKOR1;MYBL2;TEAD1;ZSCAN22;ZNF148;HES6;ZNF235;HOXB2;FOXA2;DEAF1;MLXIPL;NR3C2;IRF1;ZKSCAN7;ZNF483;PBX4;ZBTB48;FOXJ2
prerank,insulin-like growth factor I binding (GO:0031994),-0.566392006978741,-1.342251963075546,0.14254859611231102,0.3906393056386342,1.0,5/13,10.39%,ITGA6;ITGB4;IGFBP4;IGFBP6;ITGB3
prerank,alpha-actinin binding (GO:0051393),0.5464948487130893,1.3410213174447028,0.12824956672443674,0.7241058491710136,1.0,4/24,4.75%,CACNA1D;KCNA5;DAG1;CACNA1C
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.5816899513824831,1.3406695333407954,0.1527001862197393,0.7152380187934727,1.0,8/16,27.68%,ALOX12;ADI1;BCO2;ETHE1;ALOXE3;CDO1;HAAO;PIR
prerank,BMP receptor binding (GO:0070700),0.6240029188774179,1.3400416875746495,0.15028901734104047,0.707648058812916,1.0,2/12,0.46%,BMP6;BMP7
prerank,metalloexopeptidase activity (GO:0008235),0.4701627711510884,1.3397229564525965,0.103125,0.6993648137934853,1.0,13/51,15.78%,AEBP1;ACE;CPQ;CPA4;METAP2;PEPD;NPEPPS;MMP14;FOLH1;ERAP1;AGBL3;ZMPSTE24;ANPEP
prerank,pre-mRNA binding (GO:0036002),0.5287663173905238,1.339195174576335,0.14473684210526316,0.692000862715495,1.0,2/28,1.27%,CELF2;DDX5
prerank,methylation-dependent protein binding (GO:0140034),0.47075320818103583,1.3374632950512793,0.1027190332326284,0.6888069565724396,1.0,16/57,18.45%,KDM7A;ZMYND8;CXXC1;ZCWPW2;TDRD3;ATRX;CBX5;PHF1;PHF2;MPHOSPH8;MORC4;LRWD1;NCAPD3;SGF29;KMT2E;CHD8
prerank,5'-nucleotidase activity (GO:0008253),0.597579928496573,1.3367449790762576,0.17341040462427745,0.6825039871626508,1.0,7/13,18.55%,NT5C1B-RDH14;NT5C1B;NT5DC1;NT5C2;NT5C3A;NT5C3B;NT5C
prerank,MHC class II protein complex binding (GO:0023026),-0.586409538137496,-1.3306841209556735,0.14049586776859505,0.4109508362015553,1.0,7/11,17.31%,ATP1B1;YWHAE;HSP90AB1;HSPA8;HSP90AA1;PKM;CD74
prerank,adenylyltransferase activity (GO:0070566),0.5513612264739255,1.3294164912178597,0.145985401459854,0.6976583759757867,1.0,13/21,22.77%,OAS2;NMNAT1;TENT2;FLAD1;ABL1;OAS3;TENT4B;PAPOLG;NMNAT2;TUT1;SELENOO;KARS1;NMNAT3
prerank,lipid phosphatase activity (GO:0042577),-0.5566496039147129,-1.3284627397605882,0.13129102844638948,0.41047072418575614,1.0,4/14,10.22%,PLPP1;PLPPR1;PLPPR5;PLPPR4
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.6000070222768918,1.3279477206875185,0.1889483065953654,0.6934813232085051,1.0,5/15,4.34%,HS3ST3A1;HS3ST3B1;NDST1;HS2ST1;HS3ST6
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.4883529342899108,-1.3275751485793652,0.11264367816091954,0.40705900645261606,1.0,6/23,9.31%,PLCB4;EDNRA;PLCE1;CHRM3;PLCG2;PLCH1
prerank,anion transmembrane transporter activity (GO:0008509),0.6080110842799689,1.3265187988668072,0.175,0.6896479348747836,1.0,2/12,5.94%,SLC22A6;SLC19A1
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.5580341808650141,-1.3250970666081583,0.14644351464435146,0.4071396281611627,1.0,7/13,18.18%,PTPRJ;IL1R1;PDGFC;PDGFA;ITGB3;VEGFA;ITGA5
prerank,G protein-coupled receptor binding (GO:0001664),0.40023880143920326,1.321666583155681,0.07908847184986595,0.6971389325965395,1.0,17/132,10.18%,WNT5B;ACE;RNF43;WNT4;TULP3;WNT6;PRKN;GNAT2;ARRB1;ARHGEF11;ARHGEF12;GNAT3;RYK;GPRC5B;ADM;PICK1;CCL25
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.46625478617730215,1.3208710132531496,0.13278688524590163,0.6912415248305086,1.0,3/48,1.13%,TRPM3;SLC41A1;TRPM6
prerank,rRNA binding (GO:0019843),-0.4170070567324085,-1.3168993744103978,0.10422535211267606,0.41994837976126714,1.0,20/42,26.11%,CAVIN1;RPLP0;RPS3;RPL5;RPL12;RPS9;RPL23;RPS5;EMG1;NOP53;RCC1L;MRPL16;ERI1;UTP23;RPS13;RPL11;FASTKD5;RRS1;DDX28;FASTKD2
prerank,P-type ion transporter activity (GO:0015662),-0.5479650396863084,-1.3110787444571068,0.15894039735099338,0.42735819278045084,1.0,5/12,11.60%,ATP2C1;ATP2B2;ATP2A3;ATP2B4;ATP2B1
prerank,ubiquitin protein ligase activity (GO:0061630),0.3778685299378119,1.3026970941605995,0.046228710462287104,0.7434130980976852,1.0,32/228,11.43%,RNF220;RNF152;PDZRN3;SH3RF2;RNF43;ASB2;PRKN;TRIM63;KCMF1;DTX1;NEDD4;NHLRC4;RNF151;RNF135;TRIM56;RNF181;UBR4;MGRN1;UBR2;SMURF2;RNF8;HUWE1;TRIP12;RNF217;RNF19A;RNF34;UBR5;SH3RF1;RNF41;RNF13;CDC42;WWP2
prerank,tropomyosin binding (GO:0005523),0.5702758528130194,1.3024704166645091,0.16541353383458646,0.7352464796376035,1.0,3/16,5.16%,NEBL;TMOD2;TMOD3
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.37734430704439936,1.301301068744745,0.05314009661835749,0.730376927665977,1.0,33/232,11.43%,RNF220;RNF152;PDZRN3;SH3RF2;RNF43;ASB2;PRKN;TRIM63;KCMF1;DTX1;NEDD4;NHLRC4;RNF151;PIAS1;RNF135;TRIM56;RNF181;UBR4;MGRN1;UBR2;SMURF2;RNF8;HUWE1;TRIP12;RNF217;RNF19A;RNF34;UBR5;SH3RF1;RNF41;RNF13;CDC42;WWP2
prerank,ADP binding (GO:0043531),0.5249078889398275,1.3005636922456603,0.18057921635434412,0.7245898767039571,1.0,2/25,4.15%,PRKAG2;MYO18A
prerank,chloride channel inhibitor activity (GO:0019869),0.6307338802263133,1.2996806668197602,0.1976284584980237,0.719352682793339,1.0,1/10,0.45%,WNK4
prerank,bHLH transcription factor binding (GO:0043425),0.5402544285852555,1.2961687809111107,0.18453427065026362,0.7225906798207014,1.0,4/19,9.35%,SMAD3;FHL2;BHLHE41;SIRT1
prerank,androgen receptor binding (GO:0050681),0.5132544158175876,1.2917894127934173,0.18505338078291814,0.7290834589670115,1.0,6/25,8.52%,DDX5;PRKCB;NSD1;WIPI1;SMARCA4;TMF1
prerank,transcription cis-regulatory region binding (GO:0000976),0.35782658346568813,1.2876398608863646,0.036954087346024636,0.734715638842458,1.0,83/406,16.45%,AEBP1;EPAS1;RORA;SMAD3;TFDP2;OSR1;FOXN3;MXI1;NFYC;CUX1;CREBRF;ZBTB20;NPAS3;GABPB1;GABPB2;ZNF568;ARID4A;SOX5;GLI3;FOXC1;VEZF1;ASCL3;NFYB;CREB3L2;SMAD6;CUX2;RREB1;BNC2;OTP;TIPARP;HMGA1;TP53;TBL1X;SOX12;BCOR;MEF2A;RBL2;TBL1XR1;CALCOCO1;HDAC4;GLI1;TFDP1;TCF7;NR2C2;HDAC1;SOX13;ASH2L;ZFP90;FOXC2;TCF7L2;ZBTB8B;RBL1;ZFP3;PRDM5;MNT;ATF2;HNRNPL;TFAP2D;TEAD1;BRD7;FOXA2;DEAF1;IRF1;KMT2D;ZBTB48;TBP;ATF6B;TAF4;NCOR1;SNAI1;PER2;NFKB1;PURB;TAF7;HOXB8;HSF2;MZF1;NKX2-1;STAT6;RXRA;ZBTB8A;RB1;PER3
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.4633595679659004,-1.28245805892972,0.1444954128440367,0.4904011741452463,1.0,9/23,5.56%,PDE4D;PDE4B;PDE3A;PDE10A;PDE8A;PDE3B;PDE11A;PDE7B;PDE1C
prerank,potassium ion leak channel activity (GO:0022841),0.5500655132176222,1.2820799749975296,0.1989051094890511,0.7449617517433819,1.0,1/15,0.26%,KCNK2
prerank,Toll-like receptor binding (GO:0035325),-0.575220688461382,-1.2794146715438168,0.17916666666666667,0.49229124201114094,1.0,7/11,34.07%,DAB2IP;TIRAP;CD36;TOLLIP;TLR1;TLR2;MYD88
prerank,DNA binding (GO:0003677),0.3462659435687158,1.279015398038557,0.010604453870625663,0.7469046778232887,1.0,176/694,20.44%,DENND4A;EPAS1;HLF;RORA;THRB;SMAD3;APLP2;ZIC2;PPARGC1A;NFYC;CUX1;PPARA;SSBP2;SPO11;POLR2A;ZNF423;DNMT3A;GLI2;SPHK1;FOXD1;HOXA1;ARID4A;NUPR1;NR2F2;TSHZ3;NR6A1;CXXC5;FOXC1;NFIB;PCBP2;ASCL3;NFYB;FOXP2;CUX2;CHD4;TIGD3;MEIS1;POLG;DDX3X;OTP;ARID3A;NHEJ1;ESRRA;HMGA1;TP53;TSHZ1;COLEC11;BCLAF3;CAMTA2;DNASE1L1;SOX12;PARP4;POLR2D;HUWE1;SAMHD1;MEF2A;KDM2B;SMARCA4;FBH1;TWNK;TERT;SLTM;SIRT3;XRCC4;IRX1;CALCOCO1;HDAC4;SSBP1;GLI1;C1D;RBMS1;ZIC4;NR2C2;DDX60;SOX13;WDR76;FOXC2;TCF7L2;TCF4;ZNF219;HIVEP2;FOXL1;SURF6;THRAP3;ABL1;PRDM5;RTF1;ZBTB6;MAU2;ZDHHC1;RARG;RBBP8;PRKDC;MSH3;TEAD1;ZNF148;IGHMBP2;HOXB2;FOXA2;MLXIPL;RAD50;TOP3A;PNKP;TDG;IRF1;PHF1;KMT2D;PBX4;MTERF2;ZMYM6;MCM7;MCM2;DDB2;MBD6;PSIP1;TAF4;ZBTB32;ILF2;SDE2;ZKSCAN3;HOXA7;E2F4;PURB;DEDD;TDP2;TET1;ZMYM4;FUBP3;NKX2-1;POLL;RXRA;DNASE1L2;RFX2;CREBBP;CENPC;CLSPN;ILF3;SMAD4;TCF7L1;MBD4;BARX2;CHD2;MSH4;CRY1;OGG1;TINF2;EZH1;FOXO3;CHD8;TAF1;HES7;NBN;FEN1;MBD1;FOXD2;RAD51D;CARF;ZGPAT;PDS5B;APTX;RFC1;POU4F1;HDGFL2;XPA;BCL6;ZNF76;NR1H3;RTF2;LIG4;NR5A1;GTF3C3;SPDEF;MCM9;IKZF3;POLR2G;GTF2A1
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.43783755657234086,1.2786757597002085,0.14014598540145987,0.7399782455282606,1.0,15/60,14.71%,LRRK1;CTDSPL;MTMR3;PPEF2;PPP1CB;PPM1E;LRRK2;CDC14A;PTEN;PP2D1;CDC14B;PHLPP2;CTDSP2;PPM1B;CTDP1
prerank,GTPase activator activity (GO:0005096),0.3620899025103215,1.276603111158416,0.04914285714285714,0.7388144482735208,1.0,72/313,13.69%,RANBP3L;DENND4A;DOCK11;RAPGEF5;ARHGAP28;ARHGAP29;ERRFI1;SIPA1L1;SMAP2;RIN2;ARHGEF10L;ARHGEF18;FNIP1;ARHGEF16;SRGAP2;ARHGAP18;FGD4;SYDE2;RGL1;ARHGAP9;ALS2;ALDH1A1;DOCK5;NGEF;NPRL3;AKAP13;RGS16;TBC1D16;ASAP3;LRRK2;GMIP;RAPGEF3;ARHGAP26;DENND2A;RAB3IP;IQSEC2;ARRB1;WDR41;RIN3;ASAP1;NPRL2;RAB3IL1;ARHGAP17;ARFGEF2;ARHGEF11;ARFGAP3;ELMOD3;DENND5A;SH3BP5;NUCB1;DNM1L;EPS8L2;OPHN1;GRTP1;HPS1;RALGAPB;FGD1;MTSS2;RANBP3;OCRL;RALBP1;EPS8L1;RGPD1;RGP1;GNB5;ANKRD27;RIC8B;MON1A;RAP1GAP;HACD3;DENND4C;DEPDC5
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.46532277767798974,-1.2760796620271475,0.14093959731543623,0.4946090685067993,1.0,10/23,19.58%,HIP1;CLVS1;PLEKHA5;JPH2;SESTD1;PHLDA3;CLVS2;PLA2G4E;HIP1R;COMMD1
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.34358536486519164,1.2757721073636943,0.014537902388369679,0.7335398449949989,1.0,126/732,12.98%,HLF;ZKSCAN2;RORA;MAF;THRB;SMAD3;GLIS3;ZIC2;FOXN3;MXI1;NFYC;PPARA;PKNOX2;ZFHX2;FOXP4;IKZF2;ZNF423;CREB5;HOXB4;DNMT3A;GLI2;ZBTB20;ZNF160;HOXB6;FOXD1;HOXC6;HOXA1;ZNF568;NFAT5;SOX5;NR2F2;KCNIP3;ZNF697;ELF1;NR6A1;GLI3;MITF;ARNT2;FOXC1;NFIB;RFX8;HOXB3;ZBTB38;MAFG;ATOH1;NACC2;NFYB;NHLH2;FOXP2;SALL4;RREB1;MEIS1;NSD1;TEF;TIPARP;ESRRA;TEAD3;STAT2;HMGA1;HOXB9;HOXA3;HOXB5;TP53;BHLHE41;RORC;SOX12;MGA;ZSCAN29;ZIC5;MEF2A;NR1D2;HOXC4;ZSCAN25;ZIC1;IRX1;NEUROD4;TEAD2;KLF3;CALCOCO1;HDAC4;GLI1;ZBTB26;ZIC4;TCF7;NR2C2;HDAC1;SOX13;CCAR1;FOXC2;TCF7L2;TCF4;HBP1;ZNF219;MYBL1;HIVEP2;FOXL1;ZFP28;THRAP3;PRDM5;ZBTB6;ZKSCAN5;ZNF569;ZNF367;NFATC3;RARG;MNT;ATF2;ZNF467;ZBTB1;SKOR1;MYBL2;TEAD1;ZSCAN22;ZNF148;HES6;ZNF235;HOXB2;FOXA2;MLXIPL;NR3C2;IRF1;ZKSCAN7;ZNF483;PBX4;ZBTB48;FOXJ2
prerank,C-C chemokine receptor activity (GO:0016493),0.533689554364069,1.2745393697425815,0.17406749555950266,0.7298021636512473,1.0,2/21,1.57%,CCR9;ACKR2
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.4985754092522442,1.2744579475662001,0.1606837606837607,0.7225692023201751,1.0,1/29,0.04%,PRKAG2
prerank,flavin adenine dinucleotide binding (GO:0050660),0.4461409118677125,1.273896234288823,0.15333333333333332,0.7170153875272187,1.0,19/53,18.94%,DDO;MICAL3;PRODH;DPYD;POR;MTHFR;DLD;LDHD;NOX4;ACOXL;MTRR;GCDH;ACOX3;SQOR;MICAL1;KDM1A;CRY1;MMACHC;ETFDH
prerank,actin binding (GO:0003779),-0.3165948461001563,-1.2710126115701412,0.024154589371980676,0.5013431881728279,1.0,46/170,13.54%,UTRN;SYNE1;ACTN4;MYRIP;MAP1B;GSN;ABLIM1;TMSB4X;FMN2;KCNMA1;NOS3;PARVB;MICAL2;FXYD5;MOBP;KLHL2;CCDC88A;MYH9;CAP2;LIMA1;SMTN;KLHL1;MRTFA;CORO2B;ITGB1;PTK2;RDX;ANLN;CEACAM1;PDLIM1;MYO6;TRPV4;ADD2;TLNRD1;PACRG;EPS8;CALD1;SYNPO2;SPEF1;MAPT;PFN2;MTSS1;PDLIM3;DMTN;SNCA;SPTB
prerank,sequence-specific DNA binding (GO:0043565),0.3444456351056601,1.2700350374925287,0.022364217252396165,0.7211890827869691,1.0,87/590,12.44%,EPAS1;HLF;RORA;MAF;THRB;SMAD3;OSR1;PPARGC1A;CUX1;KMT2A;PPARA;PKNOX2;ZNF423;CREB5;HOXB4;GLI2;ZBTB20;HOXB6;CXXC1;FOXD1;HOXA1;NFAT5;NR2F2;ELF1;NR6A1;GLI3;ARNT2;CXXC5;FOXC1;CXXC4;NFIB;ZBTB38;MAFG;ATOH1;MBNL2;SMG1;NHLH2;FOXP2;CUX2;FBXL19;TEF;ACD;ESRRA;HOXB9;HOXB5;BHLHE41;RORC;SOX12;ZSCAN29;ZIC5;ELF2;MEF2A;KDM2B;NR1D2;HOXC4;ZIC1;KDM2A;TERT;SLTM;SIRT3;IRX1;TEAD2;KLF3;CALCOCO1;HDAC4;ZBTB26;ZIC4;TCF7;NR2C2;SOX13;FOXC2;TCF7L2;TCF4;FOXL1;ABL1;PRDM5;NFATC3;RARG;ATF2;SKOR1;MYBL2;TEAD1;ZNF148;HES6;HOXB2;FOXA2;NR3C2
prerank,N-acyltransferase activity (GO:0016410),0.4876639495023414,1.2678558098106563,0.1933884297520661,0.7213608356575999,1.0,7/32,9.35%,NMT2;NAA80;CERS6;CERS5;SAT1;SMARCE1;SIRT1
prerank,phosphoric ester hydrolase activity (GO:0042578),0.45268497014543424,1.265807763019207,0.17845659163987138,0.7204221346122515,1.0,9/49,10.90%,ATP1A2;MPPED2;PPP1CB;LHPP;PXYLP1;PTPN22;SAMHD1;PRUNE1;DUSP10
prerank,voltage-gated cation channel activity (GO:0022843),-0.3420689679410951,-1.2645886066796557,0.08540925266903915,0.51190454008968,1.0,23/97,11.64%,KCND2;CACNB2;KCNB2;CACNA1E;KCNQ5;KCNC2;KCNH7;HCN1;KCNMA1;CACNA2D1;GRIN2B;KCNQ3;PTK2B;GRIN3A;KCNS3;GRIN2A;CACNA1B;KCNA6;KCNQ1;KCNC1;KCNH5;KCNB1;KCNK1
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.464999705135212,-1.2624664264850451,0.1662921348314607,0.5113557449977476,1.0,9/21,5.56%,PDE4D;PDE4B;PDE3A;PDE10A;PDE8A;PDE3B;PDE11A;PDE7B;PDE1C
prerank,low-density lipoprotein particle binding (GO:0030169),-0.4962132743564096,-1.2607933576579355,0.18550106609808104,0.5094449116838916,1.0,8/16,9.02%,CDH13;THBS1;SCARB1;PLTP;LDLR;SORL1;STAB1;SCARF1
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.5373850943839173,-1.2581967666979603,0.17894736842105263,0.5105661655455638,1.0,7/12,27.83%,B3GALT1;B3GALNT1;B3GALT5;B3GNT3;B3GNT2;B4GAT1;B3GNT6
prerank,tRNA methyltransferase activity (GO:0008175),0.5465619506854533,1.2578605246176744,0.21880998080614203,0.7388779047085755,1.0,2/16,7.49%,TRMT9B;TRMT44
prerank,lipoprotein particle binding (GO:0071813),-0.4614427221676656,-1.257406645300319,0.17758985200845667,0.5068125969666959,1.0,8/20,9.02%,CDH13;THBS1;SCARB1;PLTP;LDLR;SORL1;STAB1;SCARF1
prerank,insulin-like growth factor binding (GO:0005520),-0.5098914042006949,-1.2569969576173072,0.19829424307036247,0.5023524473911054,1.0,5/15,10.39%,ITGA6;ITGB4;IGFBP4;IGFBP6;ITGB3
prerank,calcium activated cation channel activity (GO:0005227),-0.4895389013867587,-1.2545651384723835,0.18584070796460178,0.5033028474004654,1.0,4/17,4.51%,KCNMA1;ANO1;KCNN2;KCNMB2
prerank,myosin II binding (GO:0045159),-0.5580747396163508,-1.2507824301786243,0.1891348088531187,0.5071286769998292,1.0,4/10,9.85%,GSN;STXBP5L;SHROOM4;SHROOM1
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.3367352773258207,1.2490536325790598,0.021920668058455117,0.7598603484051398,1.0,124/731,12.98%,HLF;ZKSCAN2;RORA;MAF;THRB;SMAD3;GLIS3;ZIC2;MXI1;NFYC;PPARA;PKNOX2;ZFHX2;FOXP4;IKZF2;ZNF423;CREB5;HOXB4;DNMT3A;GLI2;ZBTB20;ZNF160;HOXB6;FOXD1;HOXC6;HOXA1;ZNF568;NFAT5;SOX5;NR2F2;KCNIP3;ZNF697;ELF1;NR6A1;GLI3;MITF;ARNT2;FOXC1;NFIB;RFX8;HOXB3;ZBTB38;MAFG;ATOH1;NACC2;NFYB;CREB3L2;NHLH2;FOXP2;SALL4;RREB1;MEIS1;NSD1;TEF;ESRRA;TEAD3;STAT2;HOXB9;HOXA3;HOXB5;TP53;BHLHE41;RORC;SOX12;MGA;ZSCAN29;ZIC5;MEF2A;NR1D2;HOXC4;ZSCAN25;ZIC1;IRX1;NEUROD4;TEAD2;KLF3;CALCOCO1;HDAC4;GLI1;ZBTB26;ZIC4;TCF7;NR2C2;HDAC1;SOX13;CCAR1;FOXC2;TCF7L2;TCF4;HBP1;ZNF219;MYBL1;HIVEP2;FOXL1;ZFP28;THRAP3;PRDM5;ZBTB6;ZKSCAN5;ZNF569;ZNF367;NFATC3;RARG;MNT;ATF2;ZNF467;ZBTB1;SKOR1;MYBL2;TEAD1;ZSCAN22;ZNF148;HES6;ZNF235;HOXB2;FOXA2;MLXIPL;NR3C2;IRF1;ZKSCAN7;ZNF483;PBX4;ZBTB48;FOXJ2
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.5405643732080077,-1.246454010257869,0.2165991902834008,0.5122765201576521,1.0,2/11,7.01%,MAP3K5;MAP3K7
prerank,sodium channel regulator activity (GO:0017080),-0.40189552716757887,-1.2440974890785033,0.17433414043583534,0.5122383745478356,1.0,14/37,21.75%,FGF14;FGF12;CAMK2D;FXYD5;NEDD4L;FGF13;ATP2B4;PTPN3;NOS1;SCN2B;FXYD6;COMMD1;SCN1B;PKP2
prerank,acetylglucosaminyltransferase activity (GO:0008375),-0.3890962262009023,-1.243909885482829,0.1358974358974359,0.5074859836579498,1.0,12/46,12.19%,MGAT4C;GCNT2;EXT1;MGAT4A;B3GALT1;HEXB;MGAT5;B3GALNT1;EXT2;LFNG;MFNG;B3GALT5
prerank,protein kinase activator activity (GO:0030295),0.42399857676223285,1.2436016138242134,0.1774960380348653,0.7699980411682705,1.0,16/60,15.84%,PRKAG2;FAM20A;GPRC5C;ALS2;DDX3X;AFAP1L2;RICTOR;NRG1;GPRC5B;IRGM;GPRC5A;WNK1;MAP2K1;MAP2K2;STK4;RPTOR
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.5276825078124593,-1.243361815566638,0.20675105485232068,0.5034392606922696,1.0,6/12,18.18%,VEGFC;CCDC88A;DAB2IP;ITGB3;VEGFA;ITGA5
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.5131082243837288,-1.2417104218752015,0.19750519750519752,0.5022538217438318,1.0,6/13,17.41%,CCDC88A;ARHGDIB;SH3BP4;RANBP1;ARHGDIA;GDI1
prerank,C-C chemokine binding (GO:0019957),0.5113691746138188,1.236694348063178,0.20422535211267606,0.7853437802204266,1.0,2/22,1.57%,CCR9;ACKR2
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.5478105069568392,-1.2350067457718035,0.2222222222222222,0.5128084914532034,1.0,2/10,5.64%,MECOM;PRDM16
prerank,transcription coregulator binding (GO:0001221),0.4391609317643896,1.233628002257396,0.18284789644012944,0.7881125934357968,1.0,16/50,17.01%,RORA;THRB;SMAD3;VGLL4;LCOR;USP11;CCNT2;TERT;TEAD2;PHF1;PER2;EHMT2;PER3;EHMT1;SMAD4;CTBP2
prerank,FAD binding (GO:0071949),0.509292985807712,1.2336047556193528,0.21715328467153286,0.7808223687028514,1.0,9/24,18.08%,DDO;MICAL3;PRODH;MTHFR;MTRR;SQOR;MICAL1;CRY1;MMACHC
prerank,protein kinase regulator activity (GO:0019887),0.3967376199859961,1.2323408743011763,0.1591549295774648,0.7780415214510613,1.0,21/95,16.60%,PRKAG2;GPRC5C;CCNA2;PRKAG3;CCNA1;CCNT2;CCND3;SH3BP5;GPRC5B;CCNB2;TRIB1;SOCS3;GPRC5A;WNK1;PRKAR1A;PARVA;CCNG1;FAF1;CCNL1;RPTOR;CCNE1
prerank,leak channel activity (GO:0022840),0.5097134331543753,1.2299329536442427,0.2306338028169014,0.7792855237068452,1.0,1/18,0.26%,KCNK2
prerank,metallocarboxypeptidase activity (GO:0004181),0.4861780230420386,1.2294869367916992,0.22166666666666668,0.7736388279011817,1.0,3/26,6.04%,AEBP1;CPA4;PEPD
prerank,MAP-kinase scaffold activity (GO:0005078),0.5887501707747548,1.2276297375090646,0.24324324324324326,0.7726676442872457,1.0,5/11,14.02%,KSR1;AKAP13;SH3RF1;MAP2K1;MAP2K2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.4336982335501548,1.2261491026938114,0.20367534456355282,0.7707244726896626,1.0,11/54,9.56%,UPB1;ASPA;HDAC8;NGLY1;ASPG;PM20D1;NAAA;SIRT5;HDAC4;SIRT1;HDAC1
prerank,chloride channel regulator activity (GO:0017081),0.5524626367296251,1.2239002725082988,0.23968565815324164,0.7709373021253695,1.0,1/14,0.45%,WNK4
prerank,carboxypeptidase activity (GO:0004180),0.4610145007309162,1.2215983723724178,0.20602218700475436,0.771358464737923,1.0,5/35,7.48%,AEBP1;CPA4;NAALADL1;PEPD;SCPEP1
prerank,potassium channel regulator activity (GO:0015459),-0.37691704194020426,-1.2200732859051213,0.1564245810055866,0.5443032378931515,1.0,12/49,7.27%,KCNIP4;DPP10;DPP6;ABCC9;KCNIP1;KCNAB1;KCNMB2;NEDD4L;YWHAE;KCNS3;FLNA;WNK2
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.4778212528297802,1.219776010715005,0.2214765100671141,0.7704321313782712,1.0,9/28,14.68%,PRKAA2;LRRK2;MAP2K5;MAPKAPK3;AURKB;MAPK10;MAP2K1;MAP2K2;MAP2K6
prerank,semaphorin receptor activity (GO:0017154),-0.5370983756745272,-1.214487479532989,0.24688796680497926,0.5533801493764932,1.0,4/11,8.86%,NRP1;NRP2;PLXNC1;PLXNA4
prerank,filamin binding (GO:0031005),0.5826701026784045,1.2118835254197633,0.26229508196721313,0.7884176726187389,1.0,1/11,0.50%,NEBL
prerank,chemokine receptor activity (GO:0004950),0.49284719000127486,1.211226329120755,0.23310810810810811,0.7840294695770244,1.0,2/24,1.57%,CCR9;ACKR2
prerank,mechanosensitive ion channel activity (GO:0008381),-0.5226203557961063,-1.2111687631482548,0.23658051689860835,0.5559938001825586,1.0,2/12,7.63%,PIEZO2;PIEZO1
prerank,myosin binding (GO:0017022),-0.35908174831774814,-1.2101539524798481,0.17270194986072424,0.5529413704800473,1.0,11/55,11.42%,MYRIP;GSN;STXBP5L;MOBP;SHROOM4;RAB3C;NKD2;MYOC;SHROOM1;CALD1;RAB27B
prerank,nucleotidase activity (GO:0008252),0.523055445267066,1.2054384332940167,0.25140712945590993,0.7955510291978183,1.0,7/15,18.55%,NT5C1B-RDH14;NT5C1B;NT5DC1;NT5C2;NT5C3A;NT5C3B;NT5C
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.36563975143172217,1.2036758200026234,0.16099476439790575,0.7943001667474502,1.0,26/147,8.94%,DENND4A;DOCK11;RAPGEF5;RIN2;ARHGEF18;FNIP1;ARHGEF16;FGD4;RGL1;ALS2;DOCK5;NGEF;AKAP13;RAPGEF3;DENND2A;RAB3IP;IQSEC2;WDR41;RIN3;RAB3IL1;ARFGEF2;ARHGEF11;DENND5A;SH3BP5;NUCB1;EPS8L2
prerank,GDP binding (GO:0019003),-0.3591834336232749,-1.2020145164158105,0.17034700315457413,0.5670471864132488,1.0,18/63,19.06%,RIT2;RAB31;KRAS;RAP1B;RAP1A;RASL12;RAB27A;GNAI1;RERG;RALB;RAP2A;RAB18;RAB27B;RRAS;ARF6;ARL8B;RHEB;RAN
prerank,calcium channel regulator activity (GO:0005246),-0.4024000589064244,-1.1999266750053976,0.17902813299232737,0.5673514709720128,1.0,12/37,15.66%,PRKG1;NRXN1;STIM2;YWHAE;CALM1;CALM2;FKBP1A;NRXN2;SLC30A1;MCUB;CACNG8;STIMATE
prerank,poly-pyrimidine tract binding (GO:0008187),0.4954296942573243,1.1969238712173278,0.2690972222222222,0.80887665619317,1.0,10/23,21.21%,RBMS2;HNRNPH1;PABPC4L;RBMS1;HNRNPC;PABPC5;DAZAP1;RBMS3;FMR1;U2AF2
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.49324147693414,-1.1964877087157062,0.257201646090535,0.5703894264105723,1.0,5/13,11.97%,RYR2;GSK3B;KCNQ1;PRKAR1B;PRKAR2B
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.3953917503975898,1.195630071791071,0.2020497803806735,0.8063708476702327,1.0,11/75,8.99%,ME2;SORD;CRYL1;AKR1B10;LDHB;BDH1;DHDH;DHRS11;DHRS3;BDH2;LDHD
prerank,poly(U) RNA binding (GO:0008266),0.5103131218023805,1.1948921440275968,0.2478031634446397,0.8021556958789665,1.0,8/20,17.54%,RBMS2;HNRNPH1;PABPC4L;RBMS1;HNRNPC;PABPC5;DAZAP1;RBMS3
prerank,actin monomer binding (GO:0003785),-0.44627154045114875,-1.1941316081464264,0.2372093023255814,0.5708299376433638,1.0,7/22,15.91%,TMSB4X;NOS3;LIMA1;MRTFA;PFN2;MTSS1;COBL
prerank,hormone receptor binding (GO:0051427),-0.4942381349373617,-1.1934133757869312,0.24949290060851928,0.5676014810883674,1.0,3/14,12.44%,SOCS2;JAK1;PTHLH
prerank,MAP kinase phosphatase activity (GO:0033549),0.5558961546563814,1.1931790885722793,0.2926829268292683,0.8006870758978022,1.0,4/12,18.08%,DUSP29;DUSP10;DUSP2;DUSP4
prerank,sterol binding (GO:0032934),0.41240751465943937,1.1905893575641977,0.234375,0.8026052869469849,1.0,10/56,9.11%,RORA;OSBPL8;GRAMD1B;INSIG2;VDAC2;OSBPL11;OSBPL9;RORC;SIDT1;SULT2B1
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.48037332808556227,1.1899555757774556,0.2703180212014134,0.7981265544809736,1.0,1/22,0.33%,CPEB2
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.5227810237999257,-1.1889201114514958,0.2571428571428571,0.573398626729887,1.0,6/11,31.97%,RPS3;HMCES;HMGA2;APEX1;APEX2;NEIL2
prerank,RNA methyltransferase activity (GO:0008173),0.5019170947452464,1.1879365735521454,0.25806451612903225,0.7980359917621874,1.0,1/19,0.80%,TRMT9B
prerank,high voltage-gated calcium channel activity (GO:0008331),0.5712360658405341,1.1872728147338902,0.286527514231499,0.7936875641406314,1.0,3/10,6.76%,CACNA1D;CACNA1C;CACNB3
prerank,GTPase regulator activity (GO:0030695),0.3490612883831536,1.1842341080958143,0.14374225526641884,0.7970327955964746,1.0,49/212,14.46%,RANBP3L;CPEB2;ARHGAP28;ARHGAP29;ERRFI1;SIPA1L1;SMAP2;RIN2;ARHGEF10L;SRGAP2;ARHGAP18;SYDE2;ARHGAP9;ALS2;ALDH1A1;NPRL3;RGS16;TBC1D16;ASAP3;LRRK2;GMIP;ARHGAP26;ARRB1;GPS2;ASAP1;NPRL2;ARHGAP17;ARFGAP3;ELMOD3;DNM1L;OPHN1;WASL;GRTP1;RALGAPB;MTSS2;RANBP3;OCRL;PDE6D;RALBP1;RGPD1;GNB5;KRIT1;RIC8B;RAP1GAP;HACD3;DEPDC5;SGSM2;FLCN;LLGL2
prerank,cytokine activity (GO:0005125),0.36342446601727835,1.1840012584666784,0.1934156378600823,0.7915336010472053,1.0,9/131,6.47%,WNT5B;BMP6;BMP7;WNT4;WNT6;IL18;IFNK;IL17D;IL12B
prerank,platelet-derived growth factor binding (GO:0048407),0.5551046383624523,1.1791056937709763,0.3066132264529058,0.8009498354317405,1.0,3/11,8.19%,COL5A1;PDGFRB;COL1A2
prerank,I-SMAD binding (GO:0070411),0.5375790943287855,1.1789873510788023,0.28893058161350843,0.7952663239328301,1.0,3/13,4.77%,SMAD3;TGFBR1;SMAD6
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.5547088871640399,1.1768064344213978,0.2879684418145957,0.7958120421001595,1.0,3/10,6.71%,RENBP;GALM;DSE
prerank,pyridoxal phosphate binding (GO:0030170),0.49630315647234224,1.1759105436538777,0.273224043715847,0.7924566092767494,1.0,5/20,12.61%,PYGM;SRR;CTH;ABAT;ACCS
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.5406624456520015,-1.1756585257653378,0.2907216494845361,0.6012134875930257,1.0,4/10,8.39%,DPP10;DPP6;FAP;NAALAD2
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.4818958864154158,-1.1738384293308792,0.256198347107438,0.6001660296650593,1.0,3/13,3.18%,PIP5K1B;PIP4K2A;PIK3C2B
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.4661611086545499,-1.1733241293337664,0.28104575163398693,0.5961165272449781,1.0,4/14,9.26%,MAL;APAF1;NOD1;ATP2A3
prerank,calcium-release channel activity (GO:0015278),0.5142157254283954,1.1697914065802857,0.27071823204419887,0.8051631093431167,1.0,3/17,3.73%,ITPR2;ITPR1;TPCN1
prerank,ubiquitin-protein transferase activity (GO:0004842),0.3297374201364658,1.1694090204592422,0.1535796766743649,0.8003107191855616,1.0,77/346,18.79%,RNF220;RNF152;PDZRN3;SH3RF2;UBE2E2;RNF43;ASB2;PRKN;TRIM63;RNF213;KCMF1;DTX1;NEDD4;NHLRC4;RNF151;RNF135;TRIM56;RNF181;UBR4;MGRN1;UBR2;SMURF2;TTC3;RNF8;FBXW11;BCOR;RNF141;HUWE1;TRIP12;RNF217;BTRC;RNF19A;RNF34;UBR5;FBXO22;SH3RF1;UBE2M;RNF41;FBXW8;FBXO4;RNF13;CDC42;WWP2;CUL4A;FBXO10;TRIM62;ASB12;DDB2;PML;FBXO11;DTX3;DZIP3;UBE2H;RNF115;RMND5A;AMFR;RNF31;HECTD1;RNF146;BIRC6;BIRC3;MAEA;RNF19B;UBR1;RNF7;UBE2E1;KCTD13;SYVN1;CDC34;RNF25;RNF20;TAF1;ARIH1;MIB2;ASB1;NHLRC3;RNF214
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.5049144640499754,1.1682981282432618,0.2952029520295203,0.7976702392564963,1.0,7/17,15.44%,DPYD;BDH2;PTGR2;MECR;TM7SF2;LBR;DECR1
prerank,MAP kinase kinase activity (GO:0004708),0.5174163446922785,1.1679927120515836,0.29454545454545455,0.7928698525050611,1.0,8/15,18.76%,LRRK2;MAP2K5;MAPKAPK3;MAPK10;MAP2K1;MAP2K2;MAP2K6;MAPK14
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),-0.3903379038091229,-1.166936330966553,0.21875,0.6066866420492765,1.0,14/35,22.71%,PEAK1;PTK2B;LYN;BMX;PTK2;TEC;FES;SYK;PKDCC;BTK;TXK;SLA;YES1;FYN
prerank,cholesterol transfer activity (GO:0120020),-0.46126425967511886,-1.1636780085905556,0.2698744769874477,0.609338051815406,1.0,6/16,12.11%,PLTP;ABCG1;NPC2;STARD5;MTTP;STARD4
prerank,phospholipase activity (GO:0004620),-0.3355418671460459,-1.1601587320157303,0.1783625730994152,0.6126375977888067,1.0,13/67,14.41%,PLCB4;PLCL1;PLA2G4A;PLCE1;MGLL;GDPD1;PDIA3;PLA2G12A;ENPP2;SMPDL3A;PITPNM3;PNPLA3;ABHD4
prerank,GABA receptor binding (GO:0050811),0.5518564482106777,1.1597191361247354,0.304,0.8113219580487542,1.0,3/11,10.10%,TRAK1;ARFGEF2;SHISA7
prerank,nucleoside monophosphate kinase activity (GO:0050145),-0.43420593625821474,-1.1590524898635388,0.271461716937355,0.6099696852704098,1.0,5/20,11.32%,DLG2;MAGI3;CASK;MPP1;CMPK1
prerank,translation elongation factor activity (GO:0003746),-0.4714764037906917,-1.1526422112350276,0.28354978354978355,0.6213319220530967,1.0,10/14,37.79%,EEF1A1;EIF5A2;EEFSEC;EEF2;TUFM;EEF1A2;GTPBP2;GFM1;EEF1B2;GTPBP1
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.44486563089983644,-1.1507655801757501,0.28794642857142855,0.6157966054215339,1.0,5/17,7.96%,EPHB1;EPHA5;EPHA6;EPHA7;EPHB2
prerank,ephrin receptor activity (GO:0005003),-0.44486563089983644,-1.1507655801757501,0.28794642857142855,0.6157966054215339,1.0,5/17,7.96%,EPHB1;EPHA5;EPHA6;EPHA7;EPHB2
prerank,cardiolipin binding (GO:1901612),0.54980757476651,1.149456849646524,0.3245967741935484,0.8360307709853235,1.0,2/10,7.06%,GSDME;OPA1
prerank,transaminase activity (GO:0008483),0.5375467455271747,1.1480169370254365,0.32719836400818,0.8345920553146287,1.0,5/11,19.84%,BCAT2;GOT2;ABAT;GOT1;GOT1L1
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.42857610992920236,1.145454297111925,0.27053140096618356,0.8364314574520753,1.0,11/35,20.86%,TRMT9B;PTRH1;TARS2;DUS4L;PUS10;LCMT2;NT5C3A;DUS3L;DTWD2;DUS2;DUS1L
prerank,hexosyltransferase activity (GO:0016758),-0.31140408648014656,-1.1418911917739438,0.19343065693430658,0.6326629377367101,1.0,17/101,12.19%,TMTC2;CSGALNACT1;MGAT4C;GCNT2;CHSY3;FUT9;EXT1;MGAT4A;DPY19L1;B4GALT5;B3GALT1;HEXB;B3GALNT1;EXT2;LFNG;MFNG;B3GALT5
prerank,ribosome binding (GO:0043022),0.40623947639707436,1.1412664573135596,0.2838499184339315,0.8428701044986235,1.0,6/46,12.07%,CPEB2;CPEB4;CPEB3;YTHDF3;IGHMBP2;ETF1
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.5422481717257734,1.141087449870308,0.3246492985971944,0.8374690008751584,1.0,1/11,1.47%,NUDT4
prerank,leucine zipper domain binding (GO:0043522),0.5529096686719371,1.1392730108590114,0.3057199211045365,0.8370605849309093,1.0,1/10,0.75%,PAWR
prerank,transcription corepressor binding (GO:0001222),0.44737488048925134,1.1391287403333157,0.288135593220339,0.8316906806612281,1.0,9/27,17.01%,RORA;LCOR;USP11;PHF1;PER2;EHMT2;PER3;EHMT1;CTBP2
prerank,copper ion binding (GO:0005507),0.41621200690080407,1.1334448239039796,0.2986627043090639,0.8423389447219478,1.0,5/42,6.50%,MOXD1;LACC1;SOD3;LOXL3;TP53
prerank,Tat protein binding (GO:0030957),-0.5013496911905334,-1.132719499736914,0.3387096774193548,0.6510006326837738,1.0,2/10,2.48%,ACTB;MDFIC
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.4455211400011496,-1.1296915640147556,0.3076923076923077,0.6535624810346254,1.0,6/15,18.32%,PLA2G4A;PLEKHA5;JPH2;SESTD1;PHLDA3;PLA2G4E
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.3696484974317442,-1.129613257267461,0.28805620608899296,0.6485318708345995,1.0,6/34,5.31%,CYTH3;ARAP2;MYO10;MYO1B;IQGAP1;ARAP3
prerank,voltage-gated calcium channel activity (GO:0005245),0.42025908311179644,1.128050682688199,0.3121951219512195,0.8527121368284382,1.0,5/37,6.76%,CACNA1D;CACNA2D3;CACNG4;CACNA1C;CACNB3
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.3869492793386038,1.1280304370285619,0.27884615384615385,0.847005017978318,1.0,5/55,3.20%,CACNA1D;SLC24A3;ITPR2;ITPR1;MCU
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.48596291595030683,-1.1279046081713084,0.33140655105973027,0.6480179231481417,1.0,2/12,13.37%,CDK19;CDK8
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.5213858319596424,1.1278779242171457,0.32723577235772355,0.8417733757852697,1.0,2/11,2.95%,SASH1;PPEF2
prerank,protein phosphatase binding (GO:0019903),-0.2922458997423574,-1.125445421788356,0.1935483870967742,0.6497792300567886,1.0,30/117,16.20%,PIK3R1;MAP3K5;PTPRT;IQGAP1;PPP1R16B;STAT3;GRIN3A;DAB2IP;MET;FOXO1;KCNQ1;PTK2;PPP1R16A;CEACAM1;FBXL2;MFHAS1;JAK1;FLT4;ERBB2;AKAP11;ATP2B4;MTMR9;CTNNB1;MAPT;SMG5;KIF3A;STRN4;MYO16;EIF2AK3;SKAP1
prerank,endopeptidase inhibitor activity (GO:0004866),0.3677567813873662,1.1226546472564447,0.27714285714285714,0.8517212644664154,1.0,10/82,8.46%,ITIH2;TIMP3;TFPI;SERPIND1;RENBP;COL4A3;KNG1;SERPINE1;SERPINA9;HRG
prerank,sterol transfer activity (GO:0120015),-0.435555541793599,-1.1222167772980502,0.3091684434968017,0.6528193974260211,1.0,6/17,12.11%,PLTP;ABCG1;NPC2;STARD5;MTTP;STARD4
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.30442071865766906,1.120167733913794,0.19300106044538706,0.853618936657056,1.0,120/597,17.59%,HLF;MAF;THRB;SMAD3;OSR1;NFYC;CUX1;PKNOX2;CREB5;HOXB4;GLI2;ZBTB20;HOXB6;GABPB1;GABPB2;HOXA1;ZNF568;ARID4A;NFAT5;SOX5;ELF1;NR6A1;GLI3;ARNT2;FOXC1;NFIB;MAFG;ATOH1;MBNL2;NFYB;CREB3L2;NHLH2;SMAD6;CUX2;BNC2;TEF;ESRRA;HOXB9;HOXB5;TP53;TBL1X;BHLHE41;RORC;SOX12;ZSCAN29;ZIC5;BCOR;ELF2;NR1D2;HOXC4;TBL1XR1;ZIC1;IRX1;TEAD2;KLF3;CALCOCO1;HDAC4;GLI1;ZBTB26;ZIC4;TCF7;NR2C2;SOX13;ASH2L;FOXC2;TCF7L2;TCF4;ABL1;PRDM5;NFATC3;RARG;ATF2;HNRNPL;SKOR1;MYBL2;TEAD1;HES6;HOXB2;BRD7;FOXA2;NR3C2;IRF1;KMT2D;KAT7;ZBTB48;FOXJ2;DHX33;MCM7;MCM2;BEND3;TBP;ORC3;ATF6B;NCOR1;ZBTB32;SNAI1;PER2;HOXA7;E2F4;NFKB1;TAF7;HOXB8;HSF2;MZF1;NKX2-1;TGIF2;RXRA;RFX2;PER3;CENPC;HSF4;KLF15;HIVEP1;SMAD4;MEF2D;TCF7L1;MBD4;POU1F1;ELF4;BARX2
prerank,phosphatase activity (GO:0016791),0.3736179851902421,1.1200533684154943,0.29895366218236175,0.8483078689508332,1.0,11/73,11.59%,ATP1A2;PPP1CB;CILP2;LHPP;HDDC2;PXYLP1;PTPN22;PRUNE1;DUSP10;OCRL;NOCT
prerank,L-amino acid transmembrane transporter activity (GO:0015179),-0.3366970079575957,-1.1193149142798857,0.27089337175792505,0.6554212532057767,1.0,16/53,13.22%,SLC47A1;SLC1A5;SLC7A5;SLC1A2;SLC38A6;SLC1A1;SLC7A1;SLC25A13;SLC1A4;SLC38A5;SLC17A6;SLC43A2;SLC6A7;SLC43A1;SFXN1;SLC38A7
prerank,phospholipase binding (GO:0043274),0.5197155768537828,1.11918487398226,0.3474088291746641,0.8454758905331681,1.0,3/13,8.75%,PRKN;ARHGAP6;PDPK1
prerank,ATPase binding (GO:0051117),-0.3207411962010474,-1.117707274867189,0.24786324786324787,0.6546037341341703,1.0,15/71,8.80%,PDE4D;CAV1;SLC2A13;ESR1;ATP6V0A1;ATP1B1;AR;NKD2;TRPC1;PSEN1;ATP6V0A4;PPP3CA;RDX;RALB;DNAJC10
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),-0.48508693484388177,-1.1161901747588696,0.3165938864628821,0.6534965746693805,1.0,1/11,2.10%,HCN1
prerank,ATP hydrolysis activity (GO:0140603),0.40696513208451685,1.1130337284311982,0.32263242375601925,0.858300666917528,1.0,6/41,8.12%,ABCA4;RNF213;MYO18A;DDX3X;CLPX;MYO19
prerank,protein tyrosine phosphatase activity (GO:0004725),0.3716419894926838,1.1121977737412976,0.3011527377521614,0.8552262991608289,1.0,15/71,9.29%,EYA1;PTPN13;EYA2;PTPN14;PTPN9;MTMR3;EYA4;TNS2;PTPN23;PTPRU;PTPN22;CDC14A;PTEN;PTPN21;CDC25A
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.409021118546806,-1.112013721560523,0.3060240963855422,0.6591299408965301,1.0,2/21,3.80%,GRIK2;GLRB
prerank,N-acetyltransferase activity (GO:0008080),0.46673905204118765,1.1093105665226228,0.3496376811594203,0.858583943763619,1.0,9/19,26.48%,NAA80;SAT1;SMARCE1;KAT2B;EP300;ESCO1;NAT1;AANAT;NAA50
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.32783214671607486,1.1089839168171332,0.26640926640926643,0.8542765595747792,1.0,60/181,18.96%,SMAD3;PPARGC1A;PPARA;NCOR2;ARNT2;RERE;IFI27;NHLH2;CHD4;PIAS1;NCOA3;TEAD3;TP53;BCAS3;BHLHE41;SMARCD3;LDB2;LDB1;MEF2A;SMARCA4;RBL2;SPEN;CDK5RAP3;PARP9;SMARCE1;HDAC4;SIRT1;HDAC1;TCF7L2;ATN1;MKKS;RBL1;ATF2;RBBP8;WWP2;BBS10;HES6;TBP;SIN3A;TAF4;NCOR1;MIER3;CTDP1;FAF1;MTA2;PIAS3;HIF1AN;BBS2;RXRA;RB1;CREBBP;GTF2I;MED1;POU1F1;RNF25;KDM1A;CRY1;TAF1;MAPK14;PIAS4
prerank,vinculin binding (GO:0017166),-0.48222096398789904,-1.1084017995941038,0.33013435700575816,0.6634659627945143,1.0,3/11,6.69%,UTRN;ACTN1;CORO2B
prerank,SH2 domain binding (GO:0042169),0.429083706303973,1.1068045817909256,0.35194585448392557,0.8554619433820619,1.0,5/31,6.84%,AFAP1;INPPL1;DAG1;SH3PXD2B;AFAP1L2
prerank,symporter activity (GO:0015293),0.5337205859356708,1.1064612214313787,0.36792452830188677,0.8510509859493351,1.0,2/10,6.87%,SLC5A5;SLC5A8
prerank,titin binding (GO:0031432),0.5140967625257766,1.1059603909992874,0.3388581952117864,0.84731214799002,1.0,2/13,2.82%,ACTN2;TRIM63
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.5071818771268026,1.1056359470698882,0.35946462715105165,0.8430504013578635,1.0,7/14,18.94%,RSAD2;NDUFS1;NFU1;ACO2;CIAO3;SDHB;ETFDH
prerank,peptide hormone receptor binding (GO:0051428),-0.4805101452715873,-1.1028822693618041,0.3464566929133858,0.6721159456124141,1.0,8/11,50.79%,PTHLH;GNRH1;VIP;UCN2;CCK;GPHB5;ADCYAP1;GHRH
prerank,gated channel activity (GO:0022836),-0.45505274660459866,-1.0981192410614784,0.3548387096774194,0.679164602044179,1.0,4/14,19.05%,PIEZO2;PIEZO1;TMEM266;TMEM63A
prerank,epidermal growth factor receptor binding (GO:0005154),-0.3951443930550128,-1.0980620585788472,0.31877729257641924,0.6743235271252247,1.0,3/25,4.40%,HIP1;ERBB4;CCDC88A
prerank,cAMP response element binding (GO:0035497),0.523391175858519,1.0972896828215726,0.37816764132553604,0.8617049088184882,1.0,3/10,11.20%,CREB5;CREB3L2;ATF2
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.44520637480137826,-1.096979988115437,0.3458149779735683,0.6723986913076766,1.0,6/15,19.85%,PIK3R1;SOCS2;PIK3R6;SOCS5;PIK3R5;CCKBR
prerank,general transcription initiation factor binding (GO:0140296),-0.392591597637173,-1.096563714440534,0.32407407407407407,0.6685658746676361,1.0,12/25,29.05%,ESR1;AR;GTF2A2;YEATS2;TAF1B;HHEX;RUVBL2;RELA;DR1;THRA;DRAP1;AHR
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.4929554860756651,1.0953543509407162,0.35589941972920697,0.8619493569043598,1.0,2/13,4.25%,AGPAT4;GPAT2
prerank,syntaxin binding (GO:0019905),0.37620589092692786,1.0947241955198102,0.3454281567489115,0.8584318065604397,1.0,10/61,12.00%,SYT9;UNC13C;SYT12;STXBP4;LRRK2;STXBP2;VPS54;BLOC1S6;ABL1;VAMP1
prerank,enoyl-CoA hydratase activity (GO:0004300),0.5296710931029626,1.0832130923369718,0.3723196881091618,0.886373016612175,1.0,5/10,21.89%,ECHDC3;ECHDC1;EHHADH;HADHA;ECHS1
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.4294292071008636,-1.0817407579715936,0.3788546255506608,0.7012483064088332,1.0,2/15,2.84%,SLC26A7;SLC26A2
prerank,ankyrin binding (GO:0030506),-0.4124333182556991,-1.0816231968668149,0.3372365339578454,0.6965574268691738,1.0,6/19,13.54%,SLC8A1;SPTBN1;PTPRC;NRCAM;CDH1;SPTB
prerank,chemokine receptor binding (GO:0042379),-0.3560982993948038,-1.080909672753962,0.348780487804878,0.6934488351251921,1.0,23/35,47.13%,CXCL12;CXCL16;CX3CR1;CCL13;CCL19;CXCL10;CCL2;CCL28;CCRL2;CXCL5;CCL11;CXCL1;CCL4;PF4;PPBP;CCL8;CCL14;CKLF;CCL1;CCL3;XCL1;CXCL13;CXCL2
prerank,histone deacetylase activity (GO:0004407),0.4565342857285753,1.0806239036117025,0.36231884057971014,0.8887400125237848,1.0,6/19,14.58%,HDAC8;SIRT3;HDAC4;SIRT1;HDAC1;MIER3
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.5162299313390057,1.0804968028205142,0.39453125,0.8837740949889327,1.0,2/10,3.53%,CFLAR;CASP3
prerank,kinase binding (GO:0019900),-0.24542610388552308,-1.0770052826312173,0.1797752808988764,0.6981950931131515,1.0,93/434,12.99%,UTRN;DLG2;FRMD5;GHR;PTPRJ;UNC5C;RHOBTB1;SLC12A7;CAV1;GSN;ACTB;PDE8A;ESR1;CADPS;TTC28;POLA1;PTPRK;NBEA;IQGAP1;RND3;STAT3;BCAR3;SLC12A2;CIT;CAV2;RPS6;ACSL3;ACVRL1;TFRC;HDAC7;ARHGEF7;HSP90AB1;PPP1R12A;PPP2R5A;GSK3B;DAB2IP;RPS19;TIAM1;CNKSR2;CALM1;PTPRC;FLNA;LAPTM4B;SNAP91;CALM2;RPS3;PLCG2;RHOB;DCX;CSPG4;CRK;DNM1;RPS7;SMAD1;EEF1A1;PTK2;WWC1;PEBP1;PTN;IRAK3;CEACAM1;BTG1;VDAC1;NSF;TRPV4;MYOM1;RHOH;ADD2;CDK5RAP2;ACTA2;TRIM14;BCAR1;CALM3;PKD1;SLC12A4;MSN;DUSP3;PIK3IP1;CNTLN;TRIM27;EIF4ENIF1;ATF4;CTNNB1;ILK;ADIPOR1;FAS;IKBKB;INKA2;EMP2;CDKN1A;MAPT;HIF1A;AXIN1
prerank,mRNA binding (GO:0003729),0.3104160384760275,1.0766498582761186,0.30445544554455445,0.8897319437218191,1.0,65/249,18.67%,CPEB2;CELF2;SRRM2;DDX5;RBM47;CPEB4;RBMS2;LARP4B;SNRNP70;PCBP2;HNRNPR;IGF2BP1;SRSF5;DDX3X;ZC3H12B;TP53;ZCCHC13;CLUH;SNIP1;HNRNPA2B1;PABPC4L;SAMD4A;RBM15;LARP1;CPEB3;IGF2BP2;NOVA1;CSDC2;RBMS1;LSM14A;YTHDF3;LUC7L3;SCAF8;NUP98;HNRNPL;MRPS7;NOCT;DDX6;ETF1;DCP1A;RBPMS2;DHX33;ZC3H12C;HNRNPC;RSL1D1;PURB;NYNRIN;PABPC5;ZFP36L1;FUBP3;RBM4;SLC4A1AP;DAZAP1;HNRNPM;MARF1;GRSF1;CRYZ;RBMS3;SRSF1;EIF4G1;BOLL;RNF20;LARP4;SRBD1;PCF11
prerank,chloride transmembrane transporter activity (GO:0015108),-0.4261740658519207,-1.0765027145482713,0.3552036199095023,0.6943643311520169,1.0,3/16,4.70%,SLC26A7;SLC26A2;SLC1A1
prerank,peptidoglycan binding (GO:0042834),-0.48285151902249074,-1.0764082104175128,0.3884297520661157,0.68981720336381,1.0,3/10,17.24%,NOD1;PGLYRP1;NOD2
prerank,protein heterodimerization activity (GO:0046982),0.3219799261821712,1.0756410320974679,0.32452830188679244,0.8875488174309368,1.0,17/178,6.93%,ATP1A2;EPAS1;BMP6;TOP2B;NPAS3;ZHX2;ARNT2;ADRA2A;KRT1;BDKRB2;MIGA2;TLR4;TPM1;IL12B;TP53;MICU1;BHLHE41
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.3538807379600756,1.0755321793291264,0.32132564841498557,0.8826538391560382,1.0,7/72,2.78%,ACTN2;TULP3;GSDME;PICALM;SNX21;AVIL;FRMPD4
prerank,voltage-gated potassium channel activity (GO:0005249),0.348726345494341,1.0738319318883773,0.32503660322108346,0.8825935109381782,1.0,6/80,1.93%,KCNK2;KCNT1;KCNJ13;KCND3;KCNA5;LRRC38
prerank,metallopeptidase activity (GO:0008237),0.33434069069134137,1.073425401076196,0.32727272727272727,0.8787037317802935,1.0,24/113,15.78%,ADAM12;ACE;ADAMTS10;TRABD2B;ADAMTS2;ADAMTS15;ADAMTSL5;METAP2;ADAMTS9;ADAM30;MMP19;RCE1;CHMP1A;BMP1;ADAM28;MMP14;ADAM18;ADAM17;ERAP1;PITRM1;ADAMTS7;ZMPSTE24;NRDC;ANPEP
prerank,clathrin adaptor activity (GO:0035615),0.4792535082986477,1.0730076830098103,0.3938223938223938,0.8748298079197158,1.0,3/15,7.68%,DAB2;STON1;AP1G2
prerank,SUMO transferase activity (GO:0019789),0.47330066859744396,1.0690323533215476,0.3829787234042553,0.8811199091714736,1.0,6/16,20.99%,PIAS1;HDAC4;NSMCE2;PIAS3;PIAS4;UBE2I
prerank,DNA-binding transcription factor binding (GO:0140297),0.3166014736700113,1.069003729260523,0.3290653008962868,0.876148255417006,1.0,57/189,19.49%,SMAD3;FHL2;ZMYND8;PPARA;CXXC5;RERE;IFI27;NFYB;NHLH2;CHD4;PIAS1;TEAD3;TP53;SIK1;BHLHE41;LDB2;LDB1;MEF2A;RBL2;SPEN;HDAC4;SIRT1;TLE1;HDAC1;TCF7L2;ATN1;MKKS;RBL1;PRDM5;ATF2;RBBP8;WWP2;CBX5;BBS10;HES6;TBP;SIN3A;TLE2;NCOR1;MIER3;PURB;MTA2;PIAS3;BBS2;RB1;CREBBP;GTF2I;MEF2D;POU1F1;KDM1A;CRTC1;TAF1;NBN;PIAS4;YAP1;MTA1;RUNX1T1
prerank,small GTPase binding (GO:0031267),0.31552932559447344,1.0655677225839362,0.3384418901660281,0.8808941967009154,1.0,54/169,19.16%,RNF152;AFDN;PICALM;ARHGEF16;SRGAP2;FGD4;ALS2;AKAP13;GCC1;LRRK2;NOX1;RAB34;BRAF;RIN3;EXOC2;TRIOBP;RABGGTA;DNM1L;DOCK7;CYRIB;RNF41;FGD1;MTSS2;OCRL;PDE6D;RALBP1;MYO1C;MAPKAP1;RGP1;ANKRD27;RAP1GAP;GOLGA4;SGSM2;RUSC2;MICALL1;EXOC4;SPHK2;RAB29;ARFIP2;GOLGA5;TMEM127;KCTD13;SGSM3;OPTN;RABGEF1;PEX5;RANBP9;PAK2;TBC1D7;EVI5;RTKN;ARHGAP1;USP33;UNC13D
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.48630929556355484,1.0645903448609018,0.4011090573012939,0.8786035756666044,1.0,5/14,16.82%,ALDH4A1;MTHFR;ALDH1L1;AASS;MTHFD1
prerank,disordered domain specific binding (GO:0097718),-0.3816979276192178,-1.0632833384288098,0.38657407407407407,0.7185850792667458,1.0,6/23,10.44%,FN1;HSP90AB1;CALM1;CALM2;HSP90AA1;CALM3
prerank,phosphatidylinositol kinase activity (GO:0052742),0.46556408541274263,1.0610982315470805,0.39611650485436894,0.883706829733701,1.0,7/15,18.64%,PI4KA;ATM;PIK3CA;PIKFYVE;PIK3R3;PI4K2B;PI4KB
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.4996633624719394,1.0604434541058168,0.3879472693032015,0.8805650852214979,1.0,4/12,16.57%,SLC25A23;SLC19A1;SLC25A42;SLC25A17
prerank,kinase activity (GO:0016301),0.33365558703794207,1.0570579003060323,0.37446808510638296,0.8854720262866796,1.0,28/109,18.85%,NADK2;EPHA4;SPHK1;PI4KA;LRRK2;GK5;TKFC;GK;PANK1;PIK3CA;COQ8B;ITPKB;DCAKD;PPIP5K2;ABL1;CSNK2A1;COQ8A;SPHK2;CERK;FN3K;FCSK;SCYL3;NADK;IP6K3;PKN2;TAF1;PI4KB;CHKA
prerank,GTPase inhibitor activity (GO:0005095),0.4811588931105723,1.0564146439284796,0.41035120147874304,0.8823441141265139,1.0,2/13,5.71%,CPEB2;GPS2
prerank,double-stranded RNA binding (GO:0003725),-0.2984561449749245,-1.0562183523069013,0.35542168674698793,0.7317647448361112,1.0,20/70,19.43%,MBNL1;ACTN1;LRRFIP1;RFTN1;ADARB1;ADARB2;TFRC;HSP90AB1;MSN;DROSHA;FXR1;STAU2;VIM;STRBP;MTDH;DHX15;DHX9;EIF4A1;SLC3A2;TLR7
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.46665584132462307,1.0556488582019674,0.3977485928705441,0.8795217757287687,1.0,2/14,1.80%,KCND3;KCNA5
prerank,nucleotidyltransferase activity (GO:0016779),0.4545257768822803,1.0546898823371131,0.40950639853747717,0.8773632968396214,1.0,7/19,16.40%,DNTT;REV1;TUT4;TERT;TENT2;TENT4B;TUT7
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.34730705350245406,1.0542383523787335,0.38405797101449274,0.8739800808199036,1.0,13/69,16.31%,LPGAT1;SPHK1;MOGAT3;ASPG;CERS6;CERS5;KAT6B;ZDHHC18;ZDHHC1;PORCN;KAT2B;NAA16;CREBBP
prerank,aspartic-type peptidase activity (GO:0070001),0.5059764198413023,1.0540172791199314,0.4027777777777778,0.8697459109444973,1.0,1/10,1.47%,BACE2
prerank,cation channel activity (GO:0005261),0.3365459767716201,1.0535071960260929,0.36403508771929827,0.8663967017577037,1.0,5/94,3.20%,TRPM3;CACNA1D;SLC24A3;TRPM6;MCU
prerank,Notch binding (GO:0005112),0.4360002721967762,1.0528159901411394,0.41798941798941797,0.8636758532113911,1.0,4/22,3.66%,SNED1;NCOR2;AAK1;DTX1
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.4687270071930328,1.0522756910469904,0.41335740072202165,0.8605553037447922,1.0,1/16,0.19%,SLC13A3
prerank,beta-tubulin binding (GO:0048487),0.40200927560377797,1.0521906173803728,0.39492753623188404,0.8562525982418436,1.0,4/31,8.60%,GJB6;EML4;BCAS3;HTT
prerank,mitogen-activated protein kinase binding (GO:0051019),0.40947636463966686,1.050244595540826,0.391653290529695,0.8572438432840154,1.0,9/29,18.76%,ACE;MAPKAPK3;CDK5RAP3;SIRT1;ABL1;DUSP10;DUSP2;DUSP4;MAPK14
prerank,TBP-class protein binding (GO:0017025),-0.39172192126485134,-1.0496525639926795,0.3648960739030023,0.7436410281780724,1.0,10/21,29.05%,ESR1;GTF2A2;YEATS2;TAF1B;HHEX;RUVBL2;DR1;THRA;DRAP1;AHR
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.46488456870120637,-1.0490724972509042,0.4176954732510288,0.7402075663756453,1.0,4/10,14.21%,ANKRD13A;DNAJC2;LAPTM5;FAAP20
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.49440711762064793,1.0477779246139014,0.428842504743833,0.859574831856324,1.0,2/12,5.76%,GNAT2;RHO
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.5020673495377835,1.047424068198947,0.40535372848948376,0.8561891411814301,1.0,4/11,16.57%,SLC25A23;SLC19A1;SLC25A42;SLC25A17
prerank,ligand-gated calcium channel activity (GO:0099604),-0.40469923818475806,-1.045531115243456,0.3939393939393939,0.7445498406566179,1.0,9/19,19.38%,RYR2;GRIN2B;RYR3;GRIN2A;TRPM2;GRIN1;ITPR3;TRPA1;RASA3
prerank,chemokine activity (GO:0008009),-0.352423163242539,-1.0440295404697986,0.3957845433255269,0.7432207482584533,1.0,21/31,47.13%,CXCL12;CXCL16;CCL13;CCL19;CXCL10;CCL2;CCL28;CXCL5;CCL11;CXCL1;CCL4;PF4;PPBP;CCL8;CCL14;CKLF;CCL1;CCL3;XCL1;CXCL13;CXCL2
prerank,protein kinase C binding (GO:0005080),0.3811842629139592,1.0436254814201036,0.391025641025641,0.8624472044556228,1.0,10/43,13.89%,PARD6G;TOP2B;GRK5;PRKCB;DACT2;PICK1;ABL1;ITGAV;ADCY6;PRKCSH
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.3938518538478086,1.0427805530106773,0.39303482587064675,0.8603225864647155,1.0,13/34,22.70%,SMYD3;KMT5B;SETD7;NSD3;KMT5A;DOT1L;EHMT2;EHMT1;KMT2E;SETD3;N6AMT1;CAMKMT;EEF1AKMT1
prerank,acetylgalactosaminyltransferase activity (GO:0008376),-0.36392707185933204,-1.036529253416876,0.4056603773584906,0.7579763265381392,1.0,5/26,12.19%,CSGALNACT1;CHSY3;B3GALT1;B3GALNT1;B3GALT5
prerank,calcium:sodium antiporter activity (GO:0005432),0.4909881347906586,1.0361130633660596,0.4085603112840467,0.8739339260983127,1.0,2/10,1.99%,SLC24A3;SLC8A3
prerank,acyl-CoA hydrolase activity (GO:0047617),0.44952042346074406,1.0350541986964363,0.43902439024390244,0.8724661983887508,1.0,6/17,17.08%,ACSBG2;PLA2G6;ACOT11;ACOT8;THEM4;ACOT12
prerank,histone methyltransferase activity (GO:0042054),0.3942107160341539,1.0345403921805258,0.43577235772357725,0.8694487043454938,1.0,10/32,17.67%,SMYD3;KMT5B;SETD7;NSD3;KMT2C;KMT5A;DOT1L;EHMT2;EHMT1;KMT2E
prerank,aspartic-type endopeptidase activity (GO:0004190),0.48639944079999714,1.0344570164032245,0.43453510436432635,0.8653424473996807,1.0,1/12,1.47%,BACE2
prerank,RNA polymerase II complex binding (GO:0000993),0.39490305589303615,1.0314181600798407,0.42105263157894735,0.8693208206743719,1.0,6/32,12.71%,CTR9;ELOF1;NCOA3;RPRD2;SCAF8;WDR43
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.3807015892571969,-1.030794336447926,0.41013824884792627,0.767974573412038,1.0,5/21,16.78%,GRM5;GRIA1;GRM1;CHRNA7;CHRFAM7A
prerank,hydro-lyase activity (GO:0016836),0.38539999358234195,1.030354774210224,0.42338072669826227,0.8679860985162273,1.0,14/41,22.46%,ECHDC3;GMDS;HACD4;HACD1;UROC1;ACO2;HACD3;ECHDC1;EHHADH;L3HYPDH;HADHA;ECHS1;CBS;PCBD1
prerank,cholesterol binding (GO:0015485),-0.3173081495424274,-1.0288256789186065,0.40425531914893614,0.7681804531866955,1.0,13/47,12.21%,CAV1;OSBPL6;PROM1;ABCG1;PTCH1;NPC2;APOD;STARD5;VDAC1;OSBP2;STARD3NL;STARD4;ERLIN1
prerank,receptor ligand activity (GO:0048018),0.2945711275529966,1.0275955877311906,0.41277641277641275,0.8709795881309019,1.0,25/245,10.32%,FGF1;WNT5B;BMP6;BMP7;WNT4;IGF1;WNT6;IL18;METRNL;EDA;DPP4;TNFSF13;SEMA3B;F2;IFNK;IL17D;IL12B;OSGIN2;GDNF;NRG1;APLN;NBL1;HBEGF;CCL25;SLURP1
prerank,PDZ domain binding (GO:0030165),0.35414305260755957,1.027021145446406,0.4143070044709389,0.8681488652083235,1.0,11/61,7.93%,TGFBR3;ARHGAP29;PRKN;ARHGEF16;CXXC4;FZD8;SYNJ2;PLEKHA2;SLC22A5;SRR;PTEN
prerank,cation:chloride symporter activity (GO:0015377),0.4864502315286415,1.0258210566671524,0.439453125,0.8669984302914748,1.0,1/10,0.37%,SLC6A1
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.30590049408787034,1.025453851931862,0.41146496815286626,0.8637063780106737,1.0,45/188,16.98%,SMAD3;NFYC;ZBTB20;GABPB1;GABPB2;ZNF568;ARID4A;SOX5;FOXC1;NFYB;CREB3L2;SMAD6;BNC2;TP53;TBL1X;SOX12;BCOR;TBL1XR1;CALCOCO1;HDAC4;GLI1;TCF7;SOX13;ASH2L;FOXC2;TCF7L2;PRDM5;HNRNPL;BRD7;FOXA2;IRF1;KMT2D;ZBTB48;TBP;ATF6B;NCOR1;PER2;NFKB1;TAF7;MZF1;NKX2-1;RXRA;PER3;KLF15;SMAD4
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.4809105519477552,1.0238513155010855,0.43418467583497056,0.863630552131939,1.0,2/11,3.53%,CFLAR;CASP3
prerank,5'-3' RNA polymerase activity (GO:0034062),0.40543739345267915,1.0236210409122313,0.4440619621342513,0.8600983066400586,1.0,9/27,23.45%,POLR2A;POLR2D;TERT;TENT2;POLR3A;POLR2G;POLRMT;POLR2F;POLR3H
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.42113894000157076,1.02336169633102,0.44194107452339687,0.8566001891239451,1.0,2/22,2.72%,DUSP29;MTMR3
prerank,protein kinase binding (GO:0019901),0.28091407774262683,1.0227303620712596,0.41118421052631576,0.8540752254541792,1.0,64/479,11.35%,PRKAG2;MAPK4;PARD6G;SMAD3;ACE;ANK2;OXSR1;ERRFI1;KIF13B;SASH1;DLG1;TOP2B;KCNA5;RHOBTB2;PRKN;EPHA4;RHOD;GRK5;CCNA2;PRKAG3;TOM1L2;PPEF2;CEP250;PPP1CB;SUFU;NISCH;ADRA2A;TPRKB;EZR;NBEAL1;PRKCB;DACT2;GYS1;FZD5;PTPN23;EXOC2;TRIB2;PDGFRB;TP53;SIK1;CACUL1;RICTOR;CCND3;MAPKAPK3;CDK5RAP3;GPRC5B;CDH5;MVP;CDC25A;SIRT1;PICK1;MAVS;TCF7L2;BECN1;NOX4;IRGM;ABL1;CASS4;DUSP10;JTB;RNF13;ATF2;TRIB1;CDC42
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),-0.33922085279756087,-1.0224653647848527,0.44072164948453607,0.779466764497826,1.0,9/30,14.19%,CST3;GAS6;SPOCK1;RPS6KA3;SERPINB9;SNCA;RPS6KA1;CARD16;MT3
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.38628173059387916,1.0202458303341484,0.43463497453310695,0.856389309560937,1.0,9/34,15.17%,FAM20A;ALS2;DDX3X;RICTOR;CCNT2;IRGM;MAP2K1;MAP2K2;STK4
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.45801303735546384,1.0197859351691467,0.44565217391304346,0.8535392342979827,1.0,2/13,2.89%,SLC38A3;SLC7A2
prerank,triglyceride lipase activity (GO:0004806),0.4386314059775891,1.018465769460604,0.4280373831775701,0.8530220259842862,1.0,3/20,8.93%,CEL;PNLIP;DDHD2
prerank,gap junction channel activity (GO:0005243),0.42078231749935247,1.016203074778765,0.44013490725126475,0.8547143938179701,1.0,1/22,0.56%,GJB6
prerank,wide pore channel activity (GO:0022829),0.41631590579620675,1.0133566977359756,0.43833333333333335,0.8581501311367594,1.0,1/23,0.56%,GJB6
prerank,iron ion binding (GO:0005506),0.36385315499738036,1.0130902700547662,0.4105754276827372,0.8548696835535559,1.0,10/48,15.71%,KDM7A;TET2;SCD5;JMJD6;CYP2R1;NFU1;ACO2;PHF2;TET1;HIF1AN
prerank,UDP-glycosyltransferase activity (GO:0008194),-0.29169764991126507,-1.0104343576704111,0.39490445859872614,0.8063237141789529,1.0,13/70,12.19%,CSGALNACT1;MGAT4C;GCNT2;CHSY3;EXT1;MGAT4A;B3GALT1;HEXB;B3GALNT1;EXT2;LFNG;MFNG;B3GALT5
prerank,serine-type endopeptidase activity (GO:0004252),0.32849183039931734,1.0091138330821703,0.4349775784753363,0.8613462305955984,1.0,6/80,5.34%,CORIN;KLK2;F11;DPP4;CTSH;F2
prerank,phospholipase A2 activity (GO:0004623),-0.3546644237919275,-1.0082481880057526,0.4613526570048309,0.8072565699091392,1.0,6/26,23.28%,PLA2G4A;PLA2G12A;PNPLA3;PLA2G4E;PLA2G15;PLA2G4F
prerank,transition metal ion binding (GO:0046914),0.27943793660523925,1.006822583488701,0.4522502744237102,0.8630479999869285,1.0,57/397,12.42%,KDM7A;SMAD3;ACE;UPB1;MOXD1;SORD;ZMYND8;KMT2A;PRKN;LACC1;MPPED2;NAPEPLD;GLI2;LARGE1;CXXC5;CXXC4;SOD3;LOXL3;NAALADL1;CHD4;FBXL19;NSD1;TET2;BBOX1;SOD2;B4GALT1;BAZ1B;TP53;ENPP3;SIRT5;KNG1;SCD5;PLSCR1;RNF8;SAMHD1;KDM2B;ADAM30;KDM2A;SIRT3;HRG;JMJD6;CYP2R1;HDAC4;TAB2;NPEPPS;CHMP1A;PTGR2;DHH;ABL1;ZKSCAN5;FNTB;DHX58;NFU1;PHF5A;ACO2;ZMYM2;LARGE2
prerank,fibroblast growth factor binding (GO:0017134),0.421474596932749,1.0062380759003593,0.47549909255898365,0.8606026869187352,1.0,6/21,11.96%,FGFR2;KL;FGFR1;FIBP;KLB;ITGAV
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.4026729044798842,1.0048642948970747,0.43856655290102387,0.8600974094116126,1.0,7/24,17.98%,ITPKB;AK3;AK4;PPIP5K2;NME6;AK8;IP6K3
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.4814585340040489,1.002513778966291,0.4613821138211382,0.8619655543648751,1.0,2/11,1.46%,ITPR2;ITPR1
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.26456206723786935,-1.0019349063501732,0.46774193548387094,0.8187274552215025,1.0,13/100,6.44%,HIP1;CYTH3;ARAP2;MYO10;MYO1B;CERT1;PLA2G4A;IQGAP1;CLVS1;ARAP3;DAB2IP;LAPTM4B;PLEKHA5
prerank,chemokine binding (GO:0019956),0.3952809962320579,1.0014957243361464,0.4651567944250871,0.8607215015349294,1.0,3/30,3.73%,CCR9;ACKR2;PDPN
prerank,ATP binding (GO:0005524),0.2858790821872092,1.0007174322198968,0.45305164319248825,0.8589235148904814,1.0,42/266,15.29%,PRKAG2;ATP1A2;WNK4;KSR1;OXSR1;SPHK1;BMPR1A;OAS2;TGFBR1;DMPK;MYO18A;P2RX3;NUAK2;CLPX;CDC42BPG;SIK1;MOV10L1;GCK;SRR;PPIP5K2;MKNK1;ABCC6;BRSK1;SRPK2;ABL1;TRIB1;IGHMBP2;GALK1;PNKP;TDG;PRKCI;KIFC1;WNK1;OAS3;HSPA4;CAD;ATP5F1D;SYN3;STK17B;ACVR1B;STK4;CARS2
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.3671991401333855,0.9981106965964639,0.45234248788368336,0.8614795478003603,1.0,5/38,8.46%,TFPI;SERPIND1;SERPINE1;SERPINA9;HRG
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.43698462125476967,0.9956280775566583,0.47173489278752434,0.8636693553182174,1.0,2/15,4.25%,AGPAT4;GPAT2
prerank,cation transmembrane transporter activity (GO:0008324),0.3528233210287303,0.9950100266397919,0.44551282051282054,0.8613021813327133,1.0,7/48,7.87%,SLC41A1;SLC38A3;SLC7A2;SFXN2;SLC6A9;SLC25A2;SLC38A1
prerank,calcium channel activity (GO:0005262),0.3195606691651888,0.9912532932143083,0.4848920863309353,0.8667191158473321,1.0,9/84,8.36%,CACNA1D;SLC24A3;CACNA2D3;CACNG4;MCU;CACNA1C;CACNB3;TRPM5;ANXA9
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.40755781774271416,-0.9903990848793728,0.47629310344827586,0.8441809573797406,1.0,5/14,8.46%,SPOCK2;SPOCK3;NGF;TIMP2;SPOCK1
prerank,alpha-tubulin binding (GO:0043014),-0.33109074249679243,-0.9902305682646205,0.47002398081534774,0.8392387969322838,1.0,12/31,18.84%,TTLL7;DIP2B;TRPV4;PACRG;SETD2;TRIM36;SNCA;CDK5R1;ARL8B;EFHC2;SPAST;TBCE
prerank,zinc ion binding (GO:0008270),0.27798091946132863,0.9900404356059331,0.4982896237172178,0.8657990587777419,1.0,37/293,10.07%,KDM7A;SMAD3;ACE;UPB1;SORD;ZMYND8;KMT2A;PRKN;NAPEPLD;GLI2;CXXC5;CXXC4;NAALADL1;CHD4;FBXL19;NSD1;TET2;BBOX1;BAZ1B;TP53;ENPP3;SIRT5;KNG1;PLSCR1;RNF8;SAMHD1;KDM2B;ADAM30;KDM2A;SIRT3;HRG;HDAC4;TAB2;NPEPPS;CHMP1A;PTGR2;DHH
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.41136895102714477,0.9894063194312002,0.4664310954063604,0.8636579132671637,1.0,3/20,8.11%,SLC30A10;SLC30A2;SLC39A13
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.4284874071704141,-0.9840643381890334,0.48822269807280516,0.8507337818832027,1.0,4/12,7.77%,PIK3R1;GNAS;SOCS2;YWHAG
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.40887675092517894,-0.9838326528003761,0.47789473684210526,0.8460397026861677,1.0,5/12,21.19%,APAF1;NOD1;ATP2A3;RPS27L;PYCARD
prerank,protein serine/threonine kinase activity (GO:0004674),0.2759729072573943,0.9836918465529878,0.5286839145106862,0.8737735843945499,1.0,62/334,15.42%,MAPK4;WNK4;ROCK2;OXSR1;PRKCZ;FAM20A;PRKAA2;GRK5;STK32B;BMPR1A;TGFBR1;DMPK;AAK1;LRRK2;TP53RK;SMG1;PRKCB;IKBKE;ATM;CAMK1;BRAF;CLK4;NUAK2;CDC42BPG;SIK1;EIF2AK2;CPNE3;TGFBR2;MAPKAPK3;PDPK1;CSNK1A1;RIPK2;PIKFYVE;RIPK1;MKNK1;BRSK1;AURKB;SRPK2;DYRK1A;MYLK3;ARAF;PRKDC;MYLK;MAPK6;CSNK2A2;CSNK2A1;PRKCA;HIPK3;MAPK10;MAP3K1;PRKCI;RPS6KC1;WNK1;BMP2K;MAP2K1;GRK3;ACVR2B;STK17B;CLK1;ACVR1B;STK4;MAPK9
prerank,GTP binding (GO:0005525),-0.24452097786697954,-0.9822364722469333,0.4517766497461929,0.8451659214830066,1.0,59/172,25.52%,RHOBTB1;RHOJ;RIT2;RND3;RAB31;KRAS;RAP1B;RAP1A;GCH1;RASL12;RAB27A;RHOB;GNAI1;RERG;EEF1A1;RALB;TUBA1A;MFHAS1;GLUD1;RAP2A;RHOH;GBP4;TUBB4A;ARL5A;ARL1;RAB27B;ARL5B;ATL2;MTG2;RAB38;RAB6A;RAB32;TUBB2B;RRAS;ARF5;ARF6;RAB39A;ARL8B;RHOBTB3;TUBB3;ATL3;RHEB;RAN;TUBA4A;MMAA;PIP4K2B;RND2;RAC3;GNL2;GEM;RAB14;TUBA1B;RHOC;RND1;TUBA1C;TUBG2;RNF112;ARF3;RAB1B
prerank,ion gated channel activity (GO:0022839),-0.34508746708655386,-0.9809757985795152,0.47897196261682246,0.8432769918726929,1.0,8/24,15.40%,KCNT2;ANO4;ANO1;ANO3;TTYH2;TTYH1;ANO5;ANO2
prerank,phosphatidylinositol binding (GO:0035091),0.31572162349704225,0.9801949127128093,0.5014925373134328,0.8788874827332216,1.0,6/91,1.86%,APPL2;TULP3;ITPR2;PICALM;ITPR1;PARD3B
prerank,adrenergic receptor binding (GO:0031690),-0.3857797414545726,-0.9785204159480201,0.5075921908893709,0.8446026718894825,1.0,2/16,1.55%,PDE4D;GNAS
prerank,G protein-coupled receptor activity (GO:0004930),-0.2344685427097599,-0.9765323850208854,0.531578947368421,0.8444670889597493,1.0,55/239,23.20%,ADGRL3;ADGRB3;ADGRL4;ADGRL2;CALCRL;GRM5;ADGRG6;GRM3;ADRA1B;ADGRE5;GRM8;RORB;XPR1;PDGFRL;AGTR1;GRM1;S1PR1;GPR156;GABBR2;P2RY12;LGR5;PTH1R;CYSLTR1;HCRTR2;CYSLTR2;GPR63;CMKLR1;ADGRA1;ADGRB1;GPR26;ADGRG1;P2RY1;HRH1;GPR34;APLNR;VIPR2;ADGRD1;CX3CR1;S1PR3;C3AR1;GPR45;PAX8;ADGRG2;GPR176;S1PR2;ADCYAP1R1;ADGRE1;GRM4;DRD2;P2RY14;MC5R;LANCL1;CXCR4;LHCGR;GPR37L1
prerank,RNA stem-loop binding (GO:0035613),0.45101392220843256,0.9753461161613151,0.510556621880998,0.8872241276460889,1.0,2/12,8.32%,DDX3X;CPEB3
prerank,ion channel inhibitor activity (GO:0008200),0.36458073257404544,0.9748879665196271,0.4876847290640394,0.8844691412740548,1.0,3/35,3.86%,WNK4;ITPR1;NEDD4
prerank,protein homodimerization activity (GO:0042803),0.2646803897271216,0.9745974143734483,0.5570824524312896,0.8812168780381606,1.0,64/589,9.89%,NADK2;MAPK4;SMAD3;APPL2;UPB1;DUSP29;TPD52L1;PAXX;KIT;CPQ;MTUS2;KMT2A;ST6GAL1;FGFR2;SRGAP2;ZHX2;SNX6;ALS2;CRYL1;NPR3;NR2F2;FGFR1;BMPR1A;NR6A1;PGRMC1;ADRA2A;DPYD;LRRK2;PEX11A;ZBTB38;NACC2;DPP4;FOXP2;NAALADL1;LHPP;MIGA2;TPM1;IL17D;GBP3;ZNF318;GALM;BHLHE41;LDB1;PANK1;RNF8;GBP2;PON3;SRR;PEX11B;IDH1;CLN6;SLC39A13;TERT;GDNF;KLHL7;SLC51A;CYP2R1;DNM1L;SSBP1;RIPK2;CBY1;BLOC1S6;RIPK1;CHMP1A
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.31072347499282993,0.9736064011662792,0.5028818443804035,0.8799812284485484,1.0,12/91,9.26%,ACTN2;TULP3;GSDME;PICALM;SNX21;AVIL;FRMPD4;TTPAL;SH3PXD2B;WIPI1;ANXA9;PLCD1
prerank,inward rectifier potassium channel activity (GO:0005242),-0.3436909043020391,-0.9717916414773341,0.5033557046979866,0.8522785281472055,1.0,8/24,15.39%,KCNJ3;KCNJ2;KCNN2;ABCC9;KCNK1;KCNJ8;KCNJ6;KCNJ12
prerank,CXCR chemokine receptor binding (GO:0045236),-0.4263569718943266,-0.970957204615311,0.5256673511293635,0.8495213004549304,1.0,6/11,37.01%,CXCL12;CXCL10;CXCL5;CXCL1;PF4;PPBP
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.39311277760748786,-0.966684783599044,0.5225225225225225,0.8558373912490371,1.0,2/14,2.84%,SLC26A7;SLC26A2
prerank,protein phosphatase 1 binding (GO:0008157),0.40018991251547087,0.9665274317094106,0.5145299145299145,0.8936076288483314,1.0,3/21,10.15%,SH3RF2;PPP1R3B;PHACTR4
prerank,GTPase activity (GO:0003924),-0.23510733625267735,-0.9626855877255757,0.5803108808290155,0.8607204395960458,1.0,51/192,19.69%,DNM3;RHOBTB1;RHOJ;GNAS;RIT2;RND3;RAB31;KRAS;RAB3C;RAP1B;RAP1A;SRPRA;GCH1;RASL12;RAB27A;RHOB;GNAI1;DNM1;RERG;ARHGDIB;EEF1A1;RALB;GNA12;RAP2A;RHOH;GBP4;RAB18;ARL1;GNA14;RAB27B;GNB2;ATL2;HBS1L;MTG2;RAB38;GNAO1;GNAL;GNB1;RAB6A;RAB32;RRAS;SEPTIN9;TPPP;ARL8B;RHOBTB3;ATL3;RHEB;RAN;EEF2;MMAA;GPN3
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.3728163853054137,-0.9624956860304322,0.5177777777777778,0.8561055400371085,1.0,6/18,19.85%,PIK3R1;SOCS2;PIK3R6;SOCS5;PIK3R5;CCKBR
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.27753648429441036,0.9623520197137936,0.5511432009626955,0.9000582583263466,1.0,36/254,13.63%,HLF;SMAD3;TFDP2;NFYC;PPARA;CREBRF;HOXA1;NFAT5;ELF1;MITF;FOXC1;NFIB;HOXB3;VEZF1;NFYB;RREB1;MEIS1;TP53;SOX12;SMARCD3;PLSCR1;MEF2A;HOXC4;TFDP1;NR2C2;FOXC2;TCF4;MYBL1;NFATC3;ATF2;MYBL2;HOXB2;IRF1;FOXJ2;NFIA;ATF6B
prerank,hormone activity (GO:0005179),0.3343206051054097,0.9610948435853822,0.5039872408293461,0.899292017065217,1.0,9/54,17.49%,IGF1;METRNL;APLN;AGRP;SPX;CCL25;NPFF;INHA;NMB
prerank,double-stranded DNA binding (GO:0003690),0.26220459498988613,0.9596780083978379,0.5815450643776824,0.8991060309236102,1.0,69/531,12.98%,HLF;MAF;THRB;OSR1;CUX1;PKNOX2;CREB5;HOXB4;GLI2;ZBTB20;HOXB6;HOXA1;NFAT5;ELF1;NR6A1;GLI3;ARNT2;NFIB;MAFG;ATOH1;MBNL2;NHLH2;CUX2;TEF;ESRRA;HOXB9;HOXB5;CAMTA2;BHLHE41;RORC;SOX12;ZSCAN29;ZIC5;ELF2;FBH1;NR1D2;HOXC4;ZIC1;IRX1;TEAD2;KLF3;ZBTB26;RBMS1;ZIC4;TCF7;NR2C2;DDX60;FOXC2;TCF4;ABL1;MAU2;NFATC3;RARG;ATF2;RBBP8;PRKDC;MSH3;SKOR1;MYBL2;TEAD1;HES6;HOXB2;FOXA2;RAD50;NR3C2;PNKP;TDG;ZBTB48;FOXJ2
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.3943307882911475,-0.9587997842025102,0.5133928571428571,0.8608546873746529,1.0,6/14,15.39%,SLC1A2;SLC1A1;SLC25A13;SLC17A6;SLC38A7;SLC1A6
prerank,poly(A) binding (GO:0008143),0.404798707207217,0.956505029459691,0.5173010380622838,0.9031709675640147,1.0,9/21,18.47%,RBMS2;DDX3X;TIA1;PABPC4L;RBMS1;PABPC5;HNRNPDL;RBMS3;LARP4
prerank,translation initiation factor activity (GO:0003743),-0.31323975000668347,-0.9557924202734533,0.5260416666666666,0.8633856321925039,1.0,10/36,20.88%,EIF3M;EIF3F;EIF2B3;EIF3B;EIF1;EIF4E;EIF4A1;EIF3L;COPS5;EIF3D
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.4295018761126479,-0.9541054766691772,0.536144578313253,0.8627531115430493,1.0,2/10,9.64%,CD200;CD47
prerank,peptide N-acetyltransferase activity (GO:0034212),0.45147276954501514,0.9540962856532657,0.5294117647058824,0.9053769137013574,1.0,3/10,15.40%,NAA80;NAA20;NAA16
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.4478201556925338,0.9532988297385041,0.5166340508806262,0.9034596545706766,1.0,4/12,7.34%,TGFBR3;BMPR1A;TGFBR1;TGFBR2
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.37773884167180755,0.9532384658278854,0.5185185185185185,0.8998529706296995,1.0,6/29,12.14%,SLC13A3;SLC26A3;SLC19A1;SLC26A1;SLC25A12;SLC25A11
prerank,phosphatase binding (GO:0019902),0.30109882012570266,0.9531098128276387,0.5572625698324022,0.8964675677349753,1.0,14/105,10.45%,SH3RF2;SMAD3;DLG1;CHCHD3;MTMR3;MAGI2;IKBKE;TP53;SH2D4A;DLG3;CDH5;MVP;ELL;GTF2F1
prerank,calmodulin-dependent protein kinase activity (GO:0004683),-0.34308096868284915,-0.9521049949210908,0.5427251732101617,0.8630206392566757,1.0,5/24,12.22%,CAMK2D;PTK2B;EEF2K;CAMK4;DAPK1
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.4026800479830943,-0.9518441849064202,0.5646817248459959,0.8587336476009414,1.0,1/12,1.49%,ENTPD1
prerank,histone deacetylase binding (GO:0042826),0.30761378281187945,0.9515565657580529,0.53737658674189,0.8965133549338992,1.0,15/88,9.56%,TOP2B;PRKN;NCOR2;GLI3;NACC2;CHD4;LCOR;TP53;CAMTA2;BHLHE41;NIPBL;BCOR;MEF2A;HDAC4;HDAC1
prerank,receptor tyrosine kinase binding (GO:0030971),0.3260468563035154,0.9506781197024291,0.5596899224806201,0.894944580413385,1.0,12/56,12.34%,LRP4;PTPN14;ARHGEF16;FRS2;TP53;GAB2;CPNE3;NRG1;ALKAL2;FLT3LG;RNF41;PITPNM2
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.37893294470550176,0.9497429971873168,0.5160714285714286,0.8934543962727168,1.0,4/25,5.35%,MICAL3;CYP27A1;CYP26B1;POR
prerank,ferrous iron binding (GO:0008198),-0.34936530068274024,-0.9494921968202787,0.5257510729613734,0.8598361435162549,1.0,7/21,20.31%,FTH1;FTL;SNCA;EGLN2;ISCU;EGLN3;ALKBH3
prerank,GTPase binding (GO:0051020),0.27689942113177474,0.9485810042629614,0.5726817042606517,0.8925741668118274,1.0,59/194,19.16%,RNF152;AFDN;PICALM;ARHGEF16;SRGAP2;FGD4;ALS2;AKAP13;GCC1;LRRK2;NOX1;RAB34;BRAF;RIN3;EXOC2;TRIOBP;AMBRA1;RABGGTA;DNM1L;DOCK7;CYRIB;BECN1;RNF41;FGD1;MTSS2;OCRL;PDE6D;RALBP1;MYO1C;MAPKAP1;RGP1;ANKRD27;RAP1GAP;GOLGA4;SGSM2;RADIL;RUSC2;MICALL1;EXOC4;SPHK2;RAB29;ARFIP2;GOLGA5;TMEM127;KCTD13;SGSM3;OPTN;RRAGD;RABGEF1;PEX5;RANBP9;PAK2;TBC1D7;EVI5;RTKN;ARHGAP1;USP33;LAMTOR1;UNC13D
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.3413080980230464,0.9473829031830068,0.5249221183800623,0.8917459250475428,1.0,11/42,17.75%,CCNA2;CCNA1;CCNT2;CCND3;CCNB2;KAT2B;CCNG1;CCNL1;CCNE1;CNPPD1;HEXIM2
prerank,carbohydrate:cation symporter activity (GO:0005402),0.4460554871205611,0.9470675528395347,0.5278276481149012,0.88878787287027,1.0,2/11,12.28%,SLC5A3;SLC5A11
prerank,protein phosphatase activator activity (GO:0072542),-0.39485534642037756,-0.9443265440806123,0.5468409586056645,0.8684840011849422,1.0,4/13,10.44%,PPP2R5A;CALM1;CALM2;CALM3
prerank,RNA polymerase core enzyme binding (GO:0043175),0.35628319674437203,0.943898584816106,0.5383386581469649,0.8924840814285784,1.0,6/33,12.71%,CTR9;ELOF1;NCOA3;RPRD2;SCAF8;WDR43
prerank,cytokine receptor binding (GO:0005126),0.30851289031546403,0.9437213305382636,0.5426917510853835,0.8893855701029867,1.0,4/83,2.00%,TGFBR3;SMAD3;IL13RA1;IL18
prerank,N-methyltransferase activity (GO:0008170),0.4006148202527393,0.9433972640247237,0.528169014084507,0.8866167528780015,1.0,9/20,27.49%,HNMT;ZCCHC4;SETD3;GNMT;FDXACB1;N6AMT1;TRMT1L;METTL5;PEMT
prerank,transforming growth factor beta binding (GO:0050431),-0.3412804108980696,-0.9402272823550748,0.5578703703703703,0.8737884122905354,1.0,7/23,7.29%,LTBP1;LTBP4;ENG;THBS1;ACVRL1;TGFB3;CD109
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.4030472311851579,0.9397037120150289,0.5286506469500925,0.8916286602677266,1.0,4/18,7.34%,TGFBR3;BMPR1A;TGFBR1;TGFBR2
prerank,cGMP binding (GO:0030553),0.45157835892959314,0.9376650375501354,0.5723014256619144,0.8928742679933229,1.0,1/11,0.72%,PDE5A
prerank,adenyl ribonucleotide binding (GO:0032559),0.2666804795117616,0.9367047527067441,0.6208092485549133,0.8914569339503519,1.0,52/291,16.25%,PRKAG2;ATP1A2;WNK4;KSR1;OXSR1;MPPED2;SPHK1;PRKAG3;BMPR1A;OAS2;TGFBR1;DMPK;MYO18A;P2RX3;SLC19A1;NUAK2;CLPX;CDC42BPG;SIK1;MOV10L1;GCK;SRR;PPIP5K2;MKNK1;ABCC6;BRSK1;CNBD2;SRPK2;ABL1;TRIB1;IGHMBP2;GALK1;PNKP;TDG;PRKCI;KIFC1;WNK1;OAS3;HSPA4;COQ8A;CAD;ATP5F1D;POPDC2;SYN3;STK17B;ACVR1B;STK4;CARS2;APRT;STK36;VPS4A;TLK2
prerank,SH3 domain binding (GO:0017124),0.31707144451157654,0.9365663687654073,0.5552147239263804,0.8882217421028518,1.0,9/62,7.94%,ADAM12;AFAP1;PRKN;SYNJ2;REPS1;AFAP1L2;PTPN22;PLSCR1;CNTNAP1
prerank,phospholipase activator activity (GO:0016004),0.45876011076397694,0.936219751339649,0.547945205479452,0.885594181127976,1.0,2/10,8.75%,ARHGAP6;PDPK1
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.3527193112091798,0.9360949331775021,0.5528455284552846,0.8824226562455445,1.0,7/33,13.46%,CTR9;ELOF1;NCOA3;RPRD2;SCAF8;WDR43;TBP
prerank,lipase activator activity (GO:0060229),0.46427692754609373,0.9360229685844719,0.5461847389558233,0.8791507781139749,1.0,2/10,8.75%,ARHGAP6;PDPK1
prerank,methyl-CpG binding (GO:0008327),0.3902983127943604,0.9336509952231057,0.5623869801084991,0.8809952069742175,1.0,8/22,21.14%,CXXC5;CXXC4;ZBTB38;TET1;LRWD1;TET3;MBD1;MBD2
prerank,syntaxin-1 binding (GO:0017075),-0.3362345499788943,-0.9330990413450791,0.5812807881773399,0.8866230111784357,1.0,7/22,12.22%,SYT1;SNAP25;UNC13B;SYPL1;NSF;SYNPR;DAPK1
prerank,hyaluronic acid binding (GO:0005540),-0.4159848374581376,-0.9301869701336359,0.590818363273453,0.8889917600949241,1.0,3/10,9.92%,CEMIP;LAYN;CD44
prerank,lipase activity (GO:0016298),0.336865137385981,0.930079708353567,0.5536277602523659,0.8856381907709803,1.0,9/43,15.31%,CEL;LIPA;PLA1A;PNLIP;LYPLA1;DDHD2;ABHD12;SEC23IP;SMPD3
prerank,nucleoside-triphosphatase activity (GO:0017111),-0.21921207266525458,-0.9293846705341947,0.7469879518072289,0.8861957640135488,1.0,90/248,27.02%,DNM3;RHOBTB1;RHOJ;GNAS;RIT2;RND3;MYL6;RAB31;MYH9;KRAS;RAB3C;RAP1B;RAP1A;SRPRA;GCH1;RASL12;RAB27A;RHOB;GNAI1;DYNC1I1;DNM1;RERG;ARHGDIB;EEF1A1;RALB;MYO6;GNA12;ABCD2;RAP2A;RHOH;GBP4;RAB18;KIF26A;HSP90AA1;ARL1;GNA14;RAB27B;ATP2B1;GNB2;ATL2;HBS1L;MTG2;RAB38;GNAO1;CLU;GNAL;GNB1;RAB6A;RAB32;RRAS;DHX9;SEPTIN9;TPPP;KIF15;ARL8B;RHOBTB3;ATAD1;DNA2;ATL3;RHEB;RAN;EEF2;MMAA;GPN3;CFTR;MYO1E;RND2;RAC3;GNL2;GEM;GPN2;RAB14;KIF5A;RHOC;RUVBL2;KIF14;RND1;MMUT;SAR1B;EEF1A2;RNF112;RAB1B;RHOG;GNG3;ABCA3;RAB5B;RAP2C;GNG8;KIF1A;TDRD9
prerank,phosphatase activator activity (GO:0019211),-0.37272035932680364,-0.9280094552271526,0.5446623093681917,0.8847026409025942,1.0,5/14,10.44%,PPP2R5A;CALM1;CALM2;BMP2;CALM3
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.3562982092874239,-0.9278657993827703,0.5697940503432495,0.8802412708902666,1.0,3/18,8.96%,STXBP6;ANXA1;PDLIM1
prerank,potassium ion antiporter activity (GO:0022821),0.40492083102580395,0.9271375505612472,0.549718574108818,0.8888677698629792,1.0,1/15,0.61%,SLC24A3
prerank,CoA hydrolase activity (GO:0016289),0.4053358976603245,0.9251354510525447,0.5518518518518518,0.8897927727895282,1.0,4/16,17.08%,ACSBG2;ACOT11;ACOT8;ACOT12
prerank,phosphatidic acid binding (GO:0070300),-0.3486422994855162,-0.925038025691409,0.5639412997903563,0.8822382978540342,1.0,6/19,14.66%,MARK1;PITPNC1;PLTP;RAPGEF6;JPH2;SESTD1
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.4386522940171387,0.9250007043967563,0.5688259109311741,0.8867121088311274,1.0,3/11,15.40%,NAA80;NAA20;NAA16
prerank,serine-type peptidase activity (GO:0008236),0.2920477279898138,0.9249309437923705,0.5801418439716312,0.8835174216392754,1.0,7/96,6.07%,CORIN;KLK2;F11;DPP4;CTSH;F2;TPP1
prerank,protein kinase C activity (GO:0004697),0.42444511331048984,0.9247616735563992,0.5652985074626866,0.8805635137751008,1.0,5/14,12.99%,PRKCZ;SMG1;PRKCB;PRKCA;PRKCI
prerank,lipoprotein particle receptor binding (GO:0070325),-0.3210874906064592,-0.9239393535699973,0.5905882352941176,0.8800206141417368,1.0,9/27,19.16%,SYT1;APOE;HSPG2;RELN;AP2M1;SNX17;CLU;DNAJA1;LDLRAP1
prerank,endopeptidase activator activity (GO:0061133),-0.42923697290354296,-0.9238792740268992,0.5560081466395111,0.8754808266285296,1.0,3/10,18.43%,VSIR;PSMD14;APH1A
prerank,alanine transmembrane transporter activity (GO:0022858),-0.4050792937440808,-0.9221793109969535,0.5643776824034334,0.874719865773674,1.0,4/12,13.22%,SLC6A6;SLC1A4;SLC38A5;SLC38A7
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",-0.4095774315674028,-0.9188781691802332,0.5669456066945606,0.8776037488359323,1.0,5/10,29.91%,EXD2;POLD1;TATDN1;MGME1;APEX1
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.4170485406829192,0.9155497035379044,0.5481335952848723,0.8977024450473118,1.0,5/13,19.02%,DNASE1L1;DICER1;DNASE1L2;FEN1;SLX4
prerank,cytochrome-c oxidase activity (GO:0004129),-0.3675851422956881,-0.9142863161452055,0.5846501128668171,0.8840222693911568,1.0,7/15,26.46%,COX4I1;COX6A1;CYB5A;COX5B;COX5A;NDUFA4L2;COX4I2
prerank,ribonuclease P activity (GO:0004526),0.4163225085258212,0.9126384100570555,0.5408560311284046,0.9003954920471721,1.0,4/11,20.86%,RPP21;PRORP;POP7;POP1
prerank,signal sequence binding (GO:0005048),-0.3018267445714291,-0.9098385261940076,0.5995085995085995,0.8899670320309689,1.0,11/35,21.78%,PEX5L;CEMIP;NFKBIA;KDELR3;AP2B1;CABP1;AP2M1;CAT;RANBP6;TOMM20;POM121
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.40570039818124376,0.9096539954767473,0.5694716242661448,0.9037412401491345,1.0,5/14,20.86%,TSEN2;RPP21;PRORP;POP7;POP1
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.35795406510459654,0.9092477277516657,0.5885416666666666,0.901332755492773,1.0,2/27,1.99%,SLC41A1;SLC8A3
prerank,aminopeptidase activity (GO:0004177),0.3642250688692855,0.9090005733053079,0.5670103092783505,0.8985541073481683,1.0,8/26,17.61%,CTSH;NAALADL1;METAP2;NPEPPS;MMP14;ERAP1;ANPEP;XPNPEP1
prerank,neurexin family protein binding (GO:0042043),0.43584191910921377,0.908314850549188,0.5675675675675675,0.8966657536550415,1.0,3/10,3.74%,SYTL3;NLGN2;CEL
prerank,protein phosphatase 2A binding (GO:0051721),-0.32174586955284024,-0.9060390578975925,0.6155660377358491,0.8945751779554484,1.0,7/23,13.82%,GRIN3A;DAB2IP;FOXO1;MFHAS1;MAPT;SMG5;STRN4
prerank,guanyl ribonucleotide binding (GO:0032561),-0.22261319173898278,-0.9059826515900129,0.75,0.8900138463858047,1.0,50/196,19.53%,RHOBTB1;RHOJ;PDE10A;PDE11A;RIT2;RND3;RAB31;KRAS;RAP1B;RAP1A;GCH1;RASL12;RAB27A;RHOB;GNAI1;RERG;EEF1A1;RALB;TUBA1A;MFHAS1;GLUD1;PDE2A;RAP2A;RHOH;GBP4;RAB18;TUBB4A;ARL5A;ARL1;RAB27B;ARL5B;ATL2;MTG2;RAB38;RAB6A;RAB32;TUBB2B;RRAS;ARF5;ARF6;RAB39A;ARL8B;RHOBTB3;TUBB3;ATL3;RHEB;RAN;TUBA4A;MMAA;PIP4K2B
prerank,adenylate cyclase binding (GO:0008179),0.4283380430937794,0.9048164207571642,0.5551330798479087,0.9010907281439883,1.0,2/10,3.92%,ADCY5;AKAP12
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.4156072316519097,0.9041476726002837,0.5661080074487895,0.8992585742452169,1.0,6/12,23.73%,TENT2;TENT4B;PAPOLG;TENT5C;TUT1;TENT5D
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.4037158692516471,-0.9025463587342141,0.6106382978723405,0.8934307484553421,1.0,2/11,2.45%,SGMS1;SGMS2
prerank,mRNA 5'-UTR binding (GO:0048027),-0.3198349857696135,-0.9025135734816474,0.5879629629629629,0.8889121395463008,1.0,5/24,7.78%,RPL41;RPL26;SYNCRIP;RPL5;RPS7
prerank,lysophospholipase activity (GO:0004622),-0.339226862847121,-0.9023020721269003,0.6031042128603105,0.8848610251082459,1.0,5/20,14.41%,PLA2G4A;MGLL;GDPD1;ENPP2;ABHD4
prerank,tubulin binding (GO:0015631),-0.21245389306701282,-0.9015371845381128,0.8509316770186336,0.8820476732316894,1.0,70/295,17.71%,DNM3;MTUS1;SGIP1;UNC5C;MAP1B;SYBU;AGBL4;STARD9;NAV3;TTLL7;REEP1;MID1;CLASP2;KIF21A;DST;MID2;CCDC88A;ARHGEF7;ARHGEF2;PAK1;RPS3;STMN2;DCX;DIP2B;DYNC1I1;KIF5C;DNM1;KIF26B;MTCL1;TUBGCP2;MAP6;FGF13;TRPV4;RP1;PACRG;CDK5RAP2;KIF26A;CLIP2;EML5;SETD2;SPEF1;MAP4;TRIM36;MAPT;RAB11FIP5;CLIP1;SNCA;KIF3A;CETN3;CDK5R1;GAS2L3;CCDC88C;ATF5;TERF1;STMN1;ALDOA;TTLL5;MAP1LC3A;KIF21B;MAP7D3;TPPP;GABARAPL2;APC;NUSAP1;CENPE;KIF15;ARL8B;EMD;FAM161A;CAPN6
prerank,magnesium ion binding (GO:0000287),0.27868940573034345,0.9010235950357143,0.6509186351706037,0.902542559814124,1.0,26/135,15.74%,EYA2;OXSR1;SPHK1;CLYBL;LRRK2;ATP4A;NUAK2;CDC42BPG;SIK1;MOV10L1;OPA1;PLSCR1;SRR;IDH1;BRSK1;SRPK2;ABL1;TDG;PGM1;THTPA;CERK;TDP2;STK4;XXYLT1;NT5C3A;RP2
prerank,solute:proton symporter activity (GO:0015295),-0.35577786056264515,-0.8995002752681888,0.5961945031712473,0.8819248506526896,1.0,1/16,1.50%,SLC2A13
prerank,anion:anion antiporter activity (GO:0015301),-0.3468298370691556,-0.8992735432066493,0.62004662004662,0.8780203782076665,1.0,2/17,2.84%,SLC26A7;SLC26A2
prerank,low-density lipoprotein particle receptor binding (GO:0050750),-0.33030759648509705,-0.8980519579631934,0.620137299771167,0.8763030946325558,1.0,8/22,19.16%,SYT1;APOE;HSPG2;AP2M1;SNX17;CLU;DNAJA1;LDLRAP1
prerank,ATPase regulator activity (GO:0060590),0.33355186008477866,0.8974797498542701,0.6076158940397351,0.9069455103367665,1.0,2/38,2.20%,ATP1B3;FNIP1
prerank,protein tyrosine kinase binding (GO:1990782),0.2955780945174448,0.8964445792324619,0.6340740740740741,0.9060208345365813,1.0,15/71,12.34%,LRP4;PTPN14;EPHA4;ARHGEF16;TP53;CPNE3;NRG1;CDH5;ALKAL2;FLT3LG;NOX4;CASS4;RNF41;PTPN11;PITPNM2
prerank,heme binding (GO:0020037),0.3021627534859692,0.8959416300795005,0.6226993865030674,0.903790048331144,1.0,11/65,11.43%,CYP27A1;FLVCR2;PGRMC1;CYP21A2;CYP26B1;SLC48A1;HRG;CYP2R1;CYB561D2;NOX4;CYB5B
prerank,cysteine-type peptidase activity (GO:0008234),-0.255664785560777,-0.8948059606458005,0.6850152905198776,0.8789021365014523,1.0,25/73,21.03%,USP29;OTUD7B;CTSC;USP13;CTSB;PDIA3;CAPN2;UCHL1;CTSL;CTSS;CASP6;ATG4A;USP50;USP46;CTSO;USP14;USP8;CASP2;USP2;CTSZ;OTULINL;CASP4;ATG4B;USP42;SFRP1
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.26903684718321275,0.8946488410650483,0.6778350515463918,0.9031804981441426,1.0,24/173,12.35%,AEBP1;MXI1;PPARA;FOXP4;ZBTB20;KCNIP3;MITF;NACC2;FOXP2;OTP;BHLHE41;RORC;IRX1;ZBTB26;SOX13;ZFP90;ZNF219;PRDM5;ZBTB6;NFATC3;MNT;ZBTB1;ZNF148;DEAF1
prerank,calcium-dependent phospholipid binding (GO:0005544),0.3118109579362585,0.89424060586952,0.6114754098360655,0.900755645586903,1.0,7/49,8.36%,SYT9;SYT11;SYT12;FER1L5;CPNE3;ANXA5;ANXA9
prerank,estrogen receptor binding (GO:0030331),0.3397338419319113,0.8936987521076311,0.6135986733001658,0.8986287235241929,1.0,4/32,7.19%,PPARGC1B;NSD1;LCOR;WIPI1
prerank,O-methyltransferase activity (GO:0008171),0.4227500790653589,0.8871311785206405,0.5897920604914934,0.9092177546695374,1.0,3/10,13.33%,LRTOMT;ASMT;CMTR2
prerank,tau-protein kinase activity (GO:0050321),0.36846953152516837,0.8866289079441796,0.5800711743772242,0.907047333273608,1.0,3/20,10.71%,ROCK2;BRSK1;DYRK1A
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.39273507656329265,-0.8850878773223987,0.6037735849056604,0.896292427735732,1.0,6/11,19.38%,RYR2;RYR3;TRPM2;ITPR3;TRPA1;RASA3
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.32847333747802565,-0.8842665204772723,0.6430205949656751,0.8936774887159865,1.0,6/21,18.08%,AKAP6;RYR2;KCNQ1;WASF1;WASF2;ACBD3
prerank,miRNA binding (GO:0035198),0.33926214121948334,0.8838390164042327,0.6115843270868825,0.9097330738373991,1.0,13/30,26.19%,ZC3H7B;HNRNPA2B1;TUT4;ZNF346;RBM4;TUT7;ZC3H10;FMR1;AGO1;SPOUT1;AGO4;AGO2;PUM2
prerank,cytokine receptor activity (GO:0004896),-0.24939705177612434,-0.8825263906912315,0.7128378378378378,0.8931354469345018,1.0,21/83,18.18%,GHR;IL1R1;OSMR;LIFR;IL1RAP;IL1RAPL2;F3;IL6ST;FZD4;IL17RD;IFNGR2;CD44;IL4R;CMKLR1;CNTFR;IL31RA;GFRA1;CX3CR1;GFRA2;CD74;CRLF1
prerank,Wnt-activated receptor activity (GO:0042813),-0.3529690458533513,-0.8821881092812739,0.6271186440677966,0.8894169641593855,1.0,4/15,10.70%,ROR1;FZD4;TSPAN12;PKD1
prerank,nuclear import signal receptor activity (GO:0061608),0.3894931309957547,0.8786962271302625,0.5992647058823529,0.917376195390147,1.0,7/15,28.29%,TNPO1;KPNA6;TNPO2;HIKESHI;KPNA4;IPO4;KPNA1
prerank,endopeptidase activity (GO:0004175),0.24942700780583488,0.8785288962259231,0.7317365269461078,0.9144860354378963,1.0,52/257,19.77%,ACE;CORIN;ADAMTS10;BACE2;KLK2;F11;TRABD2B;ADAMTS2;ADAMTS15;CASP3;ADAMTSL5;DPP4;CTSH;F2;ADAMTS9;USP9X;USP24;TPP1;USP11;MMP19;RCE1;ADAM28;USP34;MMP14;ADAM17;USP49;USP12;USP7;MBTPS1;PCSK7;USP18;PITRM1;PREP;ADAMTS7;ZMPSTE24;NRDC;PLAT;CELA3A;USP37;TYSND1;PIDD1;PRSS36;USP48;USP1;ADAMTSL4;CLPP;USP33;PCSK4;USP16;USP35;AFG3L2;ECEL1
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.3674852336114457,0.8778633515450511,0.6238532110091743,0.9127396338141558,1.0,8/22,19.96%,PARP10;IKBKE;TAB2;ZBTB1;UIMC1;OPTN;SQSTM1;WDR81
prerank,nuclear export signal receptor activity (GO:0005049),-0.382858851318743,-0.876223345495569,0.6282608695652174,0.8976564039279372,1.0,4/11,21.24%,XPO1;EIF4ENIF1;RAN;XPO6
prerank,steroid hydroxylase activity (GO:0008395),0.37875593374547156,0.8758899916359408,0.6086142322097379,0.9136728655327789,1.0,3/16,8.78%,CYP27A1;CYP21A2;CYP2R1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.42229035063708453,0.8754460184260087,0.6112115732368897,0.91137130098477,1.0,4/10,18.15%,NSD1;NSD3;ASH1L;SETD3
prerank,exopeptidase activity (GO:0008238),0.31076399881138084,0.8752270487699216,0.6546875,0.908656943941285,1.0,14/50,17.61%,ACE;DPP4;CTSH;NAALADL1;DPP8;METAP2;RCE1;NPEPPS;FOLH1;ERAP1;ZMPSTE24;ANPEP;DPP7;XPNPEP1
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.4027465068669894,0.873333306144925,0.6057142857142858,0.9092958777783656,1.0,1/11,1.34%,KCND3
prerank,CARD domain binding (GO:0050700),-0.3582501150035934,-0.8719833925473461,0.6297071129707112,0.902059788336299,1.0,6/14,19.14%,NOD1;CARD14;CARD16;NOD2;CARD19;CASP4
prerank,signaling receptor complex adaptor activity (GO:0030159),-0.281851209497311,-0.8705417357178249,0.6906077348066298,0.900737275509541,1.0,16/38,20.50%,PIK3R1;SHANK3;GRIP1;NCK2;G3BP2;SHANK2;SH2B2;AXIN1;SHANK1;NCK1;BLNK;LDLRAP1;SPATA2;IRS1;SHC1;SPAG9
prerank,solute:sodium symporter activity (GO:0015370),-0.30265074894131,-0.8683317555947505,0.6823821339950372,0.9012208540895472,1.0,2/27,5.45%,SLC4A10;SLC5A6
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.27918875776949054,-0.8622811444758889,0.7055837563451777,0.9092887311077015,1.0,9/38,15.98%,HIP1;PLA2G4A;DAB2IP;PLEKHA5;JPH2;SESTD1;PHLDA3;ZFYVE28;SNX27
prerank,ATPase activator activity (GO:0001671),0.36802982709207116,0.8612107572483094,0.6355311355311355,0.930921412187241,1.0,1/20,0.71%,ATP1B3
prerank,poly-purine tract binding (GO:0070717),0.35100382264726004,0.8607904702236093,0.6404682274247492,0.9285543586303209,1.0,10/27,18.47%,RBMS2;DDX3X;TIA1;PABPC4L;RBMS1;PABPC5;HNRNPDL;DAZAP1;RBMS3;LARP4
prerank,myosin V binding (GO:0031489),-0.3500385065496514,-0.8597660513088297,0.6587982832618026,0.9100615106989981,1.0,9/15,38.60%,RAB3C;RAB27B;RAB6A;RAB14;RAB3A;RAB3B;RAB6B;RAB25;RAB11A
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.237987952430714,0.8581429230603476,0.835005574136009,0.9307724935691577,1.0,70/431,16.25%,PRKAG2;ATP1A2;WNK4;KSR1;OXSR1;RHOQ;RHOBTB2;RHOD;SPHK1;BMPR1A;OAS2;TGFBR1;DMPK;LRRK2;MYO18A;GNAT2;P2RX3;ATL1;GBP3;NUAK2;CLPX;CDC42BPG;SIK1;GBP7;MOV10L1;GCK;GBP2;SRR;RRAS2;GTPBP4;PPIP5K2;ARL4A;RAB11B;MKNK1;ABCC6;BRSK1;RAB13;SRPK2;ABL1;RAB22A;RABL6;TRIB1;CDC42;IGHMBP2;GALK1;PNKP;TDG;PRKCI;KIFC1;WNK1;OAS3;HSPA4;DNM2;TUBB2A;CAD;GBP6;ATP5F1D;SYN3;REM1;STK17B;RAB29;ACVR1B;STK4;RAB21;CARS2;ARFIP2;ARL6;STK36;VPS4A;TLK2
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.35927281451406995,0.857601471052666,0.6677966101694915,0.9284974265088743,1.0,4/20,12.65%,SENP3;USP9X;DESI2;USP7
prerank,endonuclease activity (GO:0004519),0.3032520629031851,0.8550690857954798,0.6793313069908815,0.9305846185238076,1.0,16/49,24.43%,ZC3H12B;SND1;DICER1;PNKP;ZC3H12C;DIS3;NYNRIN;CPSF3;MBD4;OGG1;FEN1;AGO1;REXO4;SMG6;N4BP2;LACTB2
prerank,protease binding (GO:0002020),0.27126333235026906,0.8523241357845234,0.7279102384291725,0.9330796926152111,1.0,17/99,9.72%,TIMP3;PRKN;CFLAR;DPP4;BDKRB2;POLG;CD28;LCOR;TP53;SERPINE1;COMP;PTEN;COL1A2;TWNK;ANXA9;RIPK2;STIM1
prerank,nuclease activity (GO:0004518),0.3014227732142995,0.8518146284986394,0.6970149253731344,0.9309385452360938,1.0,16/52,24.86%,DNASE1L1;PLSCR1;SAMHD1;SND1;REXO5;PNKP;DFFB;DIS3;DNASE1L2;OGG1;FEN1;RNASE12;MAP1S;REXO4;N4BP2;REXO1
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.3013064934653622,0.8510067886197638,0.6938775510204082,0.9293695113699052,1.0,11/49,17.89%,PARP10;ZFAND6;BABAM2;IKBKE;TAB2;ZBTB1;UIMC1;DZIP3;UFD1;OPTN;SQSTM1
prerank,palmitoyltransferase activity (GO:0016409),-0.29123353594384627,-0.8501552719967177,0.6941747572815534,0.9253404360130623,1.0,5/28,12.49%,ZDHHC9;HHAT;ZDHHC2;GOLGA7;ZDHHC14
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),-0.3270017032844982,-0.8490859185457519,0.684085510688836,0.9230992025873939,1.0,6/18,14.19%,GAS6;RPS6KA3;SERPINB9;SNCA;RPS6KA1;MT3
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.3478574353344022,-0.8406998451244014,0.668141592920354,0.9350007162052411,1.0,5/14,11.53%,MTMR6;MTMR2;MTMR11;MTMR7;MTMR9
prerank,single-stranded DNA binding (GO:0003697),0.26696129874474495,0.8392866825673426,0.7450704225352113,0.9488838036297299,1.0,25/93,21.23%,SSBP2;PCBP2;POLR2D;SAMHD1;FBH1;TWNK;SSBP1;RBMS1;RTF1;RBBP8;MSH3;IGHMBP2;TOP3A;MCM7;MCM2;PURB;TDP2;FUBP3;RAD51D;APTX;POU4F1;MCM9;POLR2G;MLH1;MCM5
prerank,SUMO binding (GO:0032183),0.37357187696170735,0.8362970155817114,0.6184448462929476,0.9516405319425314,1.0,13/13,62.67%,TDG;PML;USPL1;SIMC1;USP25;UBA2;CASP8AP2;HERC2;HABP4;RNF111;RNF4;CBX4;SERBP1
prerank,single-stranded DNA helicase activity (GO:0017116),-0.3206099204843569,-0.8362502331555443,0.7136563876651982,0.9395689532806716,1.0,12/19,30.71%,WRNIP1;DHX9;DNA2;RFC4;RFC2;POLQ;MCM6;RFC5;HELB;CHTF18;RAD51;PIF1
prerank,Hsp70 protein binding (GO:0030544),0.3201781093751172,0.8355277343155302,0.6655172413793103,0.9500652109406642,1.0,3/31,3.01%,PRKN;PPEF2;HDAC8
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",-0.34200687316637873,-0.8352453014306399,0.6852248394004282,0.9372744053900932,1.0,4/13,30.18%,SREBF2;IDI1;EBP;DDT
prerank,retinoid X receptor binding (GO:0046965),0.39301986845380793,0.8310686716304662,0.6717557251908397,0.9553080602967234,1.0,3/11,11.14%,NSD1;HMGA1;RARG
prerank,growth factor activity (GO:0008083),0.2737557722807615,0.8310417696314226,0.7320644216691069,0.9522084201439991,1.0,16/74,18.90%,FGF1;F2;IL12B;OSGIN2;GDNF;NRG1;HBEGF;OSGIN1;VEGFD;TGFA;INHA;AMELX;NRTN;ARTN;VEGFB;BTC
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.33420623527955795,0.830004948693562,0.6774744027303754,0.9508356492153391,1.0,6/27,12.36%,PPARA;PRKN;RNF217;RNF19A;DCUN1D5;ZMYM2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.39092495972179825,0.8298685757555183,0.650994575045208,0.9479526457907624,1.0,3/11,22.07%,PADI6;PADI4;ARG1
prerank,microtubule plus-end binding (GO:0051010),-0.3054252922261033,-0.8213280926868978,0.7214611872146118,0.9593937509276077,1.0,6/20,16.95%,CLASP2;DST;CLIP4;CLIP2;CLIP1;APC
prerank,peptidase activator activity (GO:0016504),-0.30405401219906875,-0.8186208238597394,0.7272727272727273,0.959860547073684,1.0,7/22,19.66%,CAV1;MAL;VSIR;PSMD14;PINK1;APH1A;PCOLCE
prerank,motor activity (GO:0003774),-0.23778379385142828,-0.8141948180108856,0.829971181556196,0.963568269367493,1.0,24/60,26.91%,STARD9;KIF21A;MYL6;MYH9;DYNC1I1;KIF5C;KIF26B;MYO6;KIF26A;KIF3A;KIF21B;CENPE;DNAH3;KIF15;KIF11;MYO1E;KIF5A;KIF22;KIF4A;KIF3B;KIF14;KIF23;KIF1A;KIF17
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.2891028027209721,-0.8119844131059255,0.7493734335839599,0.9631262072212488,1.0,7/24,14.66%,CERT1;PLA2G4A;DAB2IP;PLEKHA5;JPH2;PLEKHA3;SESTD1
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.31824177858860225,0.8118823955584965,0.7168874172185431,0.9786493052862373,1.0,4/28,9.73%,BID;BABAM2;EDA;RIPK1
prerank,calcium channel inhibitor activity (GO:0019855),-0.3536107058221707,-0.8080065808515832,0.7142857142857143,0.9658858806378473,1.0,5/11,12.96%,CALM1;CALM2;FKBP1A;SLC30A1;MCUB
prerank,galactosyltransferase activity (GO:0008378),0.3861135108010786,0.8073616735827125,0.6751968503937008,0.9837628759273749,1.0,4/11,13.28%,B4GALT1;A3GALT2;A4GALT;B4GALT2
prerank,DNA polymerase activity (GO:0034061),0.3301774304034136,0.8062358057043532,0.7125220458553791,0.9825638542833297,1.0,6/22,15.97%,POLM;POLG;REV1;TERT;POLE2;POLL
prerank,regulatory RNA binding (GO:0061980),0.295557987079784,0.8060945038929901,0.7317073170731707,0.9797132889167472,1.0,14/38,26.19%,ZC3H7B;HNRNPA2B1;TUT4;ZNF346;DICER1;RBM4;TUT7;ZC3H10;FMR1;AGO1;SPOUT1;AGO4;AGO2;PUM2
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.23200301075692661,0.8018905610594041,0.8841978287092883,0.984016827695824,1.0,33/269,11.88%,SMAD3;SNCAIP;PPARGC1A;SYT11;FHIT;PRKN;POLR2A;DTX1;FZD8;PCBP2;SLC22A18;SMAD6;IKBKE;FZD5;ARRB1;STAT2;TRIB2;TP53;TRIOBP;PTPN22;RNF8;AMBRA1;CDK5RAP3;RNF34;DNM1L;PARP9;RIPK1;BECN1;TRIB1;MAGEC2;GLMN;AXIN2;CUL4A
prerank,chemoattractant activity (GO:0042056),-0.28998333180056113,-0.8013089844177711,0.7800925925925926,0.973397689468865,1.0,6/26,15.05%,VEGFC;FGF2;BMP4;FGF7;VEGFA;SCG2
prerank,glucuronosyltransferase activity (GO:0015020),-0.3097734863113285,-0.8010040222592018,0.7437070938215103,0.9696325345862778,1.0,3/19,9.43%,CSGALNACT1;EXT1;EXT2
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.3237902998529492,-0.8008997825127038,0.7318181818181818,0.9654574491460209,1.0,5/16,11.53%,MTMR6;MTMR2;MTMR11;MTMR7;MTMR9
prerank,microtubule binding (GO:0008017),0.2335507195138933,0.8008410963494201,0.8695652173913043,0.9827313866365818,1.0,22/222,9.72%,FMN1;GJB6;MTUS2;EML4;KIF13B;HOOK2;KIF2A;EML2;CLASP1;LRRK2;EZR;CCDC69;MAP2;KIF3C;APC2;OPA1;KIF1B;FBXW11;CEP57L1;DNM1L;KIF1C;STIM1
prerank,RNA binding (GO:0003723),0.21135109577100325,0.8004675696751924,0.9819095477386934,0.9802725236426654,1.0,242/1321,18.00%,NSA2;CPEB2;PPARGC1B;CELF2;ROCK2;TRMT9B;BICC1;SRRM2;DDX5;PPARGC1A;NUDT4;POLR2A;HOXB6;MSI2;SON;SNTB2;RBM47;TNRC6A;CPEB4;IFIT1;IFIT2;MRPS23;ZC3H7B;OAS2;RBMS2;TDRD3;NXF2;FNDC3B;TNPO1;LARP4B;SNRNP70;IFIT3;KNOP1;PCBP2;PABPN1;MYO18A;PRRC2B;MBNL2;TLR3;EZR;SMG1;HNRNPR;KYAT3;RBM28;METAP2;IGF2BP1;FAM120A;HNRNPH1;SRSF5;DDX3X;ERI3;TRIM56;SIDT2;CCDC86;ZC3H12B;ANKRD17;PNO1;POLDIP3;EIF2AK2;ANXA11;MOV10L1;LGALS1;ZCCHC13;TNS1;CLUH;CPNE3;ZC3H4;TIA1;SNIP1;HNRNPA2B1;SIDT1;GOT2;MEX3A;MRPL37;MRPL2;TUT4;POLR2D;HUWE1;TNRC6B;PABPC4L;SAMHD1;SAMD4A;PARP12;TEP1;ATXN2;RBM15;SPEN;RBM39;LARP1;CPEB3;EXOSC7;TERT;SLTM;IGF2BP2;ARHGEF1;JMJD6;DIAPH1;NOVA1;SND1;FLYWCH2;RBM27;ZC3H18;DQX1;CSDC2;SSBP1;C1D;LRP1;RBMS1;KIF1C;ZC3HAV1;DDX60;SCAF4;LARP7;GPKOW;GTPBP4;CCAR1;KHDC4;MOV10;NUP42;PPAN;LSM14A;PTRH1;TRIP6;CRKL;YTHDF3;TBRG4;LUC7L3;GTF2F1;SCAF8;RRP36;KMT2C;SURF6;THRAP3;SRPK2;LRRC47;RTF1;ZNF346;SAP18;NOM1;EIF4A2;NUP98;DDX18;NXF1;ANKHD1;PNLDC1;PRKDC;HNRNPL;DHX58;RPP21;MRPS7;NOCT;CWC15;SUGP2;DICER1;NELFCD;PHF5A;SRSF11;NOP2;IGHMBP2;DDX6;ETF1;DCP1A;SLC25A11;CLTC;NOC4L;ALDH6A1;WDR43;POLR1G;CAST;AKAP1;RBPMS2;GSPT2;LBR;DHX33;OAS3;PNISR;ZC3H12C;PSIP1;RAMAC;ILF2;HNRNPC;RSL1D1;SCAF11;UBAP2L;MRPS26;DZIP3;IMMT;PUS10;SEC23IP;FCF1;RBM34;PURB;ATP5F1C;NYNRIN;PABPC5;PRPF3;LGALS3;ANXA7;ZFP36L1;SARNP;TENT4B;VIRMA;FUBP3;SNRNP40;SEPSECS;RBM4;HNRNPDL;SLC4A1AP;DAZAP1;DUSP14;FARSA;HNRNPM;CPSF3;RPP25L;DIDO1;TUT7;NEMF;EXD1;FRG1;GRSF1;ALKBH5;MRPL1;POP7;ILF3;ATXN2L;ZCRB1;PCDHGA9;DUS3L;RBMS3;DYNC1LI1;CHD2;PRPF6;KDM1A;HEXIM2;DDX55;FAM120C;FUS;EXOSC3;SRSF1;RPUSD4;EIF4G1;PKN2
prerank,1-phosphatidylinositol binding (GO:0005545),-0.32914363501656363,-0.8000811408927884,0.7587719298245614,0.962525531298368,1.0,6/15,15.84%,EPB41;SCARB1;SNAP91;SESTD1;ZFYVE9;WDFY3
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.26653123800234146,0.7991092123231451,0.7937219730941704,0.979528618567887,1.0,10/73,13.62%,LGR4;NPR1;NPR3;BDKRB2;MC2R;NMUR1;NLRP6;KISS1R;SORCS2;VIPR1
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.2966453918978971,-0.7989489504908541,0.7677725118483413,0.960213343887448,1.0,4/22,9.26%,ATP6V0A1;ATP2C1;ATP6V0A4;ATP2A3
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.3751467300934404,0.7989056534344138,0.72552783109405,0.9767651909284117,1.0,1/11,3.07%,AKR1B10
prerank,receptor antagonist activity (GO:0048019),0.3475980940099637,0.7986133167784254,0.7351851851851852,0.9742079811920553,1.0,1/17,2.82%,DKK3
prerank,tRNA binding (GO:0000049),0.28906790442914043,0.7963508916686308,0.7556270096463023,0.975004495378137,1.0,6/43,17.96%,TRMT9B;TERT;IGHMBP2;SEPSECS;NEMF;RPUSD4
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",-0.26777141144518424,-0.7926656007776852,0.7917620137299771,0.9665814794677919,1.0,2/29,3.31%,ACER3;ACER2
prerank,hexose transmembrane transporter activity (GO:0015149),-0.3316685872839171,-0.79204074144415,0.7505330490405118,0.9633869591655831,1.0,1/12,1.36%,SLC2A1
prerank,growth factor receptor binding (GO:0070851),0.2557738433118444,0.791409429045174,0.820627802690583,0.9804385462186235,1.0,17/95,13.89%,FGF1;KL;FRS2;PDGFRB;IL12B;PLSCR1;ATXN2;HBEGF;FER;TRIP6;KLB;ADAM17;GLMN;VEGFD;TGFA;ERAP1;TLR5
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.38237300037128735,0.7907560508487836,0.7103825136612022,0.9784514192123078,1.0,3/12,11.59%,PAN3;PNLDC1;NOCT
prerank,solute:anion antiporter activity (GO:0140323),0.35926540404725715,0.790132455992765,0.7264325323475046,0.9764262268768115,1.0,3/14,7.86%,SLC7A11;SLC26A3;SLC26A1
prerank,voltage-gated chloride channel activity (GO:0005247),0.3802841625902249,0.7884903912229329,0.6875,0.9763055618189571,1.0,2/10,7.30%,CLCN2;ANO6
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.37915640645864424,0.7884388507162854,0.720558882235529,0.9733457011210307,1.0,3/11,19.14%,UBR5;AMFR;UBE4B
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.3835324945469568,0.7884352127357486,0.6892430278884463,0.97032288838463,1.0,1/10,2.05%,LACC1
prerank,ubiquitin binding (GO:0043130),0.2625242258844506,0.7875534715993682,0.8068181818181818,0.9688469227995439,1.0,4/73,5.61%,SMAD3;PRKN;NEDD4;ASCC2
prerank,telomeric DNA binding (GO:0042162),0.3031859784323637,0.7874340302829012,0.768976897689769,0.9660742850327031,1.0,10/32,19.46%,SMG1;ACD;HNRNPA2B1;TERT;RAD50;ZBTB48;TELO2;KDM1A;TINF2;UPF2
prerank,protein kinase inhibitor activity (GO:0004860),-0.24609164741026163,-0.7872786427119491,0.8501291989664083,0.9670901827515861,1.0,9/42,18.37%,CIT;YWHAB;INKA2;CDKN1A;SNCA;SPRED1;NCK1;MBIP;SPRY4
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.34261160585842465,0.7870603040906433,0.7312614259597806,0.9636968414733884,1.0,4/17,13.56%,AK3;AK4;NME6;AK8
prerank,voltage-gated anion channel activity (GO:0008308),0.348862055522351,0.7869426091286674,0.724907063197026,0.9609384719476575,1.0,3/15,7.30%,CLCN2;VDAC2;ANO6
prerank,carboxylic ester hydrolase activity (GO:0052689),0.25094106700278734,0.786184283640877,0.8345323741007195,0.9592628207621766,1.0,11/85,10.53%,PAFAH2;CEL;LIPA;ASPG;PNLIP;LYPLA1;PON3;DDHD2;PLA2G6;PTRH1;ABHD12
prerank,C2H2 zinc finger domain binding (GO:0070742),0.37750745851907014,0.7861621792139103,0.711864406779661,0.9563689499176679,1.0,1/11,1.08%,SRRM2
prerank,nucleosomal DNA binding (GO:0031492),0.3289706858332984,0.7843692609668687,0.7357512953367875,0.9563217353692628,1.0,11/21,24.41%,CHD4;SMARCA4;SMARCC2;SMARCE1;HDAC1;HNRNPC;MTA2;SMARCD2;MBD2;SMARCB1;H1-0
prerank,ephrin receptor binding (GO:0046875),0.32371695428050773,0.7842992198686735,0.7336860670194003,0.9535489423936879,1.0,1/21,0.55%,EFNB2
prerank,deoxyribonuclease activity (GO:0004536),0.3457696627545853,0.7837085431554119,0.715370018975332,0.9516541454496918,1.0,5/14,21.51%,DNASE1L1;DFFB;DNASE1L2;MBD4;MAP1S
prerank,metalloendopeptidase activity (GO:0004222),0.25916854487432184,0.7834144827357123,0.8350983358547656,0.949303512854892,1.0,14/76,15.37%,ADAMTS10;TRABD2B;ADAMTS2;ADAMTS15;ADAMTSL5;ADAMTS9;MMP19;RCE1;MMP14;ADAM17;PITRM1;ADAMTS7;ZMPSTE24;NRDC
prerank,pyrophosphatase activity (GO:0016462),0.27832064982459426,0.783259226871405,0.7753164556962026,0.9467189498046282,1.0,5/50,6.64%,NUDT4;CILP2;LHPP;DDX3X;ENPP3
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.30172082244858633,0.7791763522997541,0.7790322580645161,0.9504229836072609,1.0,9/34,17.83%,ERI3;EXOSC7;ERI2;PAN3;PNLDC1;NOCT;DIS3;DIS3L;EXOSC3
prerank,ubiquitin protein ligase binding (GO:0031625),0.2259898731647907,0.7775079746330685,0.9119420989143546,0.950150803283089,1.0,30/254,11.88%,SMAD3;SNCAIP;PPARGC1A;SYT11;FHIT;PRKN;POLR2A;DTX1;FZD8;PCBP2;SLC22A18;SMAD6;IKBKE;FZD5;ARRB1;TRIB2;TP53;TRIOBP;PTPN22;RNF8;AMBRA1;RNF34;DNM1L;RIPK1;BECN1;TRIB1;MAGEC2;GLMN;AXIN2;CUL4A
prerank,"DNA binding, bending (GO:0008301)",-0.3179994060566673,-0.7767774632981211,0.7751091703056768,0.9796617772101429,1.0,5/14,16.80%,LEF1;TFAM;TERF1;HHEX;TOP2A
prerank,mannosyltransferase activity (GO:0000030),-0.28568992970518786,-0.7702384963651667,0.8233830845771144,0.9855076560862283,1.0,2/21,5.73%,TMTC2;DPY19L1
prerank,snoRNA binding (GO:0030515),0.2979054378549588,0.7689548665136857,0.75,0.9607239054822349,1.0,1/30,1.47%,NUDT4
prerank,hexosaminidase activity (GO:0015929),-0.32020442710473657,-0.7653340785602333,0.7604790419161677,0.9886258427175647,1.0,2/12,8.51%,CEMIP;HEXB
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.36382669550953617,0.7633568844842439,0.7076612903225806,0.9665414110783043,1.0,3/10,10.43%,ATM;PIK3CA;PIK3R3
prerank,neuropeptide receptor activity (GO:0008188),-0.26715380569090585,-0.7621147766712656,0.8489702517162472,0.9892435278265258,1.0,2/29,3.35%,SORCS1;SORCS3
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.3282522732464467,-0.7585624292113012,0.802,0.9902593340200423,1.0,4/11,15.93%,TERF2IP;TERF1;STN1;RPA1
prerank,death receptor binding (GO:0005123),0.33631541601510445,0.755950913261418,0.7659963436928702,0.9745954302589048,1.0,3/15,9.73%,BID;EDA;RIPK1
prerank,dynactin binding (GO:0034452),0.3465624669927316,0.7556718397907995,0.7227722772277227,0.9720860046837713,1.0,2/12,8.60%,SNX6;HTT
prerank,tau protein binding (GO:0048156),0.28093523376709056,0.755428736934003,0.8278145695364238,0.9696150420444051,1.0,3/40,5.21%,ROCK2;PICALM;MAP2
prerank,histone methyltransferase binding (GO:1990226),-0.3353509692416067,-0.7551361356390708,0.8016194331983806,0.9911903467061673,1.0,4/11,21.02%,HSP90AB1;CTNNB1;NOP56;LCORL
prerank,phosphatidylglycerol binding (GO:1901611),0.34308824976020874,0.7539424592491539,0.7455621301775148,0.9689368875804921,1.0,2/13,7.06%,GSDME;OPA1
prerank,aminoacyl-tRNA ligase activity (GO:0004812),-0.24432232185312464,-0.7517632589871386,0.8661800486618005,0.9915955544601784,1.0,4/37,12.10%,LARS2;WARS2;GARS1;DARS2
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.3332310204889256,-0.7516904349421404,0.7685774946921444,0.9875112705461743,1.0,4/10,18.97%,B4GALT5;B3GALT1;B3GALT5;B3GALT6
prerank,E-box binding (GO:0070888),-0.24253645182504868,-0.7514172422781279,0.8428927680798005,0.9837161212758181,1.0,18/34,35.52%,HES1;SREBF2;ATOH8;TWIST1;TAL1;ZEB1;TFAP4;SNAI2;TCF3;BHLHE40;AHR;PRMT5;PER1;PPARG;ASCL1;GATA3;NEUROD2;CIART
prerank,cysteine-type endopeptidase activity (GO:0004197),0.24496129823217067,0.7498825972459446,0.868421052631579,0.9718972921379805,1.0,25/78,22.45%,CFLAR;CASP3;CAPNS2;CTSH;USP9X;USP24;USP11;USP34;USP49;USP12;USP7;USP18;CAPN15;USP37;USP48;USP1;USP33;USP16;USP35;CASP12;GPAA1;CAPN8;USP5;CASP9;USP20
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.28528497653564094,0.7494082256907436,0.8093699515347335,0.9698097165562017,1.0,6/33,12.36%,PPARA;PRKN;RNF217;RNF19A;DCUN1D5;ZMYM2
prerank,3'-5' DNA helicase activity (GO:0043138),0.3309344504729654,0.748892746995206,0.7746741154562383,0.9677020672797252,1.0,4/16,13.35%,FBH1;FANCM;MCM7;MCM2
prerank,neuropeptide receptor binding (GO:0071855),0.33389096607219637,0.7484600186701083,0.7666666666666667,0.9654460492723929,1.0,2/14,9.11%,APLN;AGRP
prerank,manganese ion binding (GO:0030145),0.26787099755322874,0.7481625453278989,0.8259493670886076,0.9630982641392419,1.0,10/48,18.70%,MPPED2;LARGE1;SOD2;B4GALT1;ABL1;LARGE2;TDP2;XXYLT1;XPNPEP1;FEN1
prerank,kinase inhibitor activity (GO:0019210),-0.2494543902744067,-0.74674709383081,0.8935643564356436,0.9858230359348478,1.0,9/33,21.98%,YWHAB;RHOH;CDKN1A;SNCA;NCK1;MBIP;SPRY4;NPM1;LRP6
prerank,gamma-tubulin binding (GO:0043015),-0.2753827194054106,-0.7430114913614054,0.8474945533769063,0.9868897516612071,1.0,5/21,12.80%,ARHGEF7;PAK1;TUBGCP2;CDK5RAP2;RAB11FIP5
prerank,ribonuclease P RNA binding (GO:0033204),0.35008885775975784,0.7413573231570135,0.7669322709163346,0.9700069553187762,1.0,3/10,20.86%,RPP21;POP7;POP1
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.3559465647526908,0.7389090708565559,0.7699443413729128,0.9677789653349582,1.0,3/10,18.08%,DUSP10;DUSP2;DUSP4
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.3559465647526908,0.7389090708565559,0.7699443413729128,0.9677789653349582,1.0,3/10,18.08%,DUSP10;DUSP2;DUSP4
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.3025335858886289,0.7352821394585212,0.7971781305114638,0.9699267182008461,1.0,3/21,7.10%,POLM;POLG;REV1
prerank,water transmembrane transporter activity (GO:0005372),-0.3209961895962056,-0.7325548168496117,0.785234899328859,0.9963084157284577,1.0,2/11,7.57%,AQP4;AQP11
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.31041395013649464,-0.7320805421155533,0.8155737704918032,0.9926998719905002,1.0,5/12,20.08%,PIK3R1;SH2B2;BLNK;IRS1;SHC1
prerank,glucose transmembrane transporter activity (GO:0005355),-0.27876104650740985,-0.7318385188667197,0.8275862068965517,0.9889739602806038,1.0,1/17,1.36%,SLC2A1
prerank,omega peptidase activity (GO:0008242),-0.20309096857323625,-0.7303715058070496,0.9615384615384616,0.9867934253985546,1.0,19/89,17.74%,USP29;OTUD7A;ASRGL1;OTUD7B;USP13;PSMD14;UCHL3;UCHL1;USP31;YOD1;USP53;USP50;USP46;USP22;VCPIP1;APEH;USP14;USP8;USP2
prerank,WW domain binding (GO:0050699),0.2928869741136842,0.7289491032864531,0.8161512027491409,0.9758102610774334,1.0,7/26,19.43%,PMEPA1;TCEAL8;TCEAL6;SCNN1A;PRRG4;NDFIP1;WBP1
prerank,deubiquitinase activity (GO:0101005),-0.20189393502282016,-0.7268346445013588,0.9768211920529801,0.98727064410184,1.0,24/88,23.65%,USP29;OTUD7A;OTUD7B;USP13;PSMD14;EIF3F;UCHL3;UCHL1;USP31;YOD1;USP53;USP50;USP46;USP22;VCPIP1;USP14;USP8;USP2;COPS5;MINDY1;USP42;MYSM1;BAP1;JOSD2
prerank,RNA polymerase binding (GO:0070063),0.3099766698716074,0.7250008206999231,0.802536231884058,0.9781462072157061,1.0,4/18,10.47%,NEDD4;PABPN1;CCNT2;SCAF8
prerank,NAD-retinol dehydrogenase activity (GO:0004745),-0.2926603597881262,-0.7219058552092152,0.8336980306345733,0.9891938117079997,1.0,2/14,10.97%,RDH10;ADH1A
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.2765264494231278,0.7171333526287161,0.844551282051282,0.985582557427937,1.0,8/33,17.83%,ERI3;EXOSC7;ERI2;PNLDC1;NOCT;DIS3;DIS3L;EXOSC3
prerank,neuropeptide hormone activity (GO:0005184),0.2919710676436067,0.7126200169483919,0.8128249566724437,0.9885179455041964,1.0,4/22,17.49%,AGRP;SPX;NPFF;NMB
prerank,DNA secondary structure binding (GO:0000217),0.26924779467443605,0.7117588399561895,0.8634751773049646,0.9868655570158908,1.0,5/31,11.25%,KMT2A;HMGA1;FANCM;ABL1;RBBP8
prerank,O-acyltransferase activity (GO:0008374),0.27351998489046825,0.7108810399206426,0.8474870017331022,0.9851630311429608,1.0,3/30,5.99%,MOGAT3;GPAT2;PIGW
prerank,NF-kappaB binding (GO:0051059),-0.25323070222510785,-0.7089430405373457,0.908256880733945,0.9999460457666354,1.0,7/24,24.04%,NFKBIA;GSK3B;TAF4B;MTDH;NPM1;SETD6;RELA
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.28162910767585575,0.7087369198757839,0.8362676056338029,0.9850896531685166,1.0,7/27,23.45%,POLR2A;POLR2D;POLR3A;POLR2G;POLRMT;POLR2F;POLR3H
prerank,proton transmembrane transporter activity (GO:0015078),-0.2281294566795501,-0.7076349857247807,0.9021164021164021,0.9972797040559738,1.0,14/39,32.33%,COX4I1;COX6A1;CLCN3;CYB5A;UQCR11;COX5B;COX5A;ATP6V1F;NDUFA4L2;ATP6V1B2;COX4I2;UQCR10;CLCN4;SLC4A11
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.2739552954691038,0.7072816016575175,0.8516129032258064,0.9840712689971504,1.0,1/31,0.77%,UBE2E2
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.30771001326193914,-0.7071704057178075,0.8505050505050505,0.9897899783993175,1.0,3/11,21.77%,HSPH1;BAG5;BAG2
prerank,adenyl nucleotide binding (GO:0030554),-0.30771001326193914,-0.7071704057178075,0.8505050505050505,0.9897899783993175,1.0,3/11,21.77%,HSPH1;BAG5;BAG2
prerank,3'-5' exonuclease activity (GO:0008408),0.2553078589098542,0.7062548033193496,0.8776758409785933,0.9825955846482027,1.0,11/45,17.83%,POLG;ERI3;EXOSC7;ERI2;PNLDC1;NOCT;RAD50;DIS3;EXD1;DIS3L;EXOSC3
prerank,NADP binding (GO:0050661),0.27056428119147324,0.7062189465796925,0.8375209380234506,0.9799249127072437,1.0,9/32,17.19%,GMDS;DPYD;NOX1;TM7SF2;MTRR;PGD;LBR;DECR1;CRYZ
prerank,endoribonuclease activity (GO:0004521),0.27142018585484096,0.7051841022312396,0.8564102564102564,0.9785107449805474,1.0,10/32,26.19%,ZC3H12B;SND1;DICER1;ZC3H12C;NYNRIN;CPSF3;AGO1;SMG6;LACTB2;AGO2
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.2859499991689677,0.7032151683876082,0.8519163763066202,0.9780393598778853,1.0,4/25,6.71%,FCHSD2;DAPP1;PLEKHA2;GAB2
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.20672328167436554,-0.702590545778751,0.9497354497354498,0.9906593259030482,1.0,20/57,29.56%,COX4I1;COX6A1;CYB5A;NDUFB7;NDUFS6;UQCR11;COX5B;COX5A;NDUFA4L2;CYBRD1;NDUFS7;NDUFB8;NDUFB5;NDUFA6;NDUFA7;NDUFA13;COX4I2;NDUFA8;UQCR10;NDUFB10
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.33228551693267094,0.7012128892869267,0.8157894736842105,0.9776676962996773,1.0,2/11,17.53%,CHRNA5;CHRNB1
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.2480464002680231,-0.7007590597665198,0.8699763593380615,0.9887150246307569,1.0,4/24,12.49%,ZDHHC9;ZDHHC2;GOLGA7;ZDHHC14
prerank,lysine N-methyltransferase activity (GO:0016278),0.29141684534139545,0.7003747922370277,0.8170289855072463,0.9759254651733832,1.0,5/20,18.15%,SETD7;KMT5A;EHMT2;EHMT1;SETD3
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.2691331605953317,0.6989441833403202,0.8470394736842105,0.9749406799162345,1.0,3/30,8.11%,SLC30A10;SLC30A2;SLC39A13
prerank,CCR chemokine receptor binding (GO:0048020),0.27284929410658354,0.6965455535996005,0.8833922261484098,0.9749052929475982,1.0,5/28,18.06%,DEFB1;CCL25;CCL15;CCR2;MSMP
prerank,DNA polymerase binding (GO:0070182),0.30241995584334674,0.6962894380983641,0.8354430379746836,0.9725672647151914,1.0,3/18,7.97%,ACD;FANCI;SMARCA4
prerank,phosphate ion binding (GO:0042301),-0.3152584219120931,-0.6935829575824571,0.8693877551020408,0.9918629661302443,1.0,4/10,36.31%,PDE2A;RELA;RPH3A;MTHFD2
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.31672584188630803,0.6934897219192621,0.8236397748592871,0.973047653309424,1.0,3/14,13.56%,AK4;NME6;AK8
prerank,protein phosphatase regulator activity (GO:0019888),0.24117575857455265,0.6933762273116232,0.8968253968253969,0.9705417010838261,1.0,11/53,17.09%,PPP2R2B;PPP4R4;DMPK;EIF2AK2;PPP2R1B;PHACTR4;PPP2R5E;LGALS3;PPP4R2;SAG;PPP6R3
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.32533093100299626,0.6920200528120166,0.8192090395480226,0.9693615309172618,1.0,6/12,27.72%,LARP1;NCBP3;GEMIN5;CYFIP2;AGO2;EIF4E2
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.25422509320206405,0.6900807180455408,0.9035947712418301,0.9687850545057535,1.0,17/40,28.43%,DNMT3A;HNMT;LRTOMT;TPMT;ASMT;SETD3;GNMT;METTL4;N6AMT1;METTL9;ICMT;PCMT1;PEMT;DNMT1;THUMPD3;FBLL1;AS3MT
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.31509308214149406,-0.6887966912575133,0.8565310492505354,0.9924439620178139,1.0,3/10,14.21%,ANKRD13A;LAPTM5;FAAP20
prerank,phospholipase inhibitor activity (GO:0004859),0.3340328222439851,0.688338023332633,0.838150289017341,0.9679652635259037,1.0,4/10,21.31%,ANXA5;ANXA9;ANXA2;ANXA4
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.30598478344675367,0.6844437301284584,0.8622641509433963,0.9669852408073761,1.0,3/16,11.06%,ATP6V0E1;ATP6V0B;ATP6V1D
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.30598478344675367,0.6844437301284584,0.8622641509433963,0.9669852408073761,1.0,3/16,11.06%,ATP6V0E1;ATP6V0B;ATP6V1D
prerank,Hsp90 protein binding (GO:0051879),0.2609281457095581,0.6842527081632006,0.8650927487352446,0.9646107633561594,1.0,3/33,3.01%,PTGES3L;PPEF2;HDAC8
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.2617251910028445,0.68084365860717,0.8961038961038961,0.9655227008272244,1.0,1/34,0.77%,UBE2E2
prerank,kinesin binding (GO:0019894),-0.23002306704572412,-0.6781967138222595,0.917312661498708,0.9984156028753209,1.0,9/27,28.83%,ACTB;SNCA;NEFH;NEK6;SPAG9;PRC1;CLSTN1;AP1AR;TTBK2
prerank,organic cation transmembrane transporter activity (GO:0015101),0.29090167684151447,0.6715724320688077,0.8495575221238938,0.9720221541781756,1.0,5/16,19.67%,SLC22A5;SLC25A42;SLC25A17;SLC25A26;SLC22A4
prerank,carboxy-lyase activity (GO:0016831),0.2720838781796946,0.6676663603687626,0.8667820069204152,0.9732747460190636,1.0,7/23,22.17%,AZIN1;MLYCD;ACOD1;ECHDC1;AZIN2;MVD;GGCX
prerank,FMN binding (GO:0010181),-0.2883251959170814,-0.6638428900421581,0.8812877263581489,1.0,1.0,2/11,12.67%,NOS3;NOS1
prerank,death domain binding (GO:0070513),-0.28780612295669583,-0.6612720301651899,0.8764568764568764,1.0,1.0,3/11,15.70%,DAPL1;DAP;CRADD
prerank,methyltransferase activity (GO:0008168),0.23491165606089026,0.6559774254866259,0.930379746835443,0.9815825878394441,1.0,13/46,22.70%,LRTOMT;COQ5;ASMT;MGMT;METTL27;EHMT1;BUD23;NSUN4;METTL4;NDUFAF7;N6AMT1;AMT;EEF1AKMT1
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.2833481052148929,0.6538215408006267,0.8708487084870848,0.980860363924561,1.0,1/16,2.38%,MACROD1
prerank,microtubule motor activity (GO:0003777),0.22937997192848553,0.6529918327470282,0.9440124416796267,0.9789997749421058,1.0,7/51,13.39%,KIF13B;KIF2A;KIF3C;KIF1B;KIF1C;KIFC1;KIF5B
prerank,glutathione transferase activity (GO:0004364),0.26160488552472816,0.6446925905339866,0.9024822695035462,0.9831954744803054,1.0,2/23,10.04%,GSTT1;GSTA3
prerank,mannose binding (GO:0005537),-0.2814425293800698,-0.6428954749514068,0.9039665970772442,1.0,1.0,3/12,18.92%,LMAN2L;LMAN2;CLN5
prerank,single-stranded RNA binding (GO:0003727),0.2322931468180139,0.6399831982201677,0.9309262166405023,0.9844130610835924,1.0,15/43,26.19%,DDX3X;ZCCHC13;POLR2D;JMJD6;DDX60;DHX58;ILF3;SNRPC;POLR2G;FMR1;U2AF2;AGO1;LACTB2;AGO4;AGO2
prerank,DNA replication origin binding (GO:0003688),-0.2309352016405786,-0.6396571762549118,0.9418103448275862,1.0,1.0,5/23,17.83%,POLA1;DHX9;ORC5;ORC2;CDC45
prerank,antiporter activity (GO:0015297),0.2691739070627114,0.6396091213455505,0.8953687821612349,0.9821459098217219,1.0,4/20,15.67%,TMEM241;SLC25A11;SLC35D1;SLC25A10
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.3000878734622145,0.6395057130866681,0.8495238095238096,0.9796890722937379,1.0,11/11,70.01%,FBXO11;NDUFAF7;PRMT2;PRMT7;PRMT6;PRMT9;CARM1;PRMT3;PRMT1;PRMT5;PRMT8
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.29665003793995065,0.6389350912590945,0.8877952755905512,0.9776625057897663,1.0,3/12,10.43%,ATM;PIK3CA;PIK3R3
prerank,thioesterase binding (GO:0031996),0.29532104825308886,0.633840876234601,0.8745098039215686,0.9792566207353502,1.0,2/11,11.35%,ADRA2A;CDC42
prerank,neuropeptide binding (GO:0042923),0.26730711045300215,0.6303653644507298,0.9171270718232044,0.9794587539168228,1.0,2/18,9.20%,SSTR3;NMUR1
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.2579514187272405,-0.6276122485140663,0.9010309278350516,1.0,1.0,6/13,37.96%,METTL1;THUMPD2;TRMT11;TRMT10C;TRMT5;TRMT10A
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.29740804598171977,0.6250350480962763,0.9001996007984032,0.9806438606629294,1.0,2/10,10.42%,NOX1;NOX4
prerank,endodeoxyribonuclease activity (GO:0004520),-0.2314471301632249,-0.6181704311902821,0.9370786516853933,1.0,1.0,4/20,18.55%,RPS3;ERCC1;ENDOV;DNA2
prerank,channel activity (GO:0015267),-0.19785129664963014,-0.6180933867074729,0.9841269841269841,1.0,1.0,8/41,18.74%,AQP4;AQP11;TRPV4;MCUB;CHRNA7;TMEM266;PANX1;TRPA1
prerank,ribonuclease activity (GO:0004540),0.21828172175631033,0.6179334889116623,0.9744360902255639,0.9830110090490862,1.0,12/56,22.90%,ZC3H12B;SAMHD1;EXOSC7;SND1;DICER1;ZC3H12C;NYNRIN;CPSF3;EXOSC3;RNASE12;AGO1;SMG6
prerank,MHC protein binding (GO:0042287),-0.229165358286755,-0.6139520888070666,0.9608695652173913,1.0,1.0,20/20,77.12%,TAP1;CD74;CD81;ATP5F1B;CD8B;COL2A1;KIR3DL2;TUBB;PILRA;FCRL6;ATP5F1A;CD4;TUBB4B;CD8A;LILRB1;TAP2;TAPBP;LAG3;DERL1;ABCB9
prerank,NADPH binding (GO:0070402),0.28706725878761963,0.6116651311919183,0.903041825095057,0.9848353393219533,1.0,5/13,19.29%,MTRR;LBR;DECR1;CRYZ;DUS2
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),-0.2598974042455618,-0.6083520335612332,0.9408033826638478,1.0,1.0,4/14,17.71%,CAPN2;CAPN10;CAPNS1;CAPN6
prerank,acetylcholine receptor activity (GO:0015464),0.24946171680887957,0.6057646854012934,0.9314586994727593,0.9860747512865455,1.0,5/22,17.53%,CHRNA5;CHRNG;ANXA9;CHRM1;CHRNB1
prerank,pseudouridine synthase activity (GO:0009982),-0.2444475551948842,-0.60095803603348,0.9344608879492601,1.0,1.0,8/13,38.31%,PUS1;PUS7;TRUB1;DKC1;RPUSD3;RPUSD2;TRUB2;PUS7L
prerank,sequence-specific mRNA binding (GO:1990825),-0.2736343957078383,-0.5962783569234584,0.9096385542168675,1.0,1.0,3/10,26.22%,SHFL;DHX9;RBM24
prerank,retinoic acid receptor binding (GO:0042974),-0.230507528481394,-0.5955691587249777,0.9485458612975392,1.0,1.0,1/17,0.92%,ACTN4
prerank,mRNA methyltransferase activity (GO:0008174),-0.2518187207760848,-0.593704642444406,0.9419642857142857,1.0,1.0,2/12,15.42%,TRMT61B;METTL3
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.2631635041199982,-0.5917749042300868,0.9330543933054394,1.0,1.0,5/10,39.11%,DPYSL5;OPLAH;DPEP1;DPYS;DPYSL2
prerank,transferrin receptor binding (GO:1990459),-0.2676800863885517,-0.5903397691942739,0.9572815533980582,1.0,1.0,3/10,27.62%,IKBKB;CD81;SNX4
prerank,H4 histone acetyltransferase activity (GO:0010485),0.2781187962599723,0.587588414153971,0.9064885496183206,0.9942591215531184,1.0,6/10,31.35%,ATF2;EP300;MSL3;NAA50;NAA60;NAA40
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.24180410188121332,-0.587289820169995,0.94824016563147,0.9982470013566958,1.0,3/14,10.68%,NCF2;AIFM1;CYBA
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.2658184485405766,0.5805684917565331,0.9207207207207208,0.9954657672117799,1.0,3/14,12.65%,USP9X;DESI2;USP7
prerank,thiol-dependent deubiquitinase (GO:0004843),0.19190344366842524,0.579915491975588,0.9926686217008798,0.9933153758126815,1.0,27/83,23.44%,USP3;USP9X;USP24;USP11;USP34;USP49;DESI2;USP12;USP7;USP18;USP37;UFD1;USP39;USP48;USP1;USP33;USP21;USP16;USP35;TANK;MPND;OTUD3;USP5;USP20;OTUD4;USP9Y;OTUB2
prerank,RNA cap binding (GO:0000339),-0.23191998920970183,-0.578313774685944,0.9584295612009238,0.998338671024968,1.0,5/16,23.46%,EIF4E;EIF4A1;LSM1;EIF3D;NCBP2
prerank,metalloaminopeptidase activity (GO:0070006),-0.22999630560771772,-0.5704309872257529,0.9606986899563319,0.9978367252422797,1.0,5/16,22.66%,ENPEP;MMP16;MMP15;TRHDE;RNPEPL1
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.22384379903094886,-0.5625405796239594,0.9720930232558139,0.9969180318243522,1.0,5/15,27.75%,P2RY12;P2RY1;GPR34;P2RY14;P2RX7
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.2382538814148417,0.5544340876716022,0.9623655913978495,1.0,1.0,2/18,12.67%,DHRS11;SRD5A2
prerank,MHC class I protein binding (GO:0042288),-0.2290646578782172,-0.5528814014624804,0.9693877551020408,0.9965368795681054,1.0,13/13,77.12%,TAP1;ATP5F1B;CD8B;TUBB;PILRA;ATP5F1A;TUBB4B;CD8A;LILRB1;TAP2;TAPBP;DERL1;ABCB9
prerank,snRNA binding (GO:0017069),0.2068032378481756,0.5522941446281875,0.9874411302982732,1.0,1.0,12/42,25.95%,SNRNP70;CCNT2;LARP7;HEXIM2;EFTUD2;SNRPC;PRPF31;SNRPA1;TUT1;RNPC3;GEMIN5;SF3B3
prerank,exonuclease activity (GO:0004527),0.20097742710145874,0.5498354478535037,0.9787878787878788,0.9992041484043076,1.0,11/46,20.25%,POLG;ENPP3;EXOSC7;RAD50;REXO5;CPSF3;EXD1;EXOSC3;FEN1;DXO;RAD9A
prerank,telomerase RNA binding (GO:0070034),0.2208634549615349,0.5415725854775403,0.9695945945945946,0.9999692440156944,1.0,7/22,24.74%,TEP1;TERT;HNRNPC;TENT4B;SMG6;XRN1;PINX1
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.17711054044691688,-0.538524033816638,0.9947643979057592,0.9973458372177745,1.0,13/35,29.52%,FOXP1;H3-3A;KLF10;TAF1B;ZBTB17;NPM1;RUVBL2;RELA;DR1;POU2F1;DRAP1;FOS;PARK7
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.24220896102008618,0.5381908954528319,0.9263351749539595,0.9987662433151804,1.0,5/12,23.15%,HDAC1;TBP;TAF1;GTF2A1;TBPL1
prerank,four-way junction DNA binding (GO:0000400),0.22624713668689134,0.5237426798910468,0.9616858237547893,1.0,1.0,5/17,21.99%,FANCM;ABL1;RAD51D;XRCC3;YY1
prerank,damaged DNA binding (GO:0003684),0.19078104711047322,0.5230635656672324,0.9935794542536116,0.9988839642537872,1.0,11/44,19.52%,RBBP8;PNKP;TDG;DDB2;SDE2;CREBBP;OGG1;NBN;FEN1;APTX;XPA
prerank,tumor necrosis factor receptor binding (GO:0005164),0.24218207289140686,0.520806708810854,0.9540441176470589,0.9970777227624201,1.0,1/12,4.00%,BABAM2
prerank,5'-3' exonuclease activity (GO:0008409),-0.20733468582374118,-0.5045962985929174,0.9862385321100917,1.0,1.0,3/14,21.06%,TRIR;XRN2;DCP2
prerank,nuclear localization sequence binding (GO:0008139),0.21124965300758902,0.4910694979545618,0.9799270072992701,1.0,1.0,2/18,10.56%,TNPO1;KPNA6
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.22572343230180172,0.49000426579305456,0.9688109161793372,1.0,1.0,12/12,77.44%,CRYZ;CRYZL1;CBR4;NQO1;AIFM2;ADH4;AKR1C1;CBR1;DHRS4;NQO2;DCXR;NDUFS7
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",-0.16433661793806098,-0.4867341173028726,0.9953917050691244,1.0,1.0,10/28,33.72%,ELAC1;DROSHA;RNASEH2A;ENDOV;POP4;APEX1;NUDT16;RPP30;AGO3;RNASEH1
prerank,microtubule minus-end binding (GO:0051011),-0.20069052102950408,-0.4784979048730432,0.9823399558498896,0.999093582024827,1.0,13/13,79.95%,TUBGCP2;HAUS4;TUBGCP6;CAMSAP3;CEP290;CAMSAP2;TUBGCP3;HAUS7;NUMA1;MACF1;TUBGCP5;CAMSAP1;TUBGCP4
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.2203590197958128,0.4742586314156298,0.9832089552238806,1.0,1.0,4/12,21.98%,CISD3;ISCA1;SDHB;CISD2
prerank,U6 snRNA binding (GO:0017070),0.21501663632368642,0.4658143447515195,0.9741219963031423,0.9997647259996101,1.0,14/14,78.52%,LARP7;TUT1;LSM3;DDX39B;PRPF4;METTL16;SART3;EIF5A;PRPF8;LSM2;RBM22;LSM8;LSM7;LSM4
prerank,phosphatase inhibitor activity (GO:0019212),-0.17019819829592614,-0.45611670740475907,0.9915966386554622,0.9985199566719957,1.0,2/20,8.73%,MGAT5;PTN
prerank,exoribonuclease activity (GO:0004532),0.21203941999874443,0.4455328140285371,0.9806201550387597,1.0,1.0,12/12,78.81%,EXOSC7;EXOSC3;EXOSC8;EXOSC9;CNOT6;EXOSC5;ZC3H12A;EXOSC2;EXOSC1;EXOSC4;EXOSC10;CNOT7
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),-0.20056800170990954,-0.4430157496709323,0.9940476190476191,0.9962683666329784,1.0,5/10,38.66%,CDKN1A;CDKN2B;HEXIM1;CDKN2D;CDKN1B
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.16676095291973128,0.43953615021346476,0.9964973730297724,0.9962575291833003,1.0,34/34,83.36%,NDUFS1;NDUFV2;NDUFS4;NDUFA2;NDUFS5;NDUFA9;NDUFB2;NDUFS2;NDUFA12;NDUFB4;NDUFS8;NDUFV3;NDUFB9;NDUFA1;NDUFA10;NDUFV1;NDUFA5;NDUFS3;NDUFB6;NDUFA4;NDUFA3;NDUFC1;NDUFB3;NDUFC2;NDUFB10;NDUFA8;NDUFA13;NDUFA7;NDUFA6;NDUFB5;NDUFB8;NDUFS7;NDUFS6;NDUFB7
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.16676095291973128,0.43953615021346476,0.9964973730297724,0.9962575291833003,1.0,34/34,83.36%,NDUFS1;NDUFV2;NDUFS4;NDUFA2;NDUFS5;NDUFA9;NDUFB2;NDUFS2;NDUFA12;NDUFB4;NDUFS8;NDUFV3;NDUFB9;NDUFA1;NDUFA10;NDUFV1;NDUFA5;NDUFS3;NDUFB6;NDUFA4;NDUFA3;NDUFC1;NDUFB3;NDUFC2;NDUFB10;NDUFA8;NDUFA13;NDUFA7;NDUFA6;NDUFB5;NDUFB8;NDUFS7;NDUFS6;NDUFB7
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.13519111278478627,0.28326583666090344,1.0,0.9999950982074145,1.0,10/10,86.49%,DESI2;OTUD4;STAMBP;STAMBPL1;ATXN3;OTUD5;USP27X;CYLD;TNFAIP3;YOD1
